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The aim of the current work was twofold. First, to develop methods that allow for 
the useful integration of distinct methods of examining the human brain, namely 
positron emission tomography and functional magnetic resonance imaging. Second, 
to apply these methods to better understand the neurobiological mechanisms 
underlying the pathways between environmental exposures, schizophrenia, and 
psychotic symptoms.  
 
The introductory chapter provides an overview of the schizophrenia concept, the 
neurobiological systems under examination, and the methodologies used. Chapter 2 
is a review article that discusses recent developments in our understanding of 
striatal structure and function, and specifically how striatal dysfunction may 
underlie many of the symptoms observed in schizophrenia. A specific issue 
discussed in Chapter 2 is, where precisely does striatal dopamine dysfunction occur 
in schizophrenia? Chapter 3 attempts to answer this using a quantitative approach. 
A meta-analysis of all studies that have used positron emission tomography (PET) 
to measure striatal dopamine function in schizophrenia, shows that dopamine 
dysfunction displays marked spatial variability, and does not occur uniformly 
across the striatum. I find that dopamine dysfunction occurs predominantly in the 
associative striatum, refuting the hypothesis that dysfunction within the limbic 
striatum specifically underlies psychotic symptoms.  
 
Chapter 4 builds on the results of the meta-analysis and uses an integrative PET-
fMRI approach to ask whether spatial variability in striatal dopamine function 
shapes psychopathology in psychosis. I show that dopamine function within striatal 
regions functionally linked to cortical sensorimotor networks is associated with 
baseline motor symptoms, while negative and affective symptoms, are linked to 
dopamine function in striatal regions linked to default mode and cinguloopercular 
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networks respectively. Chapter 5 again looks at the question of psychopathology, 
but here I study individuals who have been exposed to risk factors for psychosis, 
but who have not yet developed a psychiatric disorder. I show that exposure to 
environmental risk factors is associated with reduced adaptive and increased 
aberrant salience measures. I also find that these differences in behaviour are 
related to differences in corticostriatal connectivity 
 
Finally, Chapter 6 uses PET and fMRI to answer an ongoing question regarding 
neurobiological mechanisms underlying salience processing. Specifically – what is 
the relationship between mesolimbic dopamine function and the cortical salience 
network? This is a question of interest because both neural systems share an 
overlapping role and have been implicated in psychotic disorders. I show that while 
striatal dopamine release capacity is associated with reduced salience network 
connectivity, striatal dopamine synthesis capacity is associated with greater 
connectivity within the salience network, and that this is particularly the case for 
‘hub’ nodes playing a central role in information processing. 
 
In summary, I show that dopamine dysfunction in schizophrenia does not exist 
uniformly across the striatum, but is greatest in the associative striatum. The 
clinical relevance of this is demonstrated by the finding that psychotic symptoms 
relate to variation in the spatial profile of striatal dopamine dysfunction. In 
addition, I find that striatal connectivity is altered in individuals exposed to 
environmental risk factors. Finally, I show how systems known to be crucial to 
salience processing are linked. Together these findings advance our understanding 
of schizophrenia by suggesting mechanisms via which striatal and cortical function 
are linked, how risk factors are associated with neurobiological changes, and how 
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Schizophrenia accounts for a huge proportion of the global health care burden,1,2 
despite a lifetime prevalence of less than 1%.3 The fact that a relatively rare disorder 
is associated with such burden is because it strikes at an early age, and often has an 
impact sufficiently severe to alter an individual’s entire life trajectory.4  It is a 
disorder that can be life altering, not only for the person affected, but for families 
and communities as a whole.  
 
Schizophrenia’s place as a central object of study in both medical and neuroscientific 
research is not only a result of these economic and social costs, but also due to the 
broader questions that it poses. It is a disease that disrupts the very identity of an 
individual. The question as to how risk factors that lead to neurobiological alterations 
are then translated into disruptions of mind, is relevant both for understanding the 
disease process, and as a window into understanding how the world, brain function, 
and conscious experience are inexorably linked. 
 
The disease has been recognised throughout history, but the clear portrayal of a 
distinct syndrome occurs around the end of the 19th century with Emil Kraeplin’s 
detailed descriptions of a dementia praecox.5 Kraeplin paid particular attention to 
the chronic course of the illness, which he believed was typically accompanied by an 
ongoing deterioration in general intellectual capabilities. The illness subsequently 
became more commonly known as schizophrenia – a term coined by Eugen Bleuler 
in order to emphasise the splitting between emotional and intellectual functions that 
he proposed were central to the pathogenesis of the illness.6 These narrative 
descriptions, however, were open to interpretation, and it became apparent that the 
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threshold for diagnosis was poorly defined and thus problematic with regards to 
diagnostic reliability.7 The development of the operationalised criteria of the DSM-
III addressed this issue and led to the codification of the central features of the 
disorder that remain in clinical use today.7 
 
Although the use of standardised criteria helped to address issues regarding 
reliability, the validity of the schizophrenia concept has also been questioned.8 As 
knowledge regarding the aetiology of schizophrenia has increased, it has become clear 
that multiple pathways may lead to the development of symptoms that meet 
diagnostic criteria for the disorder.9–11 Furthermore, many risk factors,12 and 
neurobiological features associated with the illness, are observed across diagnostic 
categories.13–15 Attempts have been made to develop a neurobiologically based 
classification system,16 but the limitations of current biomarkers mean progress has 
been limited. It is currently unclear how to cross the tautological impasse inherent 
in the fact that the diagnostic gold standard remains that of clinical assessment.  
 
Some areas of research that may contribute to advancing past this point are as 
follows. First, a more detailed understanding of the neurobiological abnormalities 
seen in psychotic disorders; second, an examination of the links between risk factors 
and neurobiological alterations; third, investigation of the links between 
neurobiological alterations and symptoms; and fourth, greater understanding of how 
different neurobiological systems implicated in psychotic disorders interact.  
 
This thesis reports the results of several experiments undertaken to investigate these 
ongoing questions regarding the pathways between exposures, neurobiological 
alterations, and phenotype. Specifically, it examines: 
 
i) The precise location of striatal dopamine dysfunction in schizophrenia  
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ii) How variability in the location of striatal dopamine dysfunction is 
linked to symptoms in first-episode psychosis 
iii) The relationship between risk factor exposure, neurobiological 
alterations, and psychopathological sequelae 
iv)  The relationship between striatal dopamine and cortical connectivity 
– two systems that have been frequently proposed to underlie the schizophrenia 
syndrome 
 
In the remainder of this introduction these various topics are briefly discussed, with 
subsequent in-depth discussion in Chapter 2, as well as in the introductory sections 
of later chapters. 
 
 
Risk factors for Schizophrenia 
 
Genetic factors 
Initial evidence for a genetic contribution to schizophrenia liability came from twin 
studies. These demonstrated that concordance rates were greater in monozygotic 
compared to dizygotic twins, calculating heritability to be around 80%.17 Recent 
large scale twin studies using population registers and modern diagnostic criteria are 
in agreement with these earlier estimates of heritability.18 
 
Given this observed heritability, great efforts have been made to characterise the 
specific genetic underpinnings of schizophrenia. Initial genome sequencing studies, 
were limited by the number of single nucleotide polymorphisms they could examine, 
and therefore investigated genes that were a priori hypothesised to play a role in the 
development of schizophrenia. Recently, however, technological advances and falling 
costs have made it possible to undertake genome wide association studies (GWAS), 
allowing an unbiased, data-driven approach in which no candidate genes are 
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prespecified.19 These GWAS have found that most of the original candidate genes 
show no significant association with schizophrenia.20 In addition, they have provided 
evidence that in most individuals the genetic contribution is best understood as 
resulting from multiple common variants of small effect, rather than any single locus 
contributing large amounts of risk. 
 
The development of GWAS has also enabled the construction of polygenic risk scores. 
These allow one to calculate the odds ratio for an individual having schizophrenia 
based on their genetic loading. Individuals with greater genetic loading tend to have 
more severe symptoms, and may show a poorer response to antipsychotic drug 
treatment,21,22 although the clinical utility of this remains to be seen given that the 
finding has not been consistently replicated, perhaps due to the relatively small effect 
sizes observed.23 
 
The complexity of the pathway between genotype and phenotype is illustrated by 
the recent finding that there was no relationship between loci implicated in 
schizophrenia and subcortical brain volumes.24 This suggests that factors other than 
genetics may be driving the subcortical volumetric abnormalities in schizophrenia. It 
is apparently that despite the high degree of heritability environmental factors play 




It has become increasingly clear that a range of environmental factors are likely to 
both have an impact both on schizophrenia risk, and on illness course.26 For some of 
these, direct neurobiological links between exposure and neurobiological alteration 
can be conceived, for example although the precise mechanisms await complete 
elucidation,27,28 risk factors such as cannabis use and perinatal complication may 




For other risk factors such as childhood adversity, migration, and urbanicity it the 
path to neurobiological consequence is less clear.29–32  Some progress in understanding 
potential pathways has been made by conceptualising these risk factors as chronic 
psychosocial stressors.9,11,33 The study of individuals exposed to risk factors, but 
without a diagnosis of mental disorder, has the potential to advance understanding 
of the pathoaetiological pathway between exposure and disease. The study of disease-
free individuals has the advantage that the effect of risk factor exposure is not 
obscured by the presence of disease, nor the effects of treatment. A number of recent 
studies have used magnetic resonance imaging to investigate how exposure to 
environmental risk factors affects brain structure and function. A number of recent 
studies have used magnetic resonance imaging to investigate how exposure to 
environmental risk factors affects brain structure and function.34–38 These studies 
typically investigate single risk factors at a time. In reality, however, these exposures 
tend to cluster, and may share common underlying mechanisms.39–41 In Chapter five 
below I report the findings of a study examining individuals exposed to multiple 
environmental risk factors, with a view to investigating what effect such exposure 
has upon brain function and cognitive mechanisms implicated in psychosis. 
Specifically, how exposure to chronic psychosocial stress affects corticostriatal 
functional connectivity, and how this is linked to salience processing. 
 
20 
Dopamine and Brain Networks in Schizophrenia 
 
In addition to our increasing understanding of the pathoaetiology of schizophrenia, 
significant progress has been made in our knowledge regarding the neurobiological 
correlates of the disorder. 
 
The Role of Dopamine in Normal Brain Function 
Following its identification, dopamine was initially thought to have no biological 
purpose, and to existing only as an intermediary in the pathway between tyramine 
and noradrenaline.42 In the 1950s, this view was challenged by a series of experiments 
performed by Arvid Carlsson and colleagues. These demonstrated that the movement 
inhibiting effects of reserpine could be ameliorated by administration of the dopamine 
precursor L-DOPA, and that this was linked to the synthesis of dopamine (not 
noradrenaline) within the brain.43 Furthermore, Carlsson’s group found large 
amounts of dopamine in the brain, in areas of low noradrenaline, supporting the 
hypothesis that dopamine was an independent neurotransmitter.44 
 
Soon after these initial experiments distinct dopamine pathways were identified. 
Dopamine neurons originating within the midbrain were shown to project to both 
the striatum (the mesostriatal pathway) and cortex (mesocortical pathway). The 
mesostriatal pathway includes both mesolimbic projections (from the ventral 
tegmental area to limbic striatum), and nigrostriatal projections (from the substantia 
nigra to dorsal striatum).45 The tuberinfundibular pathway transmits dopamine from 
the infundibular nucleus of the hypothalamus to the median eminence of the 
pituitary gland. The striatum receives topographically localised inputs from the 
cortex, and can be divided into three functional subdivisions based on the topography 
of these cortical afferents. The limbic striatum (also known as ventral striatum) 
receives inputs from limbic areas of the brain such as the medial prefrontal cortex 
and amygdala, the associative striatum receives inputs from the dorsolateral 
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prefrontal cortex, while the sensorimotor striatum receives inputs from sensory and 
motor cortex.46,47  
 
Work by Mawlawi and others defined a set of boundaries for these subdivisions that 
have subsequently been used in several PET studies.47 The ‘dorsal putamen’ here is 
equivalent to the ‘motor striatum’ subdivision mentioned in several later chapters, 
and the ‘dorsal caudate’ is equivalent to the ‘associative striatum’. The boundary 
between the limbic striatum (inferiorly), dorsal caudate, and dorsal putamen 
(superiorly) consists of a line between (a) the intersection between the outer edge of 
the putamen with a vertical line going through the most superior and lateral point 
of the internal capsule; and (b) the centre of the portion of the anterior commisure 
transaxial plane overlying the striatum. This line is extended to the internal edge of 
the caudate. The other boundaries of the ventral striatum are easily distinguished 
due to its dense signal on MRI. The ventral striatum is sampled from the anterior 
boundary of the striatum to the level of the anterior commissure coronal plane. 
Similarly, the dorsal caudate is also sampled from its anterior boundary to the 
anterior commisure coronal plane. In total, for the dorsal caudate, the sampled region 
includes the dorsal part of the head of the caudate and the anterior third of the body 
of the caudate. The dorsal putamen is sampled from its anterior to posterior 
boundaries. In slices posterior to the anterior commisure plane, the medial boundary 
of the dorsal putamen is the globus pallidus. 
 
For figures giving an overview of these boundaries, for summary descriptions of the 
subdivisions, and for more in-depth discussion of dopamine pathways, and in 
particular the differences between primate and rodent pathways see Chapter 2. 
 
Mesostriatal dopamine neurons have since been shown to signify the discrepancy 
between expected and actual rewards – a ‘reward prediction error’.48 The concept of 
a prediction error expands beyond reward, and a prediction error can be considered 
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to occur in a more general sense whenever a mismatch between prior expectations 
and reality arises. This more general prediction error is closely related to the concept 
of ‘salience’, which refers to the extent to which a stimulus stands out from its 
surroundings and is thereby able to capture attention. This ‘standing out’ can occur 
secondary to various qualities of the stimulus, perceptual salience refers to attributes 
such as colour and shape, motivational salience refers to a stimulus’s ability to 
engender motivated behaviour (due to its incentivising or aversive properties), and 
surprise or novelty salience refers to the unexpectedness of a stimulus.49,50 It has 
been suggested that dopamine neurons convey information regarding the general 
salience of environmental stimuli, over and above purely reward related 
information,51 and recent findings suggest that aspects of striatal dopamine signalling 
do not track value but rather factors such as novelty and intensity, and in particular 
threat related information.52,53 
 
 
Dopamine Function in Schizophrenia  
A link between dopamine and schizophrenia came about as a result of a number of 
complementary pieces of evidence. Preclinical experiments in the early 1960s had 
suggested that the blockade of monoamine receptors accounted for the clinical effects 
of antipsychotics, but dopamine was not specifically implicated. It was not until the 
1970s, two decades after their introduction, that the clinical effects of antipsychotics 
were specifically linked to their action on dopamine receptors.54,55 Additional 
evidence implicating dopamine in schizophrenia came from findings demonstrating 
that substances that increased dopaminergic neurotransmission could induce 
psychotic symptoms in healthy individuals, and worsen symptoms in patients.56,57 
Initial direct evidence for dopaminergic abnormalities in schizophrenia came from 
post-mortem studies.58,59 These demonstrated striatal dopaminergic abnormalities in 
patients with schizophrenia, but findings were inconsistent. A major limitation was 
also the fact that samples were mostly from individuals that had received extended 
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periods of antipsychotic treatment, and so it was impossible to determine whether 
abnormalities were a result of the disease as opposed to treatment.  
 
The findings discussed implicated dopamine in the pathophysiology of schizophrenia, 
but only indirectly or after death. Positron emission tomography (PET) and single 
photon emission computed tomography (SPECT) allow for the characterization of 
the dopamine system in living individuals. This means that dopamine function can 
be investigated in patients prior to treatment with dopamine antagonists. The 
consensus established from meta-analysis of these studies is that schizophrenia is 
associated with increased striatal presynaptic dopamine synthesis and release 
capacity.60  The question as to whether post-synaptic abnormalities exist is nuanced, 
and awaits a definitive answer.61 Due to the relatively low density of dopamine 
receptors, and difficulties in generating accurate ligands for D1 receptors imaging of 
the mesocortical system has been challenging, but recent evidence suggests that 
cortical dopamine release may be reduced in schizophrenia.62 
 
Early theories of dopamine dysfunction schizophrenia posited that 
hyperdopaminergia within the mesolimbic pathway might be specifically linked to 
psychotic symptoms. The mesolimbic hypothesis originated with observations that 
epileptic seizures within limbic areas were associated with psychotic symptoms,63 
and that electrodes implanted in limbic areas were active during periods of 
psychosis.64 A link to dopamine specifically, came from animal work linking 
hyperdopaminergia within the limbic striatum to psychotic-like behaviors, and 
experiments showing that dopamine antagonism within these same areas was 
necessary and sufficient for extinguishing these behaviours.65 
 
In recent years, the improved resolution of PET cameras has allowed for 
measurement of dopamine function within functional subdivisions of the striatum. 
This in turn allows for direct testing of the mesolimbic hypothesis, which I undertake 
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in Chapter 3. In addition, potential pathophysiological mechanisms linking striatal 
dopamine dysfunction and psychotic psychopathology are discussed further in 
Chapter 2. One of these mechanisms is examined in Chapter 4, where I examine 
whether spatial variability in aberrant striatal dopamine function is mirrored by 
variability of psychotic symptoms. 
 
Brain Networks 
In contrast to the view that schizophrenia results from a localised lesion, it has also 
been proposed that the disease can be understood as a disorder of connectivity.66,67 
Two neuroimaging techniques have primarily been employed to investigate brain 
connectivity in schizophrenia. Diffusion weighted imaging allows for the 
identification of white matter pathways and this has been used to quantify what has 
been termed anatomical or structural connectivity. In contrast, functional 
connectivity can be measured using fMRI and refers to a statistical relationship (often 
a correlation), between the activity of different brain regions. 
 
Studies investigating both anatomical and functional connectivity have 
demonstrated widespread disruptions of brain networks in schizophrenia.68–70 
Recently a number of studies have highlighted the role aberrant function of a specific 
network, the salience network, may play in schizophrenia.14,71–74 In addition, recent 
meta-analyses synthesising structural and functional imaging data have identified 
this network as uniquely affected across psychiatric disorders.13,14 The salience 
network (also referred to as the cingulo-opercular network), is centred around the 
anterior insula and dorsal anterior cingulate, and has been proposed to contain 
subcortical structures such as the limbic striatum and substantia nigra. This network 
plays a central role in identifying relevant internal and external stimuli, and 
switching between the default mode network and task positive frontoparietal 




Both mesostriatal dopamine neurons and the salience network play overlapping roles 
in the identification of behaviourally relevant stimuli, and both systems show 
aberrant functioning in psychotic illness. The relationship between these two 
systems, however, is not well understood. I attempt to address this in Chapter 6, 
where PET was used to measure both dopamine synthesis and release capacity, while 




Two methods were used to investigate brain function. PET allows for the in vivo 
quantification of neurochemical functioning, while resting state MRI allows for the 
characterisation of functional brain networks. 
 
Positron Emission Tomography 
Prior to undertaking a PET scan, it is necessary to manufacture a suitable 
radiotracer.  This involves the labeling of a biologically relevant compound with a 
radionuclide such as carbon-11 (11C) or fluorine-18 (18F). The labelled compound is 
subsequently injected intravenously into the participant. The participant is placed 
in the PET scanner and as the radionuclide undergoes positron emission decay it 
emits a positron. The positron travels (typically less than 1mm) until it interacts 
with an electron – annihilating both particles and emitting a pair of gamma rays 
travelling in opposite directions. The gamma rays are detected by a scintillator 
within a detection ring and the process of image reconstruction allows the original 
position of the radionuclide, and thereby the compound of interest, to be imputed. 
 
In the studies reported, two radioligands were employed - 3,4-dihydroxy-6-
[18F]fluoro-L-phenylalanine (18F-DOPA) and [11C]-(+)-4-propyl-9-hydroxy-
naphthoxazine (11C-(+)-PHNO). 18F-DOPA PET measures the rate constant 
(Kicer) for 18F-DOPA uptake, transport into synaptic vesicles, and its conversion 
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into 18F-dopamine, thus providing a measure of dopamine synthesis capacity.79 11C-
(+)-PHNO is a D2/3 agonist and provides a means to quantify dopamine receptor 
density within the striatum. A placebo scan gives a measure of baseline D2/3R 
availability (non-displaceable binding potential, BPND), while a scan following 
dexamphetamine administration allows quantification of the change in BPND due 
to competition from increased synaptic dopamine concentrations. The percentage 
reduction in D2/3R availability between placebo and dexamphetamine scans thus 
provides an index of dopamine release capacity.  
 
PET is used in most of the chapters in this thesis. Chapter 3 is a meta-analysis of 
PET studies examining the dopamine system in schizophrenia, Chapter 4 uses 18F-
DOPA PET to measure striatal dopamine function in individuals with a first episode 
psychosis, while Chapter 6 uses both 18F-DOPA and 11C-PHNO to relate striatal 
dopamine function to salience network connectivity. 
 
Functional Magnetic Resonance Imaging 
Functional magnetic resonance imaging is provides a measure of brain activity. It is 
an indirect method in that it primarily measures blood flow, from which neural 
activity is estimated. Oxygenated haemoglobin is a diamagnetic molecule whereas 
deoxygenated haemoglobin is paramagnetic. Neural activity brings with it a demand 
for glucose, and this demand is met by increased bloodflow to the active area. The 
increased bloodflow is composed of blood that contains a greater proportion of 
oxygenated haemoglobin – leading to a measurable change in the magnetic properties 
of the region in question that can be detected using MRI.80 
 
Initial studies focused on using this technique to identify regions of the brain that 
increased in activity when performing a task. Work by Biswal, Raichle and others 
began to use functional MRI to systematically characterise the activity of the brain 
in conditions where an explicit task was not being performed.81,82 It has subsequently 
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been shown that activity within networks of brain regions is temporally correlated 
even in the absence of explicit external demands,83 and furthermore that these 
networks underlie human cognition and behaviour.84,85 
 
Resting state MRI is employed to study functional brain connections in three 
chapters of the present thesis. Chapter 4 uses corticostriatal connectivity measures 
to parcellate the striatum based on its cortical connections, and to see how dopamine 
function within these parcels relates to psychotic symptoms. Chapter 5 employs a 
seed to voxel approach to investigate corticostriatal connectivity and examines how 
this relates to exposure to environmental risk factors for psychosis, while Chapter 6 
uses a graph theoretical approach to investigate the network structure of the salience 
network and how this relates to striatal dopamine function. 
 
 
Aims and Hypotheses 
 
The overall intention of the work was to use a multimodal approach to better 
understand the pathoaetiological processes underlying psychotic symptomatology. 
More specifically, I aimed to achieve the following: 
 
• Chapter 2: To characterize the current state of scientific knowledge regarding 
striatal structure and function, in terms of both normal physiology, and the 
dysfunction observed in schizophrenia. 
 
• Chapter 3: To synthesise the results of all PET studies that have measured 
striatal presynaptic dopamine function in schizophrenia, and determine where within 
the striatum dopaminergic dysfunction is greatest. We aimed to test the mesolimbic 




i. Hypothesis: Presynaptic dopamine function will be greater in individuals with 
schizophrenia compared to healthy controls. 
ii. Hypothesis: This presynaptic hyperdopaminergia will not occur uniformly 
across the striatum but will be greater in certain subdivisions compared to 
others. Specifically, I aimed to test the mesolimbic hypothesis of schizophrenia 
– that dopaminergic dysfunction is greatest in the limbic striatum. 
 
• Chapter 4: To use PET to measure dopamine synthesis capacity in individuals 
with schizophrenia, and resting state fMRI to parcellate the striatum of these 
individuals on the basis of corticostriatal connectivity patterns. On the basis of this, 
to then investigate whether dopamine dysfunction within specific striatal regions is 
linked to the specific symptoms one would predict on the basis of the connected 
cortical area. 
i. Hypothesis: Specific symptoms will be associated with dopamine dysfunction 
in specific striatal subregions that show preferential connectivity with 
functionally-relevant cortical regions. I focus on auditory hallucinations and 
motor symptoms as these are symptoms that have a priori links to well 
circumscribed (auditory and motor) cortical areas. Specifically, we predict that 
both baseline severity, and change (following antipsychotic treatment) in 
severity, of hallucinations and of motor symptoms would correlate with 
dopamine synthesis capacity in striatal regions preferentially connected to 
auditory and motor cortex, respectively.  
ii. I undertook an exploratory analysis investigating whether any notable 
relationships occurred between dopamine dysfunction in other cortical 
connectivity defined striatal subregions and other symptom clusters.  
iii. We compared our connectivity defined striatal parcellation with published 
atlas-defined subdivisions, in order to examine whether an individualised data-
driven connectivity-based method is able to provide additional information over 




• Chapter 5: To investigate the cognitive and neurobiological correlates of 
exposure to chronic psychosocial stressors that are established environmental risk 
factors for psychosis. To do this, I employed resting state MRI and a behavioural 
task (the salience attribution task) to test the following hypotheses: 
i. Hypothesis: Individuals with a history of high exposure to chronic 
psychosocial stressors will display increased aberrant, and reduced adaptive, 
salience scores compared to individuals with a history of low exposure. 
ii. Hypothesis: Individuals with a history of high exposure to chronic 
psychosocial stressors will display altered corticostriatal functional connectivity 
compared to individuals with a history of low exposure. 
iii. Hypothesis: Alteration in corticostriatal connectivity will be related to 
alterations in salience processing. 
 
• Chapter 6: To examine the relationship between two key salience processing 
systems: the cortical salience network and the mesolimbic dopamine system. We used 
resting state fMRI to characterise the salience network in two separate cohorts – one 
that had received an 18F-DOPA PET scan (to measure dopamine synthesis 
capacity), and the other that had received an 11C-PHNO scan before and after 
amphetamine administration (to measure dopamine release capacity).  
i.  Hypothesis: Individuals with greater striatal dopamine synthesis and release 
capacity will show greater connectivity within the salience network, and, 
because of the reciprocal relationship between salience and default mode 
networks, weaker connectivity within the default mode network. 
ii.  Hypothesis: In addition, I identified within these networks, regions that 
played the most important role in information processing (“hub nodes”). Hubs 
support the rapid integration of information across a complex system and as 
such can be considered an optimal target via which a network input may 
efficiently maximize its influence in a coordinated fashion. I therefore 
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hypothesized that there would not be a uniform association between dopamine 
function and connectivity but that hub nodes would show the strongest 
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The mesolimbic hypothesis that aberrant 
functioning of midbrain dopamine projections 
to limbic regions causes psychotic symptoms 
has been a central dogma of schizophrenia for 
decades. Recently, however, advances in 
neuroimaging techniques have led to the 
unanticipated finding that dopaminergic 
dysfunction in schizophrenia is greatest within 
nigrostriatal pathways, implicating the dorsal 
striatum in the pathophysiology of the illness 
and calling into question the mesolimbic 
theory. At the same time our knowledge of 
striatal anatomy and function has progressed, 
suggesting new mechanisms via which striatal 
dysfunction may contribute to the symptoms 
of schizophrenia. This review draws together 
these developments, to explore what they 
mean for our understanding of the disorder’s 
pathophysiology, clinical manifestations, and 
treatment.  
 
Schizophrenia and the striatum 
Schizophrenia is a syndrome consisting of positive (such as delusions and 
hallucinations), negative (including flattened affect and lack of motivation), and 
cognitive symptoms. Dysregulated dopaminergic modulation of striatal function is 
fundamental to many models that seek to explain the mechanisms underlying the 
symptoms of schizophrenia[1–4]. Furthermore, all licensed pharmacological 
treatments for schizophrenia affect the dopamine system, and while several atypical 
antipsychotics have been proposed to act via alternative non–dopaminergic 
Highlights 
 
Techniques for characterising the 
mesostriatal dopamine system, 
both in humans and animal 
models, have advanced 
significantly over the past decade 
 
In vivo imaging studies in 
schizophrenia patients 
demonstrate that dopaminergic 
dysfunction in schizophrenia is 
greatest in nigrostriatal as 
opposed to mesolimbic pathways 
 
Better understanding of striatal 
structure and function has 
enhanced our insight into the 
neurobiological basis of psychotic 
symptoms 
 
The role of other 
neurotransmitters in modulating 
striatal dopamine function merits 
further exploration, and 
modulating these 
neurotransmitter systems has 




mechanisms, such as the serotonergic system, it 
is still the case that they all bind to dopamine 
receptors, and there is no clear relationship 
between efficacy and serotonergic effects[5]. 
 
In this paper, we review how advances in 
neuroscientific methods have improved our 
understanding of striatal structure and 
function. We then examine the evidence 
regarding striatal dysfunction in schizophrenia, 
and discuss how recent findings suggest a re-
evaluation of prior hypotheses may be required. 
Finally, we ask what these developments mean 
for our understanding of the disorder’s clinical 
manifestations and treatment. 
 
 
Striatal Structure and Function 
 
Striatal Connectivity 
The striatum is an integral part of the cortico-
basal ganglia circuitry. Extensive work 
mapping its pathways, as summarized below, 
suggests that it acts as an integrative hub for 
information processing in the brain. 
 
Initial primate research aimed at mapping 
striatal connections involved lesioning cortical 
areas and recording the location of subsequent 
Glossary 
 
Amphetamine sensitisation: Repetitive 
administration of amphetamine leading 
to progressively greater amphetamine 
induced dopamine release. 
Associative striatum: Precommissural 
dorsal caudate, postcommissural 
caudate, and precommissural dorsal 
putamen.  Receives afferent connections 
from the dorsolateral prefrontal cortex. 
Homologous to the rodent dorsomedial 
striatum. 
Clinical high risk (CHR): Individuals 
experiencing intermittent or attenuated 
psychotic symptoms, below the level at 
which a psychotic disorder would be 
diagnosed. 
Direct Pathway: Striatal output 
pathway, in which D1 MSNs project 
directly from the striatum to the output 
nuclei of the basal ganglia. 
Diffusion Tensor Imaging: Measurement 
of water diffusion patterns to infer the 
white matter structure of the brain and 
map anatomical connectivity between 
regions. 
Efference copy: An internally generated 
replica of an outgoing motor signal, that 
signals that the subsequent motor act is 
self-generated and thereby dampens 
sensory perceptions occurring as a result 
of that act. 
Inappropriate affect: An emotional 
expression not in keeping with the 
circumstances that provoked it. 
Indirect pathway: Striatal output 
pathway, in which D2 MSNs project 
from the striatum to the output nuclei 
of the basal ganglia indirectly via the 
pallidum. 
Limbic striatum: Equivalent to 
the ventral striatum. Receives afferent 
projections from limbic areas: vmPFC, 
OFC, dACC and medial temporal lobe  
 
44 
striatal degeneration. Later work used 
retrograde tracers injected into the striatum to 
determine both cortical and midbrain 
connections [6]. Striato-cortical connections 
were shown to run in three parallel, and 
relatively well segregated pathways, that 
effectively parcellated the striatum into limbic 
(see glossary), associative, and sensorimotor 
functional subdivisions based on their specific 
inputs and outputs (Figure 1A)[7]. At the time, 
it was thought that these corticostriatal loops 
operated in parallel with minimal cross talk, an 
idea referred to as the ‘parallel processing’ 
model. Subsequent studies, however, suggested 
that in addition to these parallel loops, there 
are projections from one loop to another [8], 
which promote ‘information funnelling’ from 
the ventral to the dorsal striatum (Figure 1A). 
 
Recent methodological advances have further 
refined our understanding of corticostriatal 
architecture [9,10]. These advances underscore 
the lack of a strict 1:1 topographic mapping, 
and indicate that corticostriatal pathways 
overlap. Based on its exceptional degree of 
input heterogeneity, the associative striatum 
has been highlighted as an information processing hub [11]. Furthermore, cluster 
analysis of corticostriatal input patterns has shown that in addition to the three 
subdivisions discussed above, a fourth subdivision is apparent in the tail of the 
Medium Spiny Neuron (MSN): 
GABAergic projection neurons of the 
striatum. Typically classified as either 
D1 type of the direct pathway, and D2 
type of the indirect pathway. 
Nucleus Accumbens (NAcc): Main 
component of the ventral striatum. 
Passivity phenomena: Symptom of 
schizophrenia in which one feels under 
external influence and no longer in 
control of one’s movements or thoughts. 
Positive psychotic symptoms: 
Symptoms such as hallucinations, 
delusions, and disorganised thought and 
behaviour. 
Positron Emission Tomography 
(PET): Imaging technique in which a 
radioactive atom is attached to a 
biologically active molecule. Positrons 
emitted by this molecule produce 
gamma rays which are detected to allow 
visualisation of its anatomical 
distribution. 
Resting state functional magnetic 
resonance imaging: Brain activity is 
measured in the absence of any explicit 
task, and correlations between 
spontaneous fluctuations allow for the 
inference of functional connectivity 
between regions. 
Salience: The quality of an item that 
causes it to stand out from its 
environment. 
Sensorimotor striatum: Post 
commissural putamen. Receives afferent 
projections from motor and premotor 
cortical areas. Homologous to 
dorsolateral striatum in rodents. 
Thought echo: A form of auditory 
hallucination in which an individual 
perceives their thoughts being spoken 
aloud as an external stimulus. 
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striatum, its most caudal part [11]. This region receives cortical input from a range 
of areas including limbic and auditory cortex, and is distinct in its composition, 
consisting almost exclusively of D1 expressing medium spiny neurons (MSNs) [12].  
  
Figure 1: Striatal Connectivity 
A) Summary of primate tracing studies mapping connections between cortex (top row), striatum (middle) and 
midbrain (bottom). 
The primate striatum can be divided into nucleus accumbens, olfactory tubercle, caudate nucleus and putamen (for 
simplicity, not indicated in the figure). The division between caudate and putamen, however, has relatively little 
biological relevance [6]. Tract tracing studies showed that striato-cortical connections run in three parallel pathways. 
Motor areas project to the caudal putamen [117]; dorsolateral prefrontal cortex to caudate and rostral putamen [118]; 
and limbic areas to the ventral striatum [119]. These subdivisions were termed the sensorimotor, associative, and 
limbic striatum. Subsequent research used retrograde tracers injected into striatum to determine midbrain 
connections [6,8]. This showed that ventral tegmental area and medial substantia nigra project primarily to limbic 
striatum, while central/ventrolateral parts of substantia nigra project to associative and sensorimotor striatum. The 
striatum in turn has efferents projecting back to the midbrain. In addition to these reciprocal connections,  ‘feed 
forward’ striato-nigro-striatal connections allow information to pass along the striatum from limbic to motor regions 
via the associative striatum [8,112,120].   
 
B) Summary of rodent-primate differences in mesostriatal connectivity. 
In rodents, the ventral striatum is proportionally larger than in primates. The NAcc shell is innervated by the medial 
VTA, the NAcc core by the central VTA, whereas the lateral VTA innervates a region homologous to the associative 
striatum; the substantia nigra also has some connections to the associative region in addition to the more dorsal regions 
of the striatum. In primates, the VTA is proportionally smaller; it innervates the ventral striatum, whereas the dorsal 
tier substantia nigra innervates the associative striatum, and the ventral tier innervates the sensorimotor striatum (for 
a more detailed review of differences between primates and rodents see [14,121]). 
 
omPFC – orbitomedial  PFC, PFC – Prefrontal cortex, SN – Substantia nigra, vmPFC – ventromedial PFC, VTA – 




In addition to its widespread cortical connectivity, the striatum has extensive 
bidirectional connections to the midbrain (Figure 1A). The development of the 
CLARITY tissue preparation method (which enables lipid removal, while preserving 
tissue structure), has allowed for in depth examination of meso-striatal connectivity, 
and has identified projections from the dorsolateral to dorsomedial projecting 
dopamine neurons, suggesting a novel pathway for lateral to medial information flow, 
in addition to previously identified medial to lateral routes (Figure 1A) [13].  
 
Many of these more recent findings on striatal connectivity have been demonstrated 
only in rodents to date, and interspecies differences must be borne in mind when 
seeking to draw parallels with primate and human anatomy (Figure 1B) [14]. Human 
neuroimaging studies have, however, produced findings that are in keeping with some 
of the pathways discussed above. Resting state functional magnetic resonance 
imaging [15] and diffusion tensor imaging [16] studies support the division of the 
striatum into functional subdivisions. Moreover, compared to anatomical divisions, 
these functional subdivisions display greater homogeneity in terms of dopamine 
release [16], highlighting their relevance for understanding striatal function. Likewise, 
the preclinical finding that the associative striatum acts as an integrative hub via 
the convergence of multiple distal cortical inputs, is consistent with human studies 
[17–19]. 
 
In summary, it appears that in addition to well-established parallel pathways, there 
also exists, across species, a high degree of pathway crossing and information 
funnelling, with regions in the associative striatum acting as integrative hubs. 
Furthermore, there appear to be a variety of pathways allowing for bidirectional 





Recent advances have refined understanding of striatal neurochemistry. In this 
section, we consider these findings and their implications for mechanisms by which 
abnormalities of non-dopaminergic neurotransmitter systems may contribute to 
dopaminergic dysfunction. We also discuss their relevance for developing new 
treatment approaches to normalise striatal dopamine function and possibly treat 
schizophrenia without requiring dopamine D2/3 receptor blockade. 
 
Most dopamine neurons have the potential to release GABA as a co-transmitter, and 
a smaller proportion co-release glutamate. This co-transmission varies across the 
striatum, and can moderate the reciprocal relationship between dopaminergic and 
cholinergic neurons [20]. Specifically, in the dorsal striatum, dopamine neurons do 
not co-release glutamate, and the firing of dopamine neurons in this region is 
accompanied by pauses in cholinergic interneuron firing secondary to dopamine D2 
receptor and GABA signalling. In the ventral striatum, by contrast, a burst-pause 
occurs secondary to glutamate co-transmission [20]. In addition to these functional 
differences across the striatum, dopamine receptors themselves show fundamentally 
different responses to dopamine, dependent on their striatal location. D2 receptors 
in the accumbens show both greater sensitivity to dopamine and a slower 
postsynaptic current compared to those in dorsal regions [21]. This is not secondary 
to differences in D2/3 ratios, but rather appears to result from differences in Gα 
subunits [21]. 
 
Corticostriatal neurons synapse upon cholinergic interneurons, which in turn 
modulate dopamine neurons via nicotinic receptors situated on these dopamine 
neurons, thereby mediating the corticostriatal control of striatal dopamine release 
[22]. It is also these cholinergic interneurons that drive GABA release from 
dopaminergic neurons [23]. Muscarinic regulation of striatal dopamine function has 
also been shown, although there is no evidence that dopamine neurons in the 
striatum display muscarinic receptors [24], and it appears this modulation occurs 
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secondary to a variety of mechanisms, including autoreceptors on cholinergic 
terminals that inhibit acetylcholine release [25], endocannabinoid signalling pathways 
[26], and modulation of MSN projections to the substantia nigra [27]. In the dorsal 
striatum both M2 and M4 receptors are needed for this muscarinic modulation of 
dopamine release, whereas in the ventral striatum only M4 receptors are required 
[24].  
 
Of relevance to the treatment of schizophrenia, Kharkwal et al. demonstrated that 
the extra pyramidal side effects of antipsychotic medications may primarily result 
from the blockade of D2 receptors on cholinergic interneurons [28]. Blockade of D2 
receptors was shown to increase the firing of D2 expressing indirect pathway MSNs, 
both due to the direct effect on these neurons, but also as a result of increased  
acetylcholine mediated activation of M1 receptors on the MSNs, occurring as a result 
of D2 blockade on cholinergic interneurons (Figure 2A)[28]. The authors suggest that 
this mechanism may have the potential to minimise movement side effects, and this 
is supported by the finding that the antipsychotic with the lowest risk of these is 
clozapine. While clozapine’s favourable profile in this domain may also result from 
its low affinity for the D2 receptor and low D2 occupancy at clinically therapeutic 
doses, it also displays significant antagonism at the M1 receptor, which these findings 









Figure 2. Striatal neurochemistry and neurotransmission 
A) The role of cholinergic interneurons in mediating extrapyramidal side effects (see Kharkwal et al [28]) 
(i)In wild type mice, D2Rs mediate inhibitory actions both by directly reducing firing of the indirect pathway MSN, and 
by reducing firing of cholinergic interneuron (ii) In knockout mice without D2R on cholinergic interneurons, D2 antagonism 
of the MSN by itself is insufficient to induce catalepsy (iii) Activating, in addition, M1Rs, results in catalepsy, which 
occurs due to increased firing of the cholinergic interneuron secondary to D2 antagonism. 
 
B) The relationship between striatal dopamine, lateral inhibition and behavioral selection(see Burke et al [35]). The 
figure illustrates three scenarios, based on a hypothetical pair of ‘functional units’ (A, and B) each controlling a specific 
behavioural outcome (behavior A and B, respectively). 
(i) Localized dopaminergic signaling in functional unit ‘A’ activates D1 direct pathway MSNs, while suppressing D2 
indirect pathway MSNs, enabling the execution of desired behavior ‘A’. GABAergic lateral inhibition suppresses competing 
behavior coded for by functional unit ‘B’. (ii) Spatially disorganized dopaminergic signaling means that there is non-
specific activation of multiple functional units, and undesirable behaviors are no longer suppressed. (iii) Dopamine 
antagonists enhances the activity of indirect pathway neurons, but without regional specificity, meaning that desirable 
behaviors are also suppressed 
 





New findings regarding striatal anatomy and neurochemistry have also refined our 
understanding of the striatum’s functional architecture. We now discuss how recent 
neurobiological advances relate to our understanding of the striatum’s role in 
behavioural selection, salience processing, and habit formation.  
 
The striatum’s output pathways include the direct and indirect pathways, where D1 
expressing MSNs project directly to the output nuclei of the basal ganglia, and D2 
type MSNs project indirectly via the pallidum (Figure 3).  Recent findings suggest, 
however, that these pathways are less distinct than previously thought, with D1 and 
D2 MSNs of the ventral striatum often not adhering to the direct and indirect 
pathways respectively [29,30]. While these classical pathways better describe the 
architecture of the dorsal striatum, inter-pathway communication has also been 
demonstrated here - lateral projections from indirect pathway MSNs inhibit direct 
pathway MSNs via GABA release, and striatal dopamine release reduces this GABA 
release thereby supressing this lateral inhibition [31]. In the opposite direction, direct 
pathway neurons show collaterals that bridge across to the indirect pathway [32]. 
Moreover, recent findings indicate that neural activity in both pathways increases 
when animals initiate a behaviour, in contrast to the classical accelerator/brake 
model [33,34]. One interpretation of this finding is that the activation observed in 
the indirect pathway corresponds to the suppression of alternative, undesirable 
behaviours [35], and that this suppression may occur via collaterals between direct 
and indirect pathway MSNs [35](Figure 2B). 
 
The activity of mesostriatal dopamine neurons has been shown to signify the 
discrepancy between expected rewards and actual rewards, which has been termed 
the reward prediction error [36].  In addition to reward processing, some models have 
emphasised mesostriatal dopamine neurons’ role in assigning salience to 
environmental stimuli, and its potential relevance to the development of psychotic 
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symptoms [1]. While it has been debated whether mesostriatal dopaminergic neurons 
carry information regarding salience that goes beyond reward related information 
[37,38], recent studies suggest that while dopamine signalling within the ventral 
striatum is strongly linked to stimulus value, dopamine signalling in more dorsal 
regions does not track value, but rather the novelty and intensity of stimuli, and in 
particular threat related information [13,39,40].  It has also been recently 
demonstrated that optogenetic stimulation of dopamine neurons is sufficient to 
imbue unremarkable environmental stimuli with motivational properties, and that 
these stimuli are subsequently able to evoke dopaminergic activity, despite never 
having possessed any intrinsic salience [41]. Recent human PET-fMRI studies also 
provide evidence that striatal dopamine has a broader role than simply encoding 
reward prediction errors, and is associated with the function of cortical salience 
networks [42], and making more general inferences about the state of the 
environment [43].  
 
Striatal function along a ventral-dorsal axis is also relevant to habit formation. 
During the learning of action-outcome pairings, performance is goal directed and 
sensitive to changes in outcome values. After extensive training, however, 
performance moves to a stimulus-response mode that is inflexible, and no longer 
responds to changes in outcome. This evolution of behaviour from contingency 
dependent learning to habitual responding has been associated with a shift from 
ventral to dorsal striatal processing [44]. Supporting this, lesions to nigrostriatal 
pathways and dorsal striatum disrupt habit formation, amphetamine sensitisation 
encourages habit formation, and it is the dorsal striatum that is implicated in the 
habitual responses to drug cues experienced by addicts [45]. Recent work has focused 
more specifically upon the role of the striatal tail, and is consistent with these earlier 
findings in that this region appears to be involved in storing stable values while the 






Figure 3. Mechanisms via which excess striatal dopamine may impair efference copy transmission 
With normal striatal dopamine signaling (left), neurons carrying the efference copy signal 
preferentially synapse onto D2 expressing GABAergic medium spiny neurons of the indirect pathway. 
Increased dopamine release within the striatum (right) inhibits these D2 expressing neurons. Excess 
striatal dopamine may therefore interfere with appropriate transmission of the efference copy signal. 
In the auditory areas of the dorsal striatum this could result in inner speech being mischaracterized 
as externally generated 
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Striatal Dopamine and Schizophrenia 
 
The Mesolimbic Dogma 
Early models of schizophrenia proposed that dysfunction of the mesolimbic pathway 
underlay positive psychotic symptoms (Box 1)[4]. Related to that, it was also 
proposed that newer antipsychotics benefit from mesolimbic selectivity when 
compared to older agents [47]. While questions were raised regarding the precise 
locus of striatal dysfunction [48], a focus on mesolimbic pathways persisted, likely 
due to the absence of robust evidence to refute it. As a result, the mesolimbic 
hypothesis became a central dogma of schizophrenia, featured in many textbooks, 
and frequently invoked in discussions regarding the pathophysiology of the illness 
[1,2,49,50]. As it was not possible to measure limbic dopamine function in vivo, the 
theory was based on indirect evidence. Moreover, it originated when the dorsal 
striatum was thought to be solely involved in motor function, and unlikely to be 
involved in psychosis. Subsequent advances suggest it may in fact be these dorsal 
regions that play a central role in the pathophysiology of the disorder.  
 
Post-mortem studies of striatal dopamine function  
Early post-mortem studies investigating striatal dopaminergic abnormalities 
produced inconsistent results. Initial studies measured concentrations of dopamine, 
and while some reported an association between schizophrenia and increased 
concentrations specifically in the nucleus accumbens (NAcc) [51],  others found 
dopamine concentrations elevated specifically in the dorsal striatum [52].  Moreover, 
tyrosine hydroxylase activity, the rate limiting enzyme in dopamine synthesis,  was 
shown to be elevated throughout the striatum [53], as were dopamine receptor 
densities[54]. 
 
More recently, no differences between patients and controls in terms of either density 
of dopaminergic terminals [55], or levels of tyrosine hydroxylase have been found in 
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the NAcc[56,57]. Inferences from post-mortem studies, however, are limited by the 
fact that most patients have received antipsychotic drug treatment, which may 
upregulate dopamine receptors [58], and alter presynaptic dopamine function[59],  
  
Clinical Findings 
The origins of the mesolimbic hypothesis date back to observations that symptoms, displayed during 
epileptic seizures localised to limbic areas, were similar to the symptoms of schizophrenia[122]. It was 
also noted that individuals with tumours in limbic areas were likely to be diagnosed with 
schizophrenia[123]. Further support came from research using electrodes implanted in individuals with 




The above mentioned clinical findings were not neurotransmitter specific. The link to dopamine was 
based on three complementary findings. First, that high doses of amphetamines were able to induce a 
florid psychotic state [125]; second, that in rodents amphetamine induced dopamine release appeared 
greatest in the NAcc[126]; and third, that amphetamine induced stereotypy was specific to 
increased dopaminergic transmission in the NAcc [127]. 
 
Antipsychotics 
Injections of antipsychotics into the NAcc abolished 
amphetamine induced behaviours, but injections into 
caudate had no effect [128]. Furthermore, some 
antipsychotics specifically upregulated dopamine 
turnover in the NAcc, supporting the hypothesis that 
dopamine blockade of this region was central to the 
‘antipsychotic’ effect of antipsychotics. This was in 
keeping with findings that while typical antipsychotic 
drugs increased c-fos and neurotensin expression in 
the NAcc and dorsal striatum, atypicals affected 
expression solely in the NAcc, suggesting that the 
NAcc was central to antipsychotic effects whereas 
dorsal actions might be solely related to motor side-
effects [129]. 
 
Together these findings led to the hypothesis that 
psychosis was due to over-activity in the mesolimbic 
dopamine pathway [2,49,50]. Modern neurochemical 
imaging findings, however, suggest that it is within 
dorsal regions of the striatum that dopaminergic 







Box 1. The Mesolimbic Hypothesis of Schizophrenia 
Figure 1: Results of a meta-analysis examining PET 
measures of presynaptic dopamine in schizophrenia 
patients and controls[61]. 
Limbic – Limbic Striatum, Assoc- Associative Striatum, 
Smst – Sensorimotor Striatum, *- Statistically 
significant difference between patients and controls 
(p<0.05 in a random effects meta-analysis) 
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and furthermore dopamine and its metabolites are greatly affected by death[60].  
 
In vivo neuroimaging of the striatum 
Positron emission tomography (PET) allows quantification of the dopamine system 
in vivo. Radiolabelling of the dopamine precursor L-dihydroxyphenylalanine enables 
the measurement of its uptake and conversion in dopamine neurons to give an index 
of dopamine synthesis capacity. Alternatively, imaging the competition between 
endogenous dopamine and radioligands specific to postsynaptic dopamine receptors 
can determine baseline levels of dopamine (following depletion of endogenous 
dopamine using compounds such as a-methylparatyrosine), as well as the magnitude 
of dopamine release (following a pharmacological or psychological challenge). 
 
Meta-analysis of studies using these PET and SPECT techniques shows that there 
is a robust increase in striatal dopamine synthesis and release in psychosis [61]. There 
is no evidence of major alterations in dopamine D2/3 receptors, although it is possible 
that increased receptor occupancy by raised endogenous dopamine levels masks this, 
or alternatively that differences between groups in the affinity state of the receptor 
are not detected with the antagonist ligands generally used [62–64]. 
 
Early PET and SPECT studies of presynaptic dopamine function could distinguish 
anatomical subdivisions of the striatum but lacked sufficient resolution to accurately 
distinguish between functional subdivisions. Accordingly, these studies reported 
outcomes for the whole striatum or anatomical subdivisions. However, the 
subsequent development of higher resolution PET scanners has enabled the 
assessment of striatal functional subdivisions as well. The first studies to report on 
these subdivisions in patients with schizophrenia found that the greatest differences 
in dopamine function were within the associative striatum, with differences in the 
limbic subdivision not reaching statistical significance [63,65]. The finding that 
dopaminergic dysfunction is greatest in the associative region has been replicated in 
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multiple studies since then [63,66–68]. Meta-analysis of these studies found that 
dopaminergic function was significantly elevated in patients relative to controls in 
associative (Hedges’ g=0.73) and sensorimotor regions (g=0.54), but was not 
significantly altered in the limbic subdivision (Box 1) [61].  
  
Studies investigating presynaptic dopamine function in individuals at clinical high 
risk (CHR) of psychosis also found the greatest abnormality to be in the associative 
striatum [65,69], and that conversion from CHR to psychosis is associated with a 
progressive increase in dopamine synthesis capacity in the dorsal (predominantly 
sensorimotor) striatum, while no significant change was observed in the limbic 
subdivision [70].  
 
In a multi-modal study, frontal activation during a working memory task was shown 
to correlate inversely with associative striatum dopamine synthesis capacity in a 
CHR group [71]. In the same sample, dopamine synthesis capacity in the associative 
striatum correlated with greater activation in the left inferior frontal region during 
a verbal fluency task in the CHR group, but not in the control group [72]. In both 
studies, no correlations were seen for limbic or sensorimotor subdivisions. fMRI only 
studies have shown hypoconnectivity between cortex and dorsal striatum in 
individuals with schizophrenia [73–76], CHR individuals [77], and individuals at 
genetic risk [73]. Greater activity within the dorsal striatum as measured during 
resting state MRI has also been shown to correlate with psychotic symptoms [78], 
and treatment response correlates with increased functional connectivity between 
associative striatum and prefrontal cortex [79]. Meanwhile, diffusion tensor imaging 
has found reduced anatomical connectivity between the dorsolateral prefrontal cortex 
and the associative striatum in schizophrenia [80]. It is important to recognize, 
however, that some fMRI studies have also shown alterations in ventral striatal 




In summary, in contrast to the mesolimbic theory, in vivo neuroimaging studies have 
provided evidence that dopaminergic dysfunction in schizophrenia is greatest within 
dorsal, as opposed to ventral regions of the striatum. 
 
 
How could striatal dysfunction lead to the symptoms of schizophrenia? 
 
An ongoing question is how the neurobiological abnormalities identified in patients 
translate to the diverse psychopathology they present with. We now suggest several 
mechanisms whereby striatal dysfunction could contribute to the clinical 
manifestations of the disorder. It is important to note, however, that many of these 
proposals are speculative at this stage, and furthermore that schizophrenia is a 
heterogeneous disorder and no single brain region or neurotransmitter is likely to be 
able to account for all symptoms in all patients. 
 
Aberrant Salience and Delusional Form 
Theoretical models linking biological substrates to phenomenological experience in 
psychosis have frequently built upon the finding that mesostriatal dopamine 
signalling is involved in marking the salience of environmental stimuli[1]. Excessive 
spontaneous dopamine transients are proposed to lend irrelevant external or internal 
stimuli significance due to the temporal association of the stimuli with striatal 
signalling[1,82]. Although interpretations have often focused upon the mesolimbic 
pathway, it is apparent that nigrostriatal pathways are also involved in signalling 
salience[13,39,40,83], and the finding that dopaminergic activity within dorsal regions 
of the striatum is tied to signalling threat related information[39], may have 
relevance to the fact that delusions are frequently persecutory in nature. 
 
Existing models have proposed that delusions then develop secondary to cognitive 
processes attempting to construct a coherent explanation for these unusual 
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experiences. Historically, however, discussions regarding the phenomenology of 
delusions have emphasised form of thought over content. Delusional form is 
characterised by a certainty of conviction, that is accompanied by an inability to 
shift perspective, and an imperviousness to counterargument[84]. Given the role of 
the dorsal striatum in habit formation and the coding of stable values[44,46], one 
can speculate that the dopaminergic dysfunction of the dorsal striatum that 
accompanies the onset of psychosis could lead to a more habit oriented mode of 
cognition, contributing to the rigid form of thought as well as its unusual content[70].  
 
Another finding of relevance to theories of aberrant salience attribution in 
schizophrenia is the following one. A stimulus, even if initially lacking inherent 
salience,  once paired with dopaminergic activity, maintains the ability to evoke 
dopaminergic activity over time [41]. This suggests that in psychosis, once an 
environmental stimulus has been ‘highlighted’ by aberrant dopamine signalling, it 
may maintain its ability to trigger dopaminergic activity, potentially cementing its 
position in a delusional framework, even if the system subsequently returns to normal 
function. 
 
The Dorsal Striatum as an Integrative Hub 
The striatum, and specifically areas of the associative striatum, can be viewed as an 
integrative hub. Regions of the caudate receive inputs from nearly the entire 
cortex[11,17]; and, additionally, via various connections with the midbrain[13], the 
associative striatum acts as a moderator of communication between limbic and motor 
regions.  
 
Given that the striatum performs an integrative role, functional disruption secondary 
to aberrant dopamine signalling may lead to the associative impairments observed 
in schizophrenia. Based on preclinical models, it has been proposed that the 
underlying pathophysiology in schizophrenia represents a combination of increased 
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aberrant spontaneous phasic dopamine release, and a reduction in adaptive phasic 
release in response to relevant stimuli[82]. This would lead to increased ‘noise’ in 
dopamine signalling in the associative striatum, which could explain findings of 
reduced functional connectivity between associative striatum and cortex[73], and 
could disrupt integration of cortical inputs from emotional, cognitive and motor 
areas. This provides a potential neurobiological correlate for Bleuler’s original 
description of the syndrome as principally resulting from a loss of association between 
thought processes, emotion and behaviour[85], and could underlie symptoms such as 
inappropriate affect. However, this has yet to be definitively tested. 
 
Regionally targeted dopamine signalling enables the precise selection of specific 
behaviours over others, and collaterals between direct and indirect pathway MSNs 
[35] mediate the appropriate integration of multiple signals (Figure 2B). Undirected 
dopamine transmission will impair this mechanism leading to disorganised behaviour. 
In contrast, in the context of pharmacological approaches, D2 antagonism will have 
the ability to supress overactivity within these systems, but will potentially impair 
the execution of desired behaviours (Figure 2B). 
 
Abnormal Perceptions and Efference Copies 
An efference copy is an internally generated replica of an outgoing motor signal, that 
has the effect of dampening sensory perceptions occurring as a result of the motor 
act, encouraging it to be perceived as self-authored and avoiding attribution to an 
external agent.  The possibility, therefore, that disruption of efference copy 
mechanisms could contribute to passivity phenomena has long been suggested[86]. 
 
Efference copies accompanying internally generated motor cortex activity travel via 
pyramidal tract neurons to the dorsal striatum[87,88]. There is some evidence that 
the glutamatergic corticostriatal neurons thought to encode the efference copy tend 
to synapse upon the GABAergic D2 striatal MSNs of the indirect pathway(figure 
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3)[87,89,90]. One might speculate therefore that excessive dopaminergic signalling 
within the striatum will inhibit D2 expressing neurons, thereby reducing activity of 
the indirect pathway and potentially impeding the appropriate transmission of the 
efference copy signal, meaning that internally generated phenomena may not be 
coded as such. However, this hypothesis remains to be tested, including in humans, 
and is only one possible mechanism of disrupted efference copy signalling. 
 
In addition to motor passivity phenomena, a similar mechanism may contribute to 
auditory hallucinations related to inner speech, such as thought echo. Inner speech 
is in certain respects a motor act, in that it is thought to result from motor plans for 
speech that are subsequently aborted[91].  Recent research suggests that efference 
copy mechanisms account for the fact that it is typically easily distinguished from 
external speech[92]. The neurobiological correlate of inner speech includes neural 
activation in cortical areas involved in the perception of external speech, such as the 
secondary auditory cortex[93], and these cortical areas project to the dorsal 
striatum[18]. Abnormalities of the dorsal striatum have been associated with 
auditory hallucinations in studies of brain structure, metabolic rate and perfusion, 
and it is possible that the mechanism discussed above may contribute to the 
relationship between these symptoms and striatal dysfunction[94–96]. 
 
Efference-copy mechanisms, however, are less likely to account for auditory 
hallucinations that are phenomenologically unrelated to inner speech, and a 
predictive coding framework, which is a more generalizable model, seems more 
relevant in this context. Predictive coding refers to the idea that the brain compares 
prior expectations with new sensory evidence, and uses the discrepancy between the 
two (the prediction error) to update its model of the world. The certainty regarding 
one’s prior expectation is described as the ‘precision’ of that prediction. Both the 
extent of the difference between prior and sensory data, and the precision of these 
determine the magnitude of the prediction error[97]. Recent research has 
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demonstrated that auditory hallucinations are related to a greater ability of priors 
to influence perception[98]. It was also demonstrated that amphetamine induced 
dopamine release in the associative striatum is associated with this increased 
weighting of priors[99]. These findings are complemented by recent preclinical 
research showing that neurons in the tail of the striatum code prior beliefs regarding 
the value of auditory stimuli[100]. 
 
Cognitive and Negative Symptoms 
It addition to the role that striatal dopamine signalling plays in the development of 
positive symptoms, several mechanisms have been suggested for its contribution to 
the cognitive and negative symptoms of the disorder as well. 
 
Cognitive impairments in schizophrenia have been suggested to result from cortical 
hypodomaminergia, an idea supported by the importance of cortical dopamine 
signalling for prefrontal related cognition [101,102]. Recent work in rodents has 
extended this framework to include striatal involvement, by showing that the 
relationship between cortical and striatal dopamine is bidirectional, and that 
increased dorsal striatal dopaminergic signalling can reduce mesocortical dopamine 
release and produce cognitive deficits[103,104]. While in vivo imaging evidence for a 
deficit in cortical dopamine transmission has emerged[105], and the multimodal 
studies discussed above have suggested that striatal dysfunction may be functionally 
linked to cortical hypofunction, the direction of causality remains unclear and has 
yet to be determined, including in human studies[71,72]. 
 
Striatal hyperdopaminergia could conceivably result in cognitive impairments either 
by disrupting signalling between frontal cortex and associative striatum, or by 
potentially driving cortical dopamine dysregulation[103]. Of relevance to this 
question is an animal model of striatal D2 receptor overexpression, designed to mimic 
the increased striatal dopamine signalling observed in schizophrenia [103,106]. 
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Studies using this model found that striatal D2 overexpression led to both reductions 
in cortical dopamine turnover and cognitive deficits[106]. These abnormalities 
persisted even following the normalisation of striatal dopamine transmission, 
suggesting that whilst increased striatal dopamine signalling may lead to cognitive 
impairments, subsequent adaptive changes may underlie their persistence[106]. This 
could contribute to the finding that the attenuation of striatal dopamine transmission 
with antipsychotics is of limited benefit in treating cognitive symptoms. This 
potential role of associative striatum, is also supported by in vivo studies showing 
that reduced connectivity of the associative striatum and substantia nigra is related 
to the severity of cognitive deficits in schizophrenia[75,107]. 
 
There is also evidence that striatal dysfunction may contribute directly to negative 
symptoms. Studies employing probabilistic learning tasks have shown that negative 
symptoms in individuals with schizophrenia may be related to impaired reward-based 
learning [108–111]. Multiple studies have demonstrated that the striatum plays a key 
role in the orchestration of this type of behaviour[112], and it has been proposed that 
excessive aberrant dopamine release may mask adaptive striatal dopamine release, 
thereby contributing to these behavioural deficits in schizophrenia[111]. This is 
consistent with neuroimaging studies showing reduced midbrain and striatal 








In this section we consider the implications of the evidence discussed earlier for the 
development of new treatments for schizophrenia that are not D2 receptor blockers 
and that might address the striatal dopamine dysfunction seen in the disorder.  
 
As previously discussed, studies have shown that the magnitude of dopaminergic 
abnormalities in schizophrenia varies across the striatum, with the most marked 
dysfunction seen in the associative striatum. These findings suggest that 
anatomically selective modulation of dopamine function would be preferable[61]. This 
could have the potential benefit of reducing adverse effects that may occur secondary 
to dopamine antagonism in regions such as the cortex, where PET imaging evidence 
indicates dopamine signalling may be unaltered or even reduced in schizophrenia.  
 
The existing mechanistic understanding of striatal circuitry points at some possible 
therapeutic approaches that could allow more anatomically precise modulation of 
striatal dopamine function. One such mechanism, as discussed earlier, is muscarinic 
modulation of striatal dopamine release. Preclinical studies have shown that M4 a 
positive allosteric modulators (PAM) act on striatal MSNs to specifically inhibit 
dorsal striatum dopamine release via endocannabinoid signaling [114,115]. Other 
preclinical studies have shown that activation of group 1 metabotropic glutamate 
receptors may also selectively reduce dorsal striatum dopamine transmission via 
interaction with M4 receptors, but that unlike M4 activation, mGlu1 PAMs appear 
to have the advantage of not reducing motivational responding[115]. Encouragingly, 
a PAM of the M1/M4 receptor has shown efficacy in treating schizophrenia, although 





Concluding remarks and future perspectives 
 
Recent in vivo imaging evidence consistently suggests that the major abnormality in 
dopamine function in schizophrenia is located within the dorsal rather than the 
limbic striatum. Increasing knowledge regarding the structure, function, and 
neurochemistry of the striatum has improved our understanding of how these 
dopaminergic abnormalities may lead to symptoms. While these developments 
highlight potential pathways for the development of new treatments, the translation 
of these advances to meaningful clinical interventions, remains a significant challenge 




Is anatomically precise modulation of dopamine signalling within the striatum possible? The 
variation across the striatum both in terms of dopamine receptor distributions, and of the 
mechanisms that control striatal dopamine and striatal function, suggests that it may be, but 
this remains to be tested. 
 
Do endocannabinoids, GABAgeric, cholinergic, and glutamatergic interventions have 
therapeutic potential given their role in modulating striatal function? 
 
Do primary striatal abnormalities exist in schizophrenia, or is dysfunction entirely secondary 
to upstream pathology? Genes associated with schizophrenia, overlap significantly with genes 
expressed by MSNs but not with those expressed by dopamine neurons. Abnormalities such 
as patch-matrix differentiation, or ones associated with cholinergic interneurons might also 
contribute to striatal dysfunction in schizophrenia. Recently, greater densities of afferent 
excitatory synapses have been found in the NAcc of individuals with schizophrenia, this could, 
via the feedforward mechanisms discussed (figure 1A), drive increased dopamine release in 
the dorsal striatum.  
 
Are specific symptoms associated with dopamine dysregulation in specific striatal loci? For 
instance, are verbal hallucinations associated with dopaminergic abnormalities in striatal 
regions displaying connectivity to the secondary auditory cortex? Are motor symptoms 
associated with the motor striatum? 
 
What is the optimal striatal parcellation? Preclinical findings suggest current atlases may 
oversimplify the picture, and point at the importance of improving our understanding of 
striatal connectivity. Could we improve our ability to characterise striatal dopamine 
dysfunction by using individual participant functional or anatomical connectivity to 
parcellate the striatum in multimodal studies of schizophrenia? 
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Studies using positron emission tomography to image striatal dopamine function, 
have demonstrated that individuals with schizophrenia display increases in 
presynaptic function. Mesolimbic dysfunction specifically, has previously been 
suggested to underlie psychotic symptoms. This has not been directly tested in vivo, 
and the precise anatomical locus of dopamine dysfunction within the striatum 
remains unclear. The current paper investigates the magnitude of dopaminergic 
abnormalities in individuals with schizophrenia, and determines how the magnitude 
of abnormality varies across functional subdivisions of the striatum.  
 
Methods 
EMBASE, PsychINFO and MEDLINE were searched from January 1, 1960, to 
December 1, 2016. Inclusion criteria were molecular imaging studies that had 
measured presynaptic striatal dopamine functioning. Effects sizes for whole striatum 
and functional subdivisions were calculated separately. The magnitude of difference 
between functional subdivisions in patients and controls was meta-analysed.  
 
Results 
21 eligible studies were identified, including 269 patients and 313 controls. 
Individuals with schizophrenia (Hedges’ g=0.68, p<0.001) demonstrated elevated 
presynaptic dopamine functioning compared to controls. Seven studies examined 
functional subdivisions. These demonstrated significant increases in patients 
compared to controls in associative (g=0.73, p=0.002) and sensorimotor (g= 0.54, 
p=0.005) regions, but not limbic (g=0.29, p=0.09). The magnitude of the difference 
between associative and limbic subdivisions was significantly greater in patients 
compared to controls (g=0.39, p=0.003).  
 
Conclusion 
In individuals with schizophrenia dopaminergic dysfunction is greater in dorsal 
compared to limbic subdivisions of the striatum. This is inconsistent with the 
mesolimbic hypothesis and identifies the dorsal striatum as a target for novel 
treatment development. 
 






Dysfunction of the dopamine system is one of the most well established findings in 
schizophrenia.1–4 Initial evidence was mostly indirect: based on preclinical work, the 
behavioral effects of drugs, and post-mortem studies.5 The development of positron 
emission tomography (PET) and single-photon emission computed tomography 
(SPECT), allowed the dopamine system to be studied in vivo in individuals with 
schizophrenia.6 Initial studies employed ligands specific to dopamine receptors, and 
allowed the quantification of receptor availability, while later work was able to 
investigate dopamine synthesis and release, and other aspects of dopaminergic 
function. Previous meta-analyses of these imaging studies have found that the major 
dopaminergic abnormality in schizophrenia is increased presynaptic activity in the 
striatum.1,3 While an elevation of postsynaptic D2 receptors has also been proposed, 
meta-analytic findings have been less convincing,1 although the presynaptic results 
raise the possibility that receptor differences may be masked by increased endogenous 
dopamine levels.7–9 
 
Although cortical dopaminergic functioning has also been studied in 
schizophrenia,10,11 the main anatomical focus for investigations of dopamine 
dysfunction has been the striatum. Animal research has demonstrated that the 
striatum can be divided into three distinct sub-regions based on function and the 
predominant topography of brain projections from limbic, associative and 
sensorimotor cortical areas to the striatum (see Figure 1).12,13 The antero-ventral 
striatum receives projections from limbic areas such as the orbital frontal cortex and 
medial temporal lobe, and consequently has been termed the limbic striatum. 
Anatomically it comprises the nucleus accumbens, and ventral parts of the caudate 
and putamen. The associative striatum, involved in higher cognitive function, 
receives projections primarily from cortical regions involved in executive and other 
higher cognitive processes, such as the dorsolateral prefrontal cortex, and is made up 
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of the majority of the caudate, and the precommisural putamen. Finally, the 
sensorimotor striatum, involved in sensory and motor processing, receives afferent 
projections predominantly from sensory, motor and premotor areas and consists of 
the postcommisural putamen. More recent imaging studies have indicated that this 
topography is paralleled in the human brain.14,15  
 
 
Figure 1: The topography of cortical afferents to the striatum illustrating the functional 
subdivisions.  
Red indicates the limbic striatum, blue the associative striatum and yellow the sensorimotor striatum. 
 
Primarily based on preclinical research, dopaminergic hyperactivity of the limbic 
striatum has long been hypothesised as underlying psychotic symptoms.16–18 In vivo 
evidence for a specific mesolimbic abnormality has, however, been lacking. Initial 
imaging studies did not have sufficient resolution to visualize these subdivisions, and 
so reported values for either the whole striatum, or the anatomical divisions of 
caudate and putamen. However, improvements in PET cameras over the past decade 
have subsequently allowed dopaminergic function to be measured in these functional 
subdivisions. Work undertaken by Laruelle, Mawlawi, Martinez and colleagues,19,20 
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defined these subregions based on anatomical landmarks to allow the consistent 
reporting of subdivision findings in PET studies, and Howes, Egerton and colleagues 
determined the reliability of this approach.21 Initial studies using these functional 
divisions suggested that the greatest abnormality was within the associative 
striatum.8,22 Several further studies have since been performed, but the results have 
not been meta-analysed.  
 
In the current paper, we aim to test the mesolimbic hypothesis by comparing the 
magnitude of dysfunction between the limbic and other striatal subdivisions. We also 
provide an update to previous meta-analyses of striatal dopamine function given that 








EMBASE, PsychINFO and MEDLINE were searched from 1960 (or 1974 in the case 
of EMBASE), to December 31, 2016. Titles and abstracts were searched for the 
words: ("schizophrenia" or "psychosis" or "schizophreniform") AND ("Positron 
Emission Tomography" or "PET" or "Single photon emission tomography" or SPET 
or "Single Photon Emission Computed Tomography" or SPECT) AND (Dopamine). 
 
For the meta-analysis of presynaptic dopamine function in schizophrenia the 
inclusion criteria were: 1) studies of patients with schizophrenia diagnosed in 
accordance with criteria specified in the Diagnostic and Statistical Manual for Mental 
Disorders (DSM), or the International Classification of Diseases (ICD)23,24 and a 
control group; 2) reporting molecular imaging measures of presynaptic dopaminergic 
function (see supplementary methods for further details) for both the patient and 
control groups; 3) providing data enabling the estimation of mean difference between 
control and clinical groups for the dopaminergic measure; 4) for the subdivision 
analysis only studies reporting all three subdivisions (limbic, associative and 
sensorimotor subdivisions) were included to enable comparisons across regions. 
 
Studies reporting data on dopaminergic functioning in individuals with treatment 
resistant schizophrenia, or co-morbid substance dependence, were excluded. This is 
because the primary neurobiological abnormality in these patients may not involve 
striatal hyperdopaminergia.25–28  
 
Data extraction 
The primary outcome of interest was the dopamine imaging parameter reported for 
the patient and control groups. For studies using labelled L-DOPA this was the 
influx constant in the region of interest relative to uptake in the reference region, 
while for studies using a release or depletion paradigm this was percent change in 
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binding potential. In addition, author, year of study, number of participants, 
participant age and gender, illness duration, antipsychotic treatment, symptom 
scores, scan length, and whether an arterial input function was used were extracted.  
 
Two studies22,29 reporting data in individuals with schizophrenia were not included 
due to sample overlap with Howes et al 2013.30 Where values for the whole striatum 
were not given but data for the caudate and putamen were reported, whole striatum 
values were calculated as described previously1 by weighting these values by their 
volumes as reported in the Oxford-GSK-Imanova Structural–Anatomical Striatal 
Atlas (43% and 57% respectively). If the ventral striatum was also reported the 
following weightings were used to derive a summary outcome for the whole striatum: 
caudate – 36%, putamen – 48%, ventral striatum – 16% 31. 
 
Statistical analysis 
All statistical analyses were carried out using the ‘metafor’ package (version 1.9-9) 
in the statistical programming language R (version 3.3.1). A minimum of three 
studies was required for meta-analysis. Standard effect sizes (Hedges’ g) for 
individual studies were estimated. The individual study effect sizes were then entered 
into a random effects meta-analytic model using restricted maximum likelihood 
estimation. I2 values were calculated to estimate between study heterogeneity. Where 
there were at least ten studies included in a meta-analysis, funnel plots were 
constructed and visually inspected, and Egger’s regression test performed to check 
for the possibility of publication bias.32 Secondary subgroup and meta-regression 
analyses were undertaken to investigate the relationship between dopaminergic 
function  and antipsychotic treatment (studies where ≥75% of patients were 
antipsychotic naïve were grouped as studies of predominantly antipsychotic naïve 
patients), scan length, paradigm type, modelling techniques, patient age and severity 
of symptoms.33 The statistical significance of differences between subgroups was 
tested for by fitting separate random effects models for each subgroup,  and then 
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comparing the subgroup estimates in a fixed effects model with a Wald-type test. A 
significance level of P<0.05 (two tailed) was used for all analyses. 
 
To test the hypothesis that dopamine dysfunction is primarily located in limbic 
regions we first determined if there was a significant difference between patients and 
controls for each individual subdivision. We next calculated the magnitude of 
subdivision differences within group, and then determined whether the size of these 
differences significantly differed between groups (see below and supplementary 
information for further details). 
 
In order to contrast and quantify the degree of dysfunction between subdivisions, a 
meta-analysis of difference was undertaken. In this we performed an inter-group 
(patient vs control) comparison of the magnitude of intra-group subdivision 
differences (e.g. associative vs limbic). This approach employs methods used to 
quantify the propagation of errors.34 For each study, mean within subject differences 
in presynaptic function between subdivisions were calculated for both patient and 
control groups. For example, for patients the mean difference between associative 
and limbic measurements   equals: 
 
 
In order to calculate the standard deviation of this mean difference,  a correlation 
coefficient for presynaptic functioning between subdivisions is required (see 
supplementary information and eFigure 1 for full methods).35 We estimated this 
correlation coefficient from individual data for 37 subjects (21 controls and 16 
individuals with schizophrenia).36 This showed Pearson’s coefficients of 0.72, 0.84, 
and 0.87 for correlations between sensorimotor-limbic, associative-limbic, and 
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associative-sensorimotor divisions respectively. To be conservative the lowest of these 
values (0.72) was used for all comparisons.  For example, to calculate the standard 




Pal = Standard deviation of limbic-associative difference 
Pa = Standard deviation of associative subdivision values 
Pl = Standard deviation of limbic subdivision values 
ral = correlation between limbic and associative subdivision values 
 
 
We repeated the exercise to calculate the control mean difference ("#$), and standard 
deviation (&'()), and then calculated the combined standard deviation of both groups 
(&+'()).  
 
The between groups effect size for the study was then calculated for each sub-division 





This was converted to the bias corrected Hedges g,37 which was then entered into 
the standard meta-analytic model described above. For further information regarding 














eFigure 1: Values used in the meta-analysis of difference.  
For illustrative purposes only – in reality the limbic values are 





eFigure 2. Flow diagram illustrating study selection 
Results 
 
A total of 1798 papers were identified. 21 of these met inclusion criteria (PRISMA 























Studies of the Whole Striatum  
21 studies of individuals with schizophrenia met inclusion criteria (see table 1 for 
study details).  The studies included a total of 269 patients (256 with a diagnosis of 
schizophrenia, 3 schizoaffective disorder, and 10 a mixture of schizophrenia/ 
schizophreniform disorder) and 313 controls. Presynaptic dopamine function was 
significantly elevated in individuals with schizophrenia relative to controls with a 
summary effect size of 0.68 (see Figure 2., 95% C.I. 0.44-0.91; P<0.001). Egger’s 
regression test was not significant (z=1.21, P=0.23), indicating publication bias was 
unlikely. Visual inspection of the funnel plot potentially suggested asymmetry (see 
eFigure 3), but a trim and fill analysis did not indicate any missing studies. The I2 
value was 42.5%, suggesting a low to moderate level of heterogeneity. Subgroup 
meta-analysis of studies of predominantly drug naïve patients, and of patients who 
were receiving antipsychotic treatment, found a greater effect size in drug naïve 
patients (g=0.78, P<0.001 and 0.64, P<0.001 respectively, see eFigure 4) but this 
difference was not statistically significant (p=0.59). Studies using a challenge or 
depletion paradigm (g=0.95, P<0.001) showed a greater effect size when compared 
to those using labelled L-DOPA (g=0.52, P<0.001), and this difference was 
statistically significant (P=0.049, see eFigure5). Neither scan time (P=0.44) nor the 
use of an arterial input function (P=0.55) was significantly associated with 
magnitude of effect size in the labelled L-DOPA studies. Meta-regressions of effect 
sizes against age (p=0.29), total symptoms (p=0.16), and positive symptoms 
(p=0.39) were not significant.
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Study Controls Patients Scan details 
 N Age mean (SD)/yr 



























8  27 (7) 7 26 (7) Scz 24  All naive PANSS 
81(14) 



















Scz 79.2  4 naïve, 7 free for 
>14 days 
BPRS 28.8 (7.2) BPRS   
6.7 (2.8) 










7  All naïve  PANSS 77.6 (na) Na na Ki [18F]DOPA 
Lindström  
199965 
10 n/a 12 31(na) Scz 31  12 naïve, 2 drug 
free > 2yr 
na na na Ki [11C]DOPA 
Laruellea  
199940 
36 40 (9) 34 40 (9) Scz na 7 naïve, 27 free 
mean 104 days 










Scz 207.6  10 medicated 
10 drug free 







18 31 (8) 18 31 (8) Scz na 8 naïve, 10 free 
for mean 139 
days 







6 34 (na) 6 35 
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18 29 (7) 18 29 (8) Scz na 6 naïve, 4 free 














20 43 (12) 7 43 
(12) 









7 23.6 (2.7) 8 25.4 
(5.8) 
Scz 24 Free for 1 week PANSS 
76(18) 












na All naïve  na PANSS  
19.0 (3.8) 





















Scz na 16 medicated, 8 










10 29.1 (8.4) 3 30 
(16) 






12 30.3 (8.4) 12 31.1 
(9.8) 









22 24.5 (4.5) 16 26.3 
(4.4) 








Table 1: Studies of presynaptic dopamine function in individuals with schizophrenia 
a  – includes all subjects from Laruelle et al. (1996)71,72, Abi‐Dargham et al. (1998)  
b – includes the entire sample from McGowan et al (2004) 29 
AMPH: amphetamine, AMPT: alpha-methyl-para-tyrosine, BP: Binding Potential,  BPRS: Brief Psychiatric Rating Scale, CASH: Comprehensive Assessment of Symptoms and History, Ki: utilization rate constant of DOPA relative to a reference region, 

























Figure 2. Forest plot of studies investigating presynaptic dopaminergic function 
in the whole striatum for individuals with schizophrenia.  
The forest plot shows the effect size (hedges g) and 95% confidence interval for the difference between 
patients and controls. There is a significant elevation in schizophrenia with a summary effect size of 0.68. 
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eFigure 4. Studies of presynaptic dopamine function in individuals with 
schizophrenia. Studies meta-analyzed separately depending on whether patients 
antipsychotic exposed or predominantly naïve (≥75% patients naïve).  
Significant patient-control differences seen both in individuals who have been exposed to antipsychotics (g=0.65, 
P<0.001) and antipsychotic naïve individuals (g=0.78, P<0.001). 
  
eFigure 3. Funnel plot for studies of presynaptic 
dopamine function in individuals with schizophrenia.   


































eFigure 5. Studies of presynaptic dopamine function in individuals with schizophrenia. 
Studies meta-analysed separately depending on whether a challenge/depletion 
paradigm or labelled L-DOPA used to index dopamine function.  
Significant patient-control differences were seen in both types of study (p<0.001 for each), although the summary effect 
size was significantly greater for the challenge/depletion studies compared to the DOPA studies (p=0.046). 
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Studies of Limbic, Associative and Sensorimotor subdivisions 
Seven studies of individuals with schizophrenia reported associative, sensorimotor 
and limbic subdivisions. These reported data on a total of 104 patients with 
schizophrenia (schizophrenia or schizophreniform disorder), and 174 controls. All 
seven studies used the subdivision definitions proposed by Mawlawi et al,20 and 
Martinez et al.19 
 
Significant differences were found between patients and controls for associative 
(schizophrenia – g=0.73, p = 0.002) and sensorimotor (schizophrenia – g = 0.54, 
p=0.009) subdivisions, but not for the limbic subdivision (schizophrenia – g=0.29, 
p=0.09) (see Figure 3A-C). The results for the associative subdivision showed the 
greatest heterogeneity (I2= 58.3%), with sensorimotor (I2=37.7%), and limbic 
subdivisions (I2=29.5%) showing relatively low levels of heterogeneity. 
 
In individuals with schizophrenia, the difference between associative and limbic 
subdivisions was significantly greater in patients compared to controls (see Figure 
3c; effect size, g=0.38, P=0.004). Presynaptic dopaminergic function in schizophrenia 
was also significantly greater in the sensorimotor compared to the limbic subdivision 
compared to the difference in controls (g= 0.29, p=0.03). There were no significant 
patient-control differences as regards the comparisons between dopamine function in 
the associative and sensorimotor subdivision (g=0.08, p=0.55). These comparisons 
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differences are significantly greater in patients than in controls   
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) Effect size and 95%
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pared to controls. (C) M
agnitude of patient-control 
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ine functioning for striatal subdivisions in individuals w
ith schizophrenia (*p <0.05 for patient-control com
parison), error bars 





Our main finding is that individuals with schizophrenia display greater elevation in 
dopaminergic functioning in the dorsal (sensorimotor and associative) relative to 
limbic striatum compared controls (see figure 3). Moreover, there was no significant 
difference in presynaptic dopaminergic functioning between patients and controls for 
the limbic subdivision. This is, to our knowledge, the first study to meta-analyze 
differences between functional subdivisions of the striatum. Our analysis of the whole 
striatum included eight additional studies published since previous reviews but is 
consistent with their findings in showing an increase in schizophrenia.1,3 
 
Methodological considerations 
Moderate heterogeneity was seen in the studies of individuals with schizophrenia. 
Methodological factors such as differences in the resolution of scanners, measurement 
time, experimental paradigm, and modelling technique may contribute to this 
heterogeneity. In addition, differences in the clinical characteristics of patients could 
contribute to between study heterogeneity, given findings that increased 
dopaminergic activity is linked to acute psychosis.38–40 Some studies included 
antipsychotic treated patients. However, our sub-analysis in antipsychotic free/naïve 
patients showed no statistically significant difference between these groups, and the 
elevation in presynaptic dopamine function was numerically larger in naïve patients 
than in antipsychotic treated patients, indicating antipsychotic treatment is unlikely 
to account for the elevation we see. Moreover chronic antipsychotic treatment may 
reduce dopamine synthesis capacity in some patients.41 
 
We combined studies using challenge and depletion paradigms with those using 
radiolabeled DOPA. Whilst there is some evidence that results from challenge 
paradigms are directly related to results from radiolabeled DOPA studies,42,43 it 
should be recognized that these measures are indexing different, albeit related, 
aspects of dopaminergic function, and could be influenced by different factors. 
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Interestingly our sensitivity analysis found that effects were greater for the 
challenge/depletion studies (efigure 6), which could suggest that these aspects of the 
dopamine system are particularly affected in schizophrenia. 
 
Another factor contributing to heterogeneity could be the inclusion of individuals 
with treatment resistant schizophrenia, or with co-morbid substance dependence, 
given recent findings these groups may show reduced presynaptic dopamine 
functioning.25,27,28,44 While we excluded studies specifically including these patients, 
many studies pre-dated these recent findings and did not specify these as exclusion 
criteria. As such it is likely that some of the included studies may have contained 
treatment resistant patients; indeed two studies report including patients taking 
clozapine.9,45 However this would, if anything reduce effect sizes given treatment 
resistant patients do not seem to show presynaptic dopamine elevation.25,46  
 
We examined the difference between subdivisions, as, in the absence of individual 
patient data, this measure can be more accurately estimated than the ratio between 
subdivisions. A potential drawback of our measure is that if, for example, associative 
values are greater than limbic values, then a uniform proportionate increase in 
dopaminergic function across the whole striatum in the clinical group would lead to 
a greater absolute increase in the associative striatum, and thus give a larger 
associative-limbic difference. In our case, however, only two of the seven control 
groups had a value for the associative region that was greater than the limbic 
value.30,36 Therefore, if anything, effects related to general increases in striatal 
functioning would reduce the magnitude of our findings. 
 
When examining the differences between subdivisions, the assumed correlation 
between subdivisions has an influence on the precision of the estimated magnitude 
of difference between subdivisions, with a stronger correlation leading to larger effect 
sizes. The correlation coefficient we employed, however was conservative, using the 
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lowest of the correlation coefficients between subdivisions that we found in individual 
participant data. Using the largest coefficient of 0.87 gave an effect size of 0.50 
(p=0.01 for associative limbic measure, and 0.29 (p=0.01) for the sensorimotor-
limbic measure (See efigure 5). Thus, the differences we report may underestimate 
the magnitude of the true difference. 
 
The limbic striatum has a smaller volume than either the associative or sensorimotor 
subdivisions. As a result it is more susceptible to partial volume effects whereby its 
true activity may be diluted by spill over and spill in from adjacent regions.47 
However, given that there is no consistent evidence of reduced limbic striatal volumes 
in schizophrenia this would be expected to affect measures in patients and controls 
equally.48–51 Moreover one study employed partial volume correction and found a 
significant elevation in the associative striatum, but not in the limbic striatum in 
schizophrenia and clinical high risk groups relative to controls,52 consistent with our 
meta-analytic findings.  The fact that measures of dopamine functioning in the limbic 
striatum may be less reliable compared to measures in other subdivisions does mean, 
however, that it is possible the reduced limbic effect size (figure 3A) could be at least 
partially due to the increased noise inherent in measuring this region.21,53 This 
possibility is supported by some25,52 (but not all30,36,46) studies where the variance of 
the limbic measure, is noticeably greater than the variance of the associative 
measure. 
 
Neither partial volume effects, nor reduced signal-to-noise, however would account 
for the patient-control differences found when examining subdivision differences 
directly (figure 3B). In this case we are, for example, looking at limbic-associative 
differences in patients, and comparing this to the limbic-associative differences in 
controls. A reduction in signal-to-noise for the limbic measure will therefore affect 
patient and control findings equally, and will not bias the results. This means that 
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while the reduced reliability of limbic measurements may increase the risk of a false 
negative, in this specific analysis it will not increase the likelihood of a false positive. 
 
The anatomical locus of dopaminergic dysfunction in psychosis 
Our meta-analysis confirms, using a larger sample, the previous meta-analytic 
findings of increased presynaptic dopamine functioning in schizophrenia in the 
striatum.1 Moreover, our meta-analysis extends understanding of the nature of 
dopamine dysfunction in psychosis by showing that the degree of dopaminergic 
dysfunction varies across the striatum, and identifies the dorsal striatum as the 
predominant locus of dopamine dysfunction in psychosis. Although patients showed 
no significant alteration in the limbic striatum relative to controls, we cannot rule 
out the possibility of a small difference in this subdivision. Nevertheless, in patients 
the dorsal to ventral balance was significantly shifted dorsally in patients when 
compared to controls. While a small mesolimbic abnormality may exist, overall these 
findings are not consistent with a hypothesis which proposes that the predominant 
locus of dopamine dysfunction is the limbic striatum.  
 
Our findings thus suggest that models highlighting a primary role for excessive 
mesolimbic dopamine transmission in psychosis may need to be revised.12–14,28 The 
associative subdivision receives dopaminergic innervation from the substantia nigra, 
12 suggesting that nigrostriatal pathways may be disrupted in schizophrenia. This 
hypothesis is in keeping with findings of increases in some,30,55 although not all,10 
aspects of dopamine functioning within the substantia nigra in schizophrenia. The 
elevation was greatest in the associative striatum, although this was not significantly 
greater than the elevation in the sensorimotor striatum. 
 
It should be noted, that while our findings support the hypothesis that dopaminergic 
functioning within the associative striatum may be abnormal in schizophrenia, this 
does not preclude the possibility that the primary site of dysfunction exists in another 
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brain region.5 The associative part of the dorsal striatum receives projections 
predominantly from dorso-lateral prefrontal cortex.13 Thus the dorsal locus of 
dopamine abnormality is consistent with the hypothesis that frontal cortical 
dysfunction underlies striatal dopamine abnormalities,16,56 although causality 
remains to be established in clinical studies. 
 
Our findings also question the proposal that mesolimbic selectivity is a desirable 
property for pharmacological treatments of schizophrenia,57 and suggest instead that 
selectivity for the dorsal, particularly associative, striatum may show advantages in 
both efficacy and tolerability. Treatment strategies may be able to make use of the 
neurochemical distinctions found across striatal subdivisions. For example, dopamine 
transporter densities are greater in the ventral, compared to dorsal, striatum.58 Due 
to this variable distribution, combination therapy with a dopamine reuptake 
inhibitor and D2 antagonist could potentially reduce dopaminergic 
neurotransmission to a greater degree in the dorsal, as opposed to ventral striatum. 
There are potential risks to this approach, but evidence suggests that in some 
patients it may have benefits for the amelioration of negative symptoms.59   
 
In conclusion, current molecular neuroimaging studies suggest that in individuals 
with schizophrenia the major locus of dopamine dysfunction is the dorsal striatum, 
and significant elevations were not seen in the limbic striatum. These findings are 
inconsistent with the mesolimbic hypothesis of schizophrenia, and suggest treatments 








Declaration of interest: RM, KB, and SJ declare no conflicts of interest. ODH has 
received investigator-initiated research funding from and/or participated in 
advisory/ speaker meetings organised by Astra-Zeneca, Autifony, BMS, Eli Lilly, 
Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and 
Roche.  Neither Dr Howes or his family have been employed by or have holdings/ 
a financial stake in any biomedical company. 
 
Funding: This work was supported by Medical Research Council-UK (no. MC-
A656-5QD30), Maudsley Charity (no. 666), Brain and Behavior Research 
Foundation, and Wellcome Trust (no. 094849/Z/10/Z) grants to ODH, a Wellcome 
Trust (no. 200102/Z/15/Z) grant to RM, and the National Institute for Health 
Research (NIHR) Biomedical Research Centre at South London and Maudsley 
NHS Foundation Trust and King’s College London. The views expressed are those 
of the author(s) and not necessarily those of the NHS, the NIHR or the 







1.  Howes OD, Kambeitz J, Stahl D, et al. The Nature of Dopamine Dysfunction 
in Schizophrenia and What This Means for Treatment. Arch Gen Psychiatry. 
2012;69(8):776–786. 
2.  Howes OD, McCutcheon R, Owen MJ, Murray RM. The Role of Genes, 
Stress, and Dopamine in the Development of Schizophrenia. Biol Psychiatry. 
2017;81(1):9–20. 
3.  Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in 
schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. 
Schizophr Bull. 2013;39(1):33–42. 
4.  Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in 
schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) 
density. Schizophr Bull. 2013;39(1):22–32. 
5.  Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: 
An update for the 21st century. J Psychopharmacol. 2015;29(2):97–115. 
6.  Howes O, Egerton A, Allan V. Mechanisms underlying psychosis and 
antipsychotic treatment response in schizophrenia: insights from PET and 
SPECT imaging. Curr Pharm Des. 2009;15(22):2550–2559. 
7.  Seeman P, Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc 
Natl Acad Sci U S A. 2000;97(14):7673–5. 
8.  Kegeles LS, Abi-Dargham A, Frankle WG, et al. Increased synaptic dopamine 
function in associative regions of the striatum in schizophrenia. Arch Gen 
Psychiatry. 2010;67(3):231–9. 
9.  Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy 




10.  Slifstein M, van de Giessen E, Van Snellenberg J, et al. Deficits in Prefrontal 
Cortical and Extrastriatal Dopamine Release in Schizophrenia. JAMA 
Psychiatry. 2015;10032:1–9. 
11.  Kambeitz J, Abi-Dargham A, Kapur S, Howes O. Alterations in cortical and 
extrastriatal subcortical dopamine function in schizophrenia: systematic review 
and meta-analysis of imaging studies. Br J Psychiatry. 2014;204(6):420–429. 
12.  Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in 
primates form an ascending spiral from the shell to the dorsolateral striatum. 
J Neurosci. 2000;20(6):2369–2382. 
13.  Haber SN. Corticostriatal circuitry. Dialogues Clin Neurosci. 2016;18(1):7–21. 
14.  Di Martino A, Scheres A, Margulies DS, et al. Functional connectivity of 
human striatum: a resting state fMRI study. Cereb cortex. 2008;18(12):2735–
47. 
15.  Draganski B, Kherif F, Klo S, et al. Evidence for Segregated and Integrative 
Connectivity Patterns in the Human Basal Ganglia. J Neurosci. 
2008;28(28):7143–7152. 
16.  Weinberger D. Implications of normal brain development for the pathogenesis 
of schizophrenia. Arch Gen Psychiatry. 1987;45(11):1055. 
17.  Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review 
and reconceptualization. Am J Psychiatry. 1991;148:1474–1486. 
18.  Sadock BJ, Sadock VA. Kaplan & Sadock’s concise textbook of clinical 
psychiatry. Lippincott Williams & Wilkins; 2008. 
19.  Martinez D, Slifstein M, Broft A, et al. Imaging Human Mesolimbic Dopamine 
Transmission With Positron Emission Tomography . Part II : Amphetamine-
Induced Dopamine Release in the Functional Subdivisions of the Striatum. J 
Cereb Blood Flow Metab. 2003;23:285–300. 
20.  Mawlawi O, Martinez D, Slifstein M, et al. Imaging Human Mesolimbic 
Dopamine Transmission With Positron Emission Tomography : I . Accuracy 
 
108 
and Precision of D 2 Receptor Parameter Measurements in Ventral Striatum. 
J Cereb Blood Flow Metab. 2001;21:1034–1057. 
21.  Egerton A, Demjaha A, McGuire P, Mehta MA, Howes OD. The test-retest 
reliability of 18F-DOPA PET in assessing striatal and extrastriatal 
presynaptic dopaminergic function. Neuroimage. 2010;50:524–531. 
22.  Howes OD, Montgomery AJ, Asselin M-C, et al. Elevated striatal dopamine 
function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 
2009;66(1):13–20. 
23.  World Health Organization. The ICD-10 classification of mental and 
behavioural disorders.; 1992. 
24.  American Psychiatric Association. Diagnostic and statistical manual of mental 
disorders (DSM-5®). American Psychiatric Pub; 2013. 
25.  Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD. Dopamine 
synthesis capacity in patients with treatment-resistant schizophrenia. Am J 
Psychiatry. 2012;169(11):1203–10. 
26.  Howes OD, Kapur S. A neurobiological hypothesis for the classification of 
schizophrenia: Type a (hyperdopaminergic) and type b (normodopaminergic). 
Br J Psychiatry. 2014;205:1–3. 
27.  Thompson JL, Urban N, Slifstein M, et al. Striatal dopamine release in 
schizophrenia comorbid with substance dependence. Mol Psychiatry. 
2013;18(8):909–15. 
28.  Bloomfield M a P, Morgan CJ a, Egerton A, Kapur S, Curran HV, Howes OD. 
Dopaminergic function in cannabis users and its relationship to cannabis-
induced psychotic symptoms. Biol Psychiatry. 2014;75(6):470–8. 
29.  Mcgowan S, Lawrence AD, Sales T. Presynaptic Dopaminergic Dysfunction in 
Schizophrenia. Arch Gen Psychiatry. 2004;61(2):134–142. 
30.  Howes OOD, Williams M, Ibrahim K, et al. Midbrain dopamine function in 
schizophrenia and depression: a post-mortem and positron emission 
tomographic imaging study. Brain. 2013;136(11):3242–3251. 
 
109 
31.  Tziortzi AC, Searle GE, Tzimopoulou S, et al. Imaging dopamine receptors in 
humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy. 
Neuroimage. 2011;54(1):264–277. 
32.  Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining 
and interpreting funnel plot asymmetry in meta-analyses of randomised 
controlled trials. BMJ. 2011;343(7109):d4002. 
33.  Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of 
Interventions. John Wiley & Sons; 2008. 
34.  Ku HH. Notes on the use of propagation of error formulas. J Res Natl Bur 
Stand Sect C Eng Instrum. 1966;70C(4):263. 
35.  Borenstein M, L.V. H, Higgins JPT, Rothstein HR. Introduction to Meta-
Analysis - Complex Data Structures. John Wiley & Sons; 2009. 
36.  Jauhar S, Nour MM, Veronese M, et al. A Test of the Transdiagnostic 
Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic 
Imaging in Bipolar Affective Disorder and Schizophrenia. JAMA Psychiatry. 
2017. 
37.  Hedges L V. Distribution Theory for Glass’s Estimator of Effect Size and 
Related Estimators. J Educ Stat. 1981;6(2):107. 
38.  Valli I, Howes OD, Tyrer P, McGuire P, Grasby PM. Longitudinal PET 
Imaging in a Patient With Schizophrenia Did Not Show Marked Changes in 
Dopaminergic Function With Relapse of Psychosis. Am J Psychiatry. 
2008;165(12):1613–1614. 
39.  Howes O, Bose S, Turkheimer F, et al. Progressive increase in striatal 
dopamine synthesis capacity as patients develop psychosis : a PET study. Mol 
Psychiatry. 2011;16(9):885–886. 
40.  Laruelle M, Abi-Dargham  a, Gil R, Kegeles L, Innis R. Increased dopamine 




41.  Gründer G, Vernaleken I, Müller MJ, et al. Subchronic Haloperidol 
Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic 
Patients In Vivo. Neuropsychopharmacology. 2003;28(4):787–794. 
42.  Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. 
Baseline and amphetamine-stimulated dopamine activity are related in drug-
naïve schizophrenic subjects. Biol Psychiatry. 2009;65(12):1091–3. 
43.  Piccini P, Pavese N, Brooks DJ. Endogenous dopamine release after 
pharmacological challenges in Parkinson’s disease. Ann Neurol. 
2003;53(5):647–653. 
44.  Mizrahi R, Kenk M, Suridjan I, et al. Stress-Induced Dopamine Response in 
Subjects at Clinical High Risk for Schizophrenia with and without Concurrent 
Cannabis Use. Neuropsychopharmacology. 2013;39(6):1479–1489. 
45.  Elkashef A, Doudet D, Bryant T. 6- 18 F-DOPA PET study in patients with 
schizophrenia. Psychiatry Res Neuroimaging. 2000;100(1):1–11. 
46.  Kim E, Howes OD, Veronese M, et al. Presynaptic Dopamine Capacity in 
Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An 
[18F]DOPA PET Study. Neuropsychopharmacology. 2017;42(4):941–950. 
47.  Kim E, Shidahara M, Tsoumpas C, et al. Partial volume correction using 
structural-functional synergistic resolution recovery: comparison with 
geometric transfer matrix method. J Cereb Blood Flow Metab. 2013;33(6):914–
20. 
48.  van Haren NEM, Schnack HG, Koevoets MGJC, Cahn W, Hulshoff Pol HE, 
Kahn RS. Trajectories of subcortical volume change in schizophrenia: A 5-year 
follow-up. Schizophr Res. 2016;173(3):140–145. 
49.  Gunduz H, Wu H, Ashtari M, et al. Basal Ganglia Volumes in First-Episode 
Schizophrenia and Healthy Comparison Subjects. 2002;51:801–808. 
50.  Bois C, Levita L, Ripp I, et al. Hippocampal, amygdala and nucleus 
accumbens volume in first-episode schizophrenia patients and individuals at 
 
111 
high familial risk: A cross-sectional comparison. Schizophr Res. 
2015;165(1):45–51. 
51.  Lauer M, Senitz D, Beckmann H. Increased volume of the nucleus accumbens 
in schizophrenia. J Neural Transm. 2001;108(6):645–660. 
52.  Mizrahi R, Addington J, Rusjan PM, et al. Increased stress-induced dopamine 
release in psychosis. Biol Psychiatry. 2012;71(6):561–7. 
53.  Yoder KK, Albrecht DS, Kareken DA, et al. Test-retest variability of 
[11C]raclopride-binding potential in nontreatment-seeking alcoholics. Synapse. 
2011;65(7):553–561. 
54.  Stahl S. Stahl’s essential psychopharmacology: neuroscientific basis and 
practical applications. Cambridge University Press: Cambridge University 
Press; 2013. 
55.  Kumakura Y, Cumming P, Vernaleken I, et al. Elevated [18F]fluorodopamine 
turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron 
emission tomography study. J Neurosci. 2007;27(30):8080–7. 
56.  Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III--
the final common pathway. Schizophr Bull. 2009;35(3):549–62. 
57.  Kinon BJ, Lieberman J a. Mechanisms of action of atypical antipsychotic 
drugs: a critical analysis. Psychopharmacology (Berl). 1996;124(1–2):2–34. 
58.  Haber SN, Knutson B. The Reward Circuit : Linking Primate Anatomy and 
Human Imaging. Neuropsychopharmacology. 2009;35(1):4–26. 
59.  Lindenmayer JP, Nasrallah H, Pucci M, James S, Citrome L. A systematic 
review of psychostimulant treatment of negative symptoms of schizophrenia: 
Challenges and therapeutic opportunities. Schizophr Res. 2013;147:241–252. 
60.  Reith J, Benkelfat C, Sherwin  a, et al. Elevated dopa decarboxylase activity 




61.  Hietala J, Syvälahti E, Kuoppamäki M, et al. Presynaptic dopamine function 
in striatum of neuroleptic-naive schizophrenic patients. Lancet. 
1995;346(8983):1130–1131. 
62.  Dao-Castellana MH, Paillère-Martinot ML, Hantraye P, et al. Presynaptic 
dopaminergic function in the striatum of schizophrenic patients. Schizophr 
Res. 1997;23(2):167–74. 
63.  Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated 
amphetamine-induced synaptic dopamine concentrations: evidence from a 
novel positron emission tomography method. Proc Natl Acad Sci U S A. 
1997;94(6):2569–74. 
64.  Hietala J, Syvälahti E, Vilkman H, et al. Depressive symptoms and 
presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr 
Res. 1999;35(1):41–50. 
65.  Lindstrom LH, Gefvert O, Hagberg G, Lundberg T. Increased dopamine 
synthesis rate in medial prefrontal cortex and striatum in schizophrenia 
indicated by L-(β- 11 C) DOPA and PET. Biol Psychiatry. 1999;46(5):681–
688. 
66.  Meyer-Lindenberg A, Miletich RS, Kohn PD, et al. Reduced prefrontal 
activity predicts exaggerated striatal dopaminergic function in schizophrenia. 
Nat Neurosci. 2002;5(3):267–71. 
67.  Nozaki S, Kato M, Takano H, et al. Regional dopamine synthesis in patients 
with schizophrenia using L-[beta-11C]DOPA PET. Schizophr Res. 2009;108(1–
3):78–84. 
68.  Shotbolt P, Stokes PR, Owens SF, et al. Striatal dopamine synthesis capacity 
in twins discordant for schizophrenia. Psychol Med. 2011;41(11):2331–8. 
69.  Pogarell O, Koch W, Karch S, et al. Dopaminergic neurotransmission in 
patients with schizophrenia in relation to positive and negative symptoms. 
Pharmacopsychiatry. 2012;45 Suppl 1:S36-41. 
 
113 
70.  Caravaggio F, Borlido C, Wilson A, Graff-Guerrero A. Examining endogenous 
dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission 
tomography: A pilot study. Clin Chim Acta. 2015;449:60–62. 
71.  Laruelle M, Abi-Dargham A, Dyck CH Van, et al. Single photon emission 
computerized tomography imaging of schizophrenic subjects. Proc Natl Acad 
Sci. 1996;93:9235–9240. 
72.  Abi-Dargham  a, Gil R, Krystal J, et al. Increased striatal dopamine 







The measurement of presynaptic dopamine functioning 
 
Methods for measurement of presynaptic dopamine function included the use of 
either radiolabelled L-dopa, or a dopamine receptor ligand in combination with a 
release or depletion paradigm.  Radiolabelled L-dopa provides a measure of 
presynaptic dopamine synthesis capacity.1,2 Amphetamine stimulates dopamine 
release from neuron terminals, and inhibits its reuptake to increase extracellular 
dopamine levels.3 This can be quantified by measuring the degree to which 
amphetamine induced dopamine release displaces postsynaptic D2/3 receptor 
radioligands.4,5 A similar method can be employed to measure the magnitude of 
dopamine release in response to a psychological stress.6 Conversely, the 
administration of the dopamine depleting agent alpha methyl-paratyrosine, allows 
intrasynaptic levels of dopamine to be deduced, by measuring the increase in D2/3 
radioligand binding following dopamine depletion.7,8 Together, these paradigms can 
be taken as measures of presynaptic dopamine functioning.9   
 
 
Calculating whole striatal values from caudate and putamen values 
 
A number of papers did not report whole striatal values but only anatomical 
subdivisions of caudate, putamen and ventral striatum. In these cases a whole striatal 
value was calculated based on previously reported methods.9 Volume based 
weightings were derived from the Oxford-GSK-Imanova Structural–anatomical 
Striatal Atlas to give weights of 0.43 and 0.57 respectively.10 If ventral striatum was 
also reported we used weights of 0.48, 0.36 and 0.16 for the caudate, putamen and 
ventral striatum respectively. A correlation of 0.7 for  was used (as in the analysis 
of difference of functional subdivisions). If it was necessary to combine left and right 
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caudate/putamen, when the bilateral result was not reported, a correlation 





Calculating effect sizes for subdivision differences 
 
In order to quantify the difference in dopaminergic alterations between subdivisions 
a meta-analysis of difference was undertaken. This involved calculating for each 
study mean within-group differences for subdivisions, and then contrasting patient 
and control groups against one another. eFigure 1 illustrates the measurements used. 
The mathematical basis of this comparison is well established and is based upon the 
concept of propogation of variance.11 Below follows an illustrative example, 
comparing associative and limbic subdivisions: 
 
 
1. We first quantified the within group difference in subdivision means for an 
individual study:  
 
For patients the mean difference between associative and limbic 
measurements (!"#): 
 
!"# = !" − !# 
'!" = ()*+*,,-./*0/1)1*23)4 





2. The standard deviation of this difference (6789) can be calculated as follows: 
 




This requires the calculation of the correlation coefficient ‘’ between presynaptic 
functioning in the various subdivisions.12 Examination of individual patient 
data from Jauhar et al13 (in press) showed Pearson’s coefficients of 0.72, 0.84, 
and 0.87 for correlations between sensorimotor-limbic, associative-limbic, and 
associative-sensorimotor respectively. The lowest (i.e. most conservative) of 
these values (0.72) was used for all comparisons. 
 
Repeating the exercise for the controls allows the calculation of the control 
mean difference (?"#), and standard deviation (6@89) . 
 
3. The following steps are simply those used to calculate a between groups  
effect size in the usual manner. In the current study this was performed in R 
using the metafor package. The values calculated above allow for the calculation 
of the combined standard deviation of both groups: 
 
67@"# = A
(+7 − 1)6789; + (+@ − 1)6@89; + +7'!"# − !?"#4 + +@(?"# − !?"#)
(+7 + +@ − 1)
 
 
Which allows for the calculation of the between groups effect size for the study:  
 





This can be bias corrected in the usual manner to provide Hedges g, which can 
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Striatal dopamine dysfunction has been proposed to underlie symptoms in psychosis, 
yet it remains unclear how a single neurotransmitter could underlie the diverse and 
heterogeneous presentations that are observed in clinical practice. One hypothesis is 
that the symptomatic consequences of aberrant dopamine signalling may vary 
depending on precisely where within the striatum this dysfunction occurs. We test 
this hypothesis for the first time using a multimodal imaging approach in 29 
unmedicated and minimally-treated patients with first episode psychosis and 21 
healthy controls.  Patients were clinically assessed using the Positive and Negative 
Syndrome Scale at baseline, and following a minimum of four weeks’ treatment with 
a dopamine-2 receptor antagonist. Each participant received two brain scans at 
baseline assessment: one 18F-DOPA positron emission tomography to index striatal 
dopamine synthesis capacity, and a resting state functional MRI to map 
corticostriatal functional connectivity. We used these participant-specific functional 
connectivity maps to derive the preferential cortical connectivity of each voxel within 
the striatum separately for each participant. Dopamine synthesis capacity within 
areas of the striatum showing strong functional connections to sensorimotor cortex 
was related to the baseline motor symptoms (p=0.01), and the change in motor 
symptoms following treatment (p=0.001). We also found associations between 
negative symptoms and striatal dopamine synthesis capacity in striatal regions 
connected to the default mode cortical network, and between affective symptoms 
and regions connected to the cinguloopercular cortical network. No relationship was 
observed between hallucinations and dopamine function in striatal regions connected 
to auditory regions (p>0.05). These findings suggest that the heterogeneity of 
symptoms and response to treatment observed in psychosis partly results from 
individual differences in the topography of dopamine dysfunction within the striatum 
and cortico-striatal circuits. 
 





Psychotic symptoms occur across a range of mental illnesses including schizophrenia, 
bipolar disorder, and psychotic depression. Even when examining a single disorder 
such as schizophrenia, marked symptomatic diversity exists, with clusters including 
positive symptoms such as hallucinations and delusions, negative symptoms such as 
emotional blunting and amotivation, motor symptoms and cognitive deficits (Arndt, 
1995; Marder et al., 1997; McGrath et al., 2004; Jauhar et al., 2018a). Given that 
both symptom and neurobiological abnormalities manifest across multiple mental 
illnesses (McTeague et al., 2017), there has been an increasing focus on characterising 
neuronal circuits that have transdiagnostic relevance for understanding 
psychopathology (Insel et al., 2010; Insel and Cuthbert, 2015). It has been proposed 
that psychotic symptoms result from aberrant dopamine signalling within the 
striatum (Abi-Dargham et al., 1998; Laruelle and Abi-Dargham, 1999; Laruelle et 
al., 1999; Heinz and Schlagenhauf, 2010; McCutcheon et al., 2019), based on findings 
that dopamine agonists induce psychotic symptoms whilst dopamine antagonists 
treat them (Bell, 1973; Seeman and Lee, 1975), as well as preclinical studies (Grace, 
2016), theoretical models (Maia and Frank, 2017), and in vivo measurement of 
striatal dopamine function using positron emission tomography (PET) (Laruelle et 
al., 1996, 1999; Abi-Dargham et al., 1998; Heinz and Schlagenhauf, 2010; 
McCutcheon et al., 2018a). Most work has focused on the link between positive 
symptoms and dopamine (Laruelle and Abi-Dargham, 1999; Laruelle et al., 1999; 
Heinz and Schlagenhauf, 2010; Jauhar et al., 2017), and it remains an open question 
as to whether striatal dopamine alterations are linked to other symptoms seen in 
psychotic disorders.   
 
The striatum is a central processing hub within the brain, receiving input from 
almost the entire cortex (Haber, 2016), and as such plays a role in sensory, motor, 
affective, and cognitive processes (Phillips et al., 2003; Grahn et al., 2008; Guo et 
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al., 2018). Thus, dysfunction in the striatum could disrupt these systems to lead to 
hallucinations, delusions, emotional blunting and other affective symptoms, motor 
symptoms and cognitive deficits. Cortical neurons largely project to discrete regions 
within the striatum, so there is a topographical distribution of cortical inputs to the 
striatum (Haber, 2016). Dopamine is a neuromodulator that plays a key role in 
regulating inputs and signal transmission from the striatum. Given the topographical 
distribution of cortical inputs, this suggests that the localisation of dopamine 
dysfunction within the striatum may determine the corticostriatal circuits most 
affected (McCutcheon et al., 2019). For example, dopamine dysfunction within 
regions of the striatum receiving input from cortical auditory areas might disrupt 
auditory processing to lead to auditory hallucinations, while dopamine dysfunction 
within regions connected to motor areas would lead to motor symptoms.  
 
Several recent advances have made it possible to test this hypothesis in vivo. 
Improvements in the resolution of PET scanners have meant that greater anatomical 
precision is possible when imaging striatal dopamine. This has led to the finding that 
dopamine dysfunction in schizophrenia is not uniform across the striatum, but shows 
significant spatial variability (Howes et al., 2009; Kegeles et al., 2010; McCutcheon 
et al., 2018a, 2019). Additional advances in our understanding regarding the role of 
dopamine have also come from findings that striatal dopamine synthesis capacity 
predicts symptomatic change following treatment with a dopamine antagonist 
(Jauhar et al., 2018c). In addition, recent in vivo studies using resting state 
functional magnetic resonance imaging (rMRI) have shown that functional 
corticostriatal connections can be identified based on the patterns of correlated 
neural activity (Choi et al., 2012; Jaspers et al., 2017). These developments together 
allow us to map both corticostriatal connectivity, and spatial variability in striatal 
dopamine, and to test the hypothesis that variation in dopamine function across the 





In the current study, we use rMRI to map functional corticostriatal connections in 
individuals presenting with a first episode psychosis, and PET to examine striatal 
dopamine synthesis capacity within the same individuals. By combining rMRI and 
PET we were able to evaluate dopamine function within subregions of the striatum 
that had been defined on the basis of their cortical connectivity at an individual 
level.  We used this data-driven parcellation to examine whether dopamine synthesis 
capacity within individualised connectivity-defined regions correlated with specific 
symptoms at baseline assessment, and to improvement in symptoms following 
treatment with a D2 receptor antagonist. We hypothesised that distribution of 
symptom-dopamine relationships across the striatum would reflect the individual 
topography of cortical projections to the striatum. We focused on auditory 
hallucinations and motor symptoms as the secondary auditory cortex and motor 
cortical areas show well circumscribed projections to the striatum, and there are 
clear apriori potential relationships between symptoms and neurobiological 
substrate. Specifically, we predicted that both baseline severity and change in 
severity of hallucinations and of motor symptoms would correlate with dopamine 
synthesis capacity in striatal regions preferentially connected to auditory and motor 
cortex, respectively. We also undertook an exploratory analysis to determine whether 
there were relationships between dopamine function in other striatal regions and 
other symptom clusters. Finally, we compared our connectivity defined striatal 
parcellation with published atlas-defined subdivisions (Mawlawi et al., 2001; 
Martinez et al., 2003), in order to examine whether our individualised connectivity-
based method is able to provide additional information over an atlas-based approach.  
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Materials and methods 
 
Overview 
29 first episode psychosis patients and 21 healthy controls received a 3,4-dihydroxy-
6-[18F]fluoro-L-phenylalanine (18F-DOPA) PET scan and an MRI scan at baseline. 
Clinical ratings were performed at baseline, and for 19 patients ratings were 
performed for a second time after a minimum of four weeks treatment with a D2 
receptor antagonist (given that this is the period during which most symptomatic 
response occurs) (Agid et al., 2003; Kahn et al., 2008; Kinon et al., 2010). 
 
For each participant, we used functional connectivity between cortical resting state 
networks and the striatum to generate individualised connectivity-defined striatal 
maps. We use these maps to calculate dopamine synthesis capacity for striatal 
subregions preferentially connected to each cortical network, and investigated 
whether dopamine function within these different striatal regions showed a 
relationship with both baseline symptomatology and change in symptoms. The 
statistical significance of these symptom-dopamine correlations was then tested with 
a permutation testing approach to investigate the specificity of the observed 
relationship. The analysis approach is summarised in Figure 1 and described in detail 






Figure 1. Overview of methods.  
(A) Participants receive clinical assessment, MRI and PET at baseline, a subset of patients then received clinical followup. Analysis of 
baseline data consisted of: (A) Cortical nodes are assigned to networks based on corticocortical resting state functional connectivity (B) 
Connectivity of each striatal voxel to these cortical networks is calculated (C) Weighted striatal connectivity maps produced for each 
network (see eFigure 1 and figure 2b) (D) Voxelwise Kicer maps weighted by these striatal connectivity maps to give a Kicer value for each 
network 
 
(B) Significance testing of Kicer-symptom relationships using a permutation testing approach. In addition to  permuting participants (not 
pictured) cortical ROIs were permuted to generate null distributions: (A)Cortical ROIs shuffled into random networks 10,000 times (B) 
These shuffled network sets used to calculate Kicer with the same method described above in 1A (C)Symptom-Kicer correlations calculated for 
each null set of Kicer (D)Null distribution created from repeating step C for each of the null network sets (E) True correlation values 




Participants were experiencing their first episode of a psychotic illness, meeting ICD-
10 criteria (World Health Organization, 1992), with no previous illness or treatment 
episodes, and were either antipsychotic naïve (n=11), antipsychotic free for at least 
6 weeks (n=16), or minimally treated for less than 2 weeks (n=2). Age-matched 
(within 5 years) healthy controls were recruited from the same geographical area 
through local media advertisements. Controls had no previous or current history of 
psychiatric illness (assessed by the Structured Clinical Interview for DSM-IV Axis I 
disorders), no concurrent psychotropic medication use, and no family history of 
psychosis. See Supplementary Methods and previously published reports for further 
details regarding recruitment and assessment (Jauhar et al., 2018c, b). A subset of 
participants subsequently received treatment with a D2 receptor antagonist or partial 
agonist and clinical follow up. Change in individual symptoms was quantified as the 
difference between baseline and follow up scores. Some of the PET data for these 
participants has been previously reported (Jauhar et al., 2017, 2018b). 
 
Image Acquisition 
Participants received a 18F-DOPA pet scan, providing a measure of striatal dopamine 
synthesis capacity (Kumakura and Cumming, 2009). The cerebellum was used as a 
reference region, and voxelwise parametric images of dopamine synthesis capacity 
(Kicer) were constructed from movement-corrected images using a wavelet-based 
Patlak approach (Turkheimer et al., 2006). We also determined Kicer for limbic, 
associative (the pre- and postcommissural caudate, and precommissural putamen) 
and sensorimotor (post-commisural putamen) striatal subdivisions, using the atlas-
based parcellation approach outlined by Martinez et al. (Martinez et al., 2003). 
Participants also received a 8.5 minute rfMRI scan on a 3T GE Signa MR scanner. 
See Supplemental Methods for further details. 
 
Image Analysis – Cortical Network Definition 
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fMRI signal time series were extracted from the 333 cortical regions (nodes) of the 
Gordon cortical atlas. Functional connectivity between every pair of nodes was 
defined as the pairwise z-transformed Pearson correlation coefficients between the 
fMRI timeseries of each region (Gordon et al., 2016), and was used to define a 
333*333 functional connectivity matrix for each participant. The Louvain 
community detection algorithm was then employed on this whole-cortex connectivity 
matrix, to group each cortical node into non-overlapping communities in a manner 
that maximises the modularity of the final network (Blondel et al., 2008). The 
detected communities corresponded to well recognised resting state networks: the 
default mode, sensorimotor, cinguloopercular, dorsal attention, auditory and visual 
networks. The visual network, however, was excluded from subsequent analyses 
given its relative lack of direct connections with the striatum (Parent and Hazrati, 
1995). Analysis was performed with in-house python code freely available at 
https://github.com/robmcc10/DOPA_symptom. 
 
Image Analysis - Striatal Parcellation and PET Integration 
An individual level probabilistic approach was employed. For each participant, for 
each cortical network identified above, each striatal voxel was assigned a connectivity 
score between 0 and 1 based on its mean connectivity to all nodes within that 
network (see eFigure 1). A weighted striatal map was thereby constructed for each 
of the networks identified. These striatal maps were then overlaid on the PET 
voxelwise Kicer maps to enable the calculation of network-specific Kicer values.  
 
These network-specific Kicer values were compared with the Kicer values calculated 
using the traditional (atlas-based) approach of Martinez et al (Mawlawi et al., 2001; 
Martinez et al., 2003). Specifically, the correlation coefficients between subdivisions  
across all participants defined with one method were compared to the correlation 
coefficients between subdivisions defined using the other method, using a procedure 
implemented in the R package cocor (version 1.1-3) (Silver et al., 2004). This allowed 
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us to determine whether the connectivity based parcellation led to greater 
orthogonality between subdivision Kicers compared to the Martinez approach.  
 
Dopamine-Symptom Relationships 
For both baseline symptoms and change in symptoms, Pearson correlation 
coefficients were calculated between each item of the Positive and Negative 
Symptoms Scale (PANSS) and each network-specific Kicer.  We hypothesised that 
auditory hallucinations (captured in item P3 of the PANSS) would be related to 
Kicer within the auditory striatum, and that motor retardation (item G7) would 
relate to Kicer within the sensorimotor striatum. Based on previous findings (Abi-
Dargham et al., 1998; Demjaha et al., 2012; Jauhar et al., 2018c), we tested the 
hypothesis that Kicer would be linearly related to severity of symptoms at baseline, 
and improvement following treatment with a dopamine antagonist. For hallucinatory 
behaviour we anticipated a positive correlation, given that previous PET studies 
have found a positive association between Ki and positive psychotic symptoms 
(Jauhar et al., 2017), while for motor retardation we anticipated a negative 
correlation, given that previous PET studies have found markedly reduced Kicer in 
individuals displaying motor retardation (Hietala et al., 1995, 1999; Dao-Castellana 
et al., 1997). 
 
Statistical significance was assessed using two separate permutation testing 
approaches. First, we permuted participants (10,000 permutations), and compared 
the correlation coefficients between subregion Kicer and symptom scores observed in 
the actual data, with the coefficients observed in the permuted data. This approach, 
however, does not account for the general relationship between whole striatum Kicer 
and total symptoms, in that any significant findings could reflect a general 
association between whole striatal Kicer and symptoms in general. Therefore, we also 
employed a separate approach in which we permuted the cortical nodes assigned to 
networks (10,000 permutations), thereby creating a null distribution that retained 
 
130 
the relationship with mean striatal dopamine synthesis capacity (Figure 1B). With 
this approach we were able to test whether our observed subdivision Kicer-symptom 
correlation was truly specific to that identified subdivision over and above the general 
striatal Kicer-symptom relationships present in the data.  
 
Using these two permutation testing approaches we performed a further analysis in 
order to account for the collinearity of symptom severity, and further probe the 
specificity of observed relationships. We employed the same permutation testing 
approaches, but tested the significance of the correlation coefficient for the symptom 
in question, minus the mean correlation coefficient for all other PANSS items, giving 
a measure of how strong the observed association was after accounting for the overall 
relationship with symptoms.  
 
Symptoms were clustered on the basis of between-individual Pearson correlations 
using the same community detection algorithm used for the clustering of brain 
regions. This approach clusters subsets of symptoms together so that symptoms in a 
subset will have a strong association with other symptoms in this subset and a weaker 
associations with symptoms in other subsets (see supplementary for details)(Blondel 
et al., 2008). This resulted in symptom clusters that could be described as positive, 
negative/cognitive, affective, and insight based. In a post-hoc analysis we then 
examined the relationship between the affective symptoms cluster and 
‘cingulopercular’ striatum Kicer, and between the negative symptoms cluster and the 
‘default mode’ striatum Kicer. The same permutation testing approach was taken as 
when examining single symptoms, and when looking at the difference between the 
cluster and other symptoms the mean of the coefficients for that cluster was 
calculated, and the difference score was taken to be this mean cluster score minus 
the mean of the remaining coefficients. We also examined patient vs. control 





All code used for analysis is freely available at 







50 participants took part in the study (21 controls and 29 patients). Demographic 
details are given in Table 1. 15 patients had a diagnosis of schizophrenia, 12 of 
bipolar disorder, one of psychotic depression, and one of delusional disorder. At 
baseline, mean total PANSS score was 66.7 (SD 20.7). Median time between PET 
and MRI scan was 15.5 days. 19 of the patients received antipsychotic treatment 









Male 13(62%) 22(76%) 15(78%) 



















































152.9(12.6) 143.5(7.4) 142.9(9.1) 
 
Table 1 Demographic details of study participants 
Data are expressed as n (%) or mean (SD). PANSS=Positive and Negative Syndrome Scale. 
1Receiving antipsychotic medication for 2 weeks or less 
 
 
Cortical Network Assignment and Striatal Connectivity Maps 
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The community detection algorithm assigned nodes to 5 separate networks, these 
corresponded to well recognised resting state networks; specifically, the default mode 
(DMN), auditory (AUD), dorsal attention (DAT), sensorimotor (SMN), and 
cinguloopercular (CON) networks (Figure 1A). The connectivity between these 
networks and the striatum was calculated at the individual participant level, 
although for display purposes group averaged maps are shown in Figure 2B. 
 
Baseline Symptom-Dopamine Relationships 
Correlation coefficients between baseline symptoms and subdivision Kicer are 
displayed in Figure 3A. The relationship between SMN Kicer and motor retardation 
(PANSS item G7) was not significant when permuting participants in terms of the 
G7-SMN Kicer coefficient itself (p=0.06), but was significant when the difference with 
other symptom-SMN Kicer correlations was tested (p=0.009) (Figure 3). When 
cortical nodes were permuted this was significant for both the coefficient itself 
(p=0.012), and the difference measure (p=0.0098) (Figure 3). 
 
Of those patient reporting hallucinations, all reported that these were solely auditory 
and not occurring in any other modality. There was no significant relationship 
between baseline hallucination severity (PANSS item P3) and AUD Kicer in terms 
of participant permutations (coefficient only p=0.09, difference p=0.33), or cortical 
node permutations (coefficient-only p=0.43, difference p=0.61). 
 
 
Symptom Change-Dopamine Relationships 
The relationship between SMN Kicer and change in motor retardation following 
dopamine antagonist treatment was significant when examined either by permuting 
participants (coefficient only p=0.0001, difference p<0.0001), or cortical nodes 
(coefficient only p=0.0008, difference p=0.0006) (Figure 4). AUD Kicer only showed 
a significant relationship with change in hallucinatory symptoms when examining 
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participant permutations in terms of the specific item (single item p=0.038, difference 
p=0.13) (Figure 4). 
  
Figure 2. Clustering of psychotic symptoms and connectivity derived striatal maps 
A) Heatmap showing the correlations between individual PANSS items, clustered using the Louvain community detection algorithm.  
B) Striatal connectivity maps used to weight voxelwise Kicer maps and generate network specific Kicer. Greater intensity of colour indicates 
that a voxel displays greater connectivity to the cortical network in question. The maps are at group level and thresholded for display 
purposes to show differences between networks more clearly (see efigure for unthresholded maps), while individualised maps were used in 
practice. 
 






Figure 3. Baseline psychotic symptoms and striatal dopamine 
A) Correlations between individual PANSS items and striatal Kicer across different connectivity defined striatal regions. 
B) Specific symptom-Kicer relationships of interest: AUD and hallucinatory behaviour(p3) where the positive slope indicates greater Kicer 
associated with more severe symptoms, SMN and motor retardation (g7), CON and the affective symptom cluster, DMN and the 
negative symptom cluster. 
C) Testing the these symptom-Kicer relationships: The vertical lines show the position of the observed results. Where the x axis is labelled 
‘z’ this refers to the z-transformed correlation coefficient between the network Kicer and symptom in question, where it is labelled ‘z-
difference’ this is the z-transformed coefficient in question minus the mean of the other coefficients for that network Kicer. Curves show a 
null distribution of z-transformed coefficients created from 10,000 permutations, in (i) this null model is created by permuting individual 
participants, whereas in (ii) this is achieved by permuting the cortical ROIs from which the striatal maps are derived. * indicates that 
the difference between the observed result and null distribution is statistically significant at p<0.05.  
 




Figure 4. Change in psychotic symptoms and striatal dopamine 
A) Correlations between change in individual PANSS items and striatal Kicer across different connectivity defined striatal regions 
B) Specific symptom-Kicer relationships of interest: Greater baseline  AUD Kicer associated with subsequent improvement in hallucinatory 
behaviour (p3), SMN and change in motor retardation (g7), CON and change in the affective symptom cluster, DMN and change in 
the negative symptom cluster. 
C) Testing these relationships: The vertical lines show the position of the observed results. Where the x axis is labelled ‘z’ this refers to 
the z-transformed correlation coefficient between the network Kicer and symptom in question, where it is labelled ‘z-difference’ this is 
the z-transformed coefficient in question minus the mean of the other coefficients for that network Kicer (e.g. when examining a single 
symptom this will be the mean of 29 coefficients). Curves show a null distribution of z-transformed coefficients created from 10,000 
permutations, in (i) this null model is created by permuting individual participants, whereas in (ii) this is achieved by permuting the 
cortical ROIs from which the striatal maps are derived. * indicates that the difference between the observed result and null 
distribution is statistically significant at p<0.05. 
 




Symptom Clusters and Exploratory Analyses 
The community detection algorithm assigned PANSS items to four clusters based on 
the pattern of between-participant symptom correlations (Figure 2A). Clusters 
corresponded to positive psychotic symptoms (P1, P3, N7, G1, G9, G11, G15), 
manic/affective symptoms (P4, P5, P7, G2, G3, G4, G14), negative/cognitive 
symptoms (P2, P6, N1-N6, G5, G6, G7, G13, G16), and insight (G8, G10, G12). 
 
Following visual inspection of the correlation matrices, post hoc exploratory analyses 
were performed examining for relationships between DMN Kicer and the 
negative/cognitive symptom cluster, and CON Kicer and the affective symptom 
cluster. The DMN-negative/cognitive relationship was statistically significant when 
examining both participant permutations (cluster coefficient only p<0.0001, 
difference p=0.038) and cortical permutations (cluster coefficient only p=0.0003, 
difference p=0.026) (Figure 3). The CON-affective relationship was significant for 
participant permutations (cluster coefficient only p=0.029, difference p=0.013), but 
only for the difference score when cortical permutations were examined (cluster 
coefficient only p=0.13, difference p=0.0018) (Figure 3). 
 
Exploratory analyses were again performed examining for symptom change following 
treatment. The DMN-negative/cognitive relationship was not statistically significant 
for any tests (participant permutation item only p=0.14, difference p=0.32, cortical 
node permutation item only p=0.86, difference p=0.92) (Figure 4). The CON-
affective relationship was significant for participant permutations (item only 
p=0.013, difference p=0.028) and for the difference score when cortical nodes were 
permuted (item only p=0.091, difference p=0.0156) (Figure 4). 
 
A post-hoc analysis of patient vs. control differences between subdivisions showed 
the greatest difference between groups was within the DMN subregion, although this 





Comparison with Existing Parcellation Methods 
Orthogonality between subdivision Kicers is required for the investigation of unique 
subdivision-symptom relationships, as a high degree of correlation between 
subdivisions effectively prevents individual subdivision relationships from being 
studied. We analysed orthogonality in our individualised connectivity-based 
topographical approach and that in a group based approach that used the atlas-
based striatal subdivisions from Martinez et al. (Mawlawi et al., 2001; Martinez et 
al., 2003).  Correlations between subdivisions showed that the Martinez subdivisions 
showed a highly collinear relationship (rp=0.76-0.92), while in contrast the 
individualised connectivity defined subdivisions showed much greater orthogonality 
(rp 0.23-0.65) that was statistically significant for 26 of 30 possible comparisons 






We found that the relationship between dopamine function and symptoms varied 
according to the striatal region examined. Specifically, dopamine function in striatal 
regions linked to sensorimotor cortex was associated with both the severity of motor 
retardation pre-treatment, and the change in motor retardation following treatment 
with a dopamine antagonist. There was no clear association, however, between 
hallucination severity and dopamine function within striatal regions linked to the 
auditory cortex. In the exploratory analysis, dopamine function within the striatal 
regions linked to the default mode network, and cingulopercular network were 
associated with negative/cognitive and affective symptoms respectively. 
 
While previous studies have investigated the relationship between striatal dopamine 
function and symptoms in psychotic disorders, this has predominantly been at the 
level of the whole striatum, and so has not addressed the question of specific 
symptom-subregion relationships (Abi-Dargham et al., 1998; Demjaha et al., 2012; 
Jauhar et al., 2018c). Although more recent studies have examined subdivisions, the 
typical approach employed precludes investigation of the current hypothesis due to 
the high degree of collinearity between subdivisions. We demonstrated significantly 
greater orthogonality in our individualised connectivity-based approach, which 
allowed, for the first time to our knowledge, specific subregion-symptom relationship 
to be investigated. Moreover, in contrast to our data-driven parcellation approach, 
traditional atlas-based subdivisions do not take into account the likely considerable 
spatial variability in striatal functional specificity that occurs between participants. 
Finally, our permutation testing approach is robust to outliers and skewed data 
distributions, and allowed for thorough testing of the specificity of relationships both 




Although motor symptoms are frequently ascribed to antipsychotic drug treatment, 
recent studies show that around 20% of antipsychotic naïve first episode patients are 
affected by motor signs and symptoms (Pappa and Dazzan, 2009). Furthermore, 
historical descriptions of schizophrenia prior to the use of antipsychotic drugs were 
almost unanimous in their inclusion of motor signs as a core feature of the syndrome 
(Kendler, 2016). We found that a lower Kicer within striatal regions linked to 
sensorimotor cortex was associated with more severe motor retardation. 
Interestingly, this lower Kicer also predicted a greater improvement following 
antipsychotic treatment. One would not necessarily expect a symptom purportedly 
driven by low presynaptic dopamine to respond to treatment with a dopamine 
antagonist. It may therefore be the case, that the relationship observed with 
treatment may represent a regression to the mean, although a placebo arm would be 
required to definitively test this. 
 
We found no specific relationship between Kicer in the auditory regions of the 
striatum and the severity of hallucinatory behaviour. This may be taken to suggest 
that auditory hallucinations are not directly driven by dopaminergic dysfunction 
within this specific region, and are associated with either more general dopaminergic 
dysfunction across the striatum, or potentially a non-dopaminergic mechanism 
(Howes et al., 2013). Alternatively, the lack of a finding may conceivably be 
secondary to the noise inherent in both imaging and symptom measures.  The fact 
that a small number of patients were receiving antipsychotic treatment at the time 
of scan is unlikely to have had a significant impact given that this does not appear 
to affect presynaptic dopamine function (Jauhar et al., 2019). 
 
The default mode network predominantly mapped onto striatal areas that have been 
defined as ‘associative’ based on their connection to cortical regions broadly involved 
in cognition (Martinez et al., 2003). Dopamine dysfunction within this region showed 
an association with the severity of negative/cognitive symptoms. Recent work has 
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suggested mechanisms via which excessive striatal dopamine transmission may 
underlie these symptoms through a range of mechanisms including impairments in 
probabilistic learning and disrupting corticostriatal connectivity (Maia and Frank, 
2017; McCutcheon et al., 2019). While it can be hard to determine in first episode 
cohorts whether negative symptoms are secondary to positive symptoms, the 
symptom clustering approach we adopted mitigates against this by maximising the 
orthogonality of symptom clusters. A previous PET study found a relationship 
between greater negative symptom severity and reduced synaptic dopamine levels 
(Kegeles et al., 2010), differences here may result from marked differences in 
experimental technique, and the fact that the current study included only first 
episode patients while the other cohort mostly consisted of chronically ill patients.  
The cingulopercular network mapped onto regions of the striatum that 
predominantly receive projections from limbic cortical regions such as the medial 
prefrontal cortex and anterior cingulate (Martinez et al., 2003). The association 
observed with affective symptoms therefore, is in keeping with research linking this 
part of the striatum to affective processing (Price and Drevets, 2012).  However, 
given the exploratory nature of these analyses, we suggest these findings warrant 
further testing in new cohorts. 
 
As reported previously, we did not observe a significant difference between patients 
and controls in terms of striatal Kicer (Jauhar et al., 2018b).  This may represent a 
type II error, possibly exacerbated by the fact that our cohort included a number 
individuals that were nonresponsive to antipsychotic treatment, a characteristic 
associated with normal Kicer (Demjaha et al., 2012; Jauhar et al., 2018c). 
Nevertheless, this raises a more general question as to how one characterises 
‘aberrant’ dopamine function, given that even in responsive individuals there is 




Previous PET studies looking at striatal subdivisions in schizophrenia have used a 
group template based approach when parcellating the striatum (Howes et al., 2009; 
Kegeles et al., 2010; Mizrahi et al., 2012). This may be inappropriate given that wide 
variety that is apparent in terms of striatal volume, shape, and anatomical 
connectivity (Chakravarty et al., 2015; Levitt et al., 2017). An individualised 
connectivity based approach may also be preferable given that schizophrenia is 
associated with altered functional corticostriatal connectivity (McCutcheon et al., 
2019), and the fact that both corticostriatal (Kim et al., 2018), and corticocortical 
connectivity (McCutcheon et al., 2018b), appear to show a relationship with striatal 
dopamine function. The individualised approach we employed may potentially 
account for some of these differences. We used a probabilistic (as opposed to a 
winner-takes-all) approach in our main analyses given the fact that although 
corticostriatal pathways run in parallel there is a high degree of overlap (Haber, 
2016).  
 
Future work would benefit from more detailed behavioural assessment, and larger 
sample sizes. Obtaining PET and MRI measures simultaneously with combined 
PET-MR may improve the signal-to-noise ratio. It would also be of interest to 
explore alternative methods for parcellating the striatum, both using resting state 
data (Barnes, 2010; Jaspers et al., 2017), but also mapping anatomical connectivity 
using diffusion tensor imaging (Tziortzi et al., 2011). 
 
In conclusion, we show that motor retardation associated with schizophrenia are 
specifically linked to dopamine dysfunction within regions of the striatum linked to 
the sensorimotor cortex. We also find some evidence to suggest that dopamine 
dysfunction within striatal regions linked to the default mode network, and 
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This study was approved by the East of England-Cambridge East NHS Research 
Ethics Committee, and Administration of Radioactive Substances Advisory 
Committee (ARSAC). All participants provided informed written consent to 
participate. 
 
Participants – Recruitment 
Participants were recruited from clinical services in South and West London. 
Exclusion criteria for all subjects were: history of significant head trauma, 
dependence on illicit substances, medical co-morbidity (other than minor illnesses), 
lifetime use of antipsychotic drugs for longer than two weeks,1 contra-indications to 
PET and MRI scanning (such as pregnancy), or prescription of mood stabilizer 
medication. 
 
Participants – Clinical Assessment 
Participants were classified by antipsychotic exposure as antipsychotic naïve, 
antipsychotic free (prior oral antipsychotic medication but free of treatment for at 
least 6 weeks (oral) or 6 months (depot, if relevant)) or minimally treated (taking 
antipsychotic medication for two weeks or less). 
 
Participants were assessed using the Positive and Negative Syndrome Scale 
(PANSS)2 at baseline and after taking a dopamine antagonist at a therapeutic dose 
(as specified by the Maudsley Prescribing Guideline)3 for a minimum of four weeks. 
To assess antipsychotic concordance we used required evidence of good adherence 
from at least two of the following sources: antipsychotic blood plasma levels, 
pharmacy and electronic medical dispensing records, patient report and independent 
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source report (e.g. carer). Subjects were required to have taken at least 80% of 
prescribe doses.4 
 
Choice of antipsychotic medication was at the discretion of the treating clinician as 
per usual clinical care. 
 
18F-DOPA PET Data Acquisition and Analysis 
Participants were not permitted to smoke or consume caffeine for four hours 
preceding the scan. After acquiring a CT scan for attenuation correction, PET 
images were acquired using a Siemens Biograph HiRez XVI PET scanner (Siemens 
Healthcare, Erlangen, Germany) at Imanova Centre for Imaging Sciences.   
 
One hour prior to scanning, participants received 400mg entacapone and 150mg 
carbidopa, to prevent formation of radiolabelled metabolites and reduce peripheral 
metabolism. Approximately 160 MBq of 18F-DOPA was administered by bolus 
intravenous injection. The quantification pipeline was consistent with previous 
works.5 Correction for head movement during the scan was performed by denoising 
the non- attenuation-corrected dynamic images using a level 2, order 64 Battle-
Lemarie wavelet filter. Frames were realigned to a single reference frame, acquired 
20 minutes post-injection, employing a mutual information algorithm.6,7 The 
transformation parameters were then applied to the corresponding attenuated-
corrected dynamic images, creating a movement-corrected dynamic image, which 
was used in the analysis. Realigned frames were then summated to create an 
individual motion-corrected reference map for the brain tissue segmentation. The 
cerebellum was used as a reference region, and Kicer was calculated with the Patlak-
Gjedde graphical approach adapted for reference tissue input function.8 Image 




In order to generate the voxelwise Ki maps we implemented a previously 
established method9 in which Kicer parametric images of the brain were constructed 
from motion-corrected images using a wavelet-based approach.10 The parametric 
image for each participant was then normalized into Montreal Neurological 
Institute standard space (matrix dimension: 91x109x91; voxel size: 2mm isotropic) 
using the participant’s PET summation image and the 18F-DOPA template.  
 
MRI Acquisition and Preprocessing 
Participants also received a rfMRI scan on a 3T GE Signa MR scanner. Functional 
imaging consisted of T2* weighted echo planar image slices. 256 volumes were 
acquired, consisting of 39 interleaved slices (3.5 mm slice thickness, 3.75 mm x 3.75 
mm voxel dimensions in plane) with a repetition time (TR) of 2000 ms, and echo 
time (TE) 30 ms. A structural image was obtained using a gradient-echo scan 
(TR=7.0s, TE=2.8s, flip angle=11°, in plane resolution=1mm x 1mm, slice 
thickness=1.2mm, 196 slices). 
 
Image pre-processing was performed using a standard pipeline implemented in the 
CONN toolbox (version 17.b)11 for Statistical Parametric Mapping software (SPM 
12 (6906)).  A standard preprocessing pipeline was used consisting of slice timing 
correction, realignment, and normalisation to MNI space. Images were smoothed 
with a Gaussian kernel of 8mm full-width-half-maximum. The ART toolbox was 
used to account for motion and artefact detection using anatomical component based 
correction (aCompCor) of temporal confounds relating to head movement and 
physiological noise. This method models noise effects at a voxel level based on 
estimates derived from principal components of noise regions of interest (white 
matter and CSF, eroded by one voxel to minimise partial volume effects), and then 
removes these from the BOLD timeseries using linear regression.  Six residual head 
motion parameters and their first order temporal derivatives were also entered as 
regressors into the first level model. A confounding effect accounting for 
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magnetisation stabilisation, and its first order derivative was entered. 
Artifact/outlier scans (average intensity deviated more than 5 standard deviations 
from the mean intensity in the session, or composite head movement exceeded 0.9 
mm from the previous image) were also regressed out. Preprocessed data were 
temporally bandpass filtered (0.008-0.09 Hz) 
 
Cortical Network Assignment 
Time series were extracted from the 333 nodes of the Gordon atlas.12 The Gordon 
parcellation was developed using resting state boundary maps observed in a sample 
of 120 healthy young adults, it shows superior within parcel homogeneity in 
comparison to other parcellations, making it an appropriate choice for the analysis 
of resting state data. For each participant, a 333x333 connectivity matrix (also 
termed a graph) was constructed where each edge between two nodes represents the 
z-transformed Pearson correlation coefficient of the time series of these nodes. 
 
A group averaged connectivity matrix was then constructed. To do this we first 
rescaled each participant’s graph, by subtracting from each edge that participant’s 
average edge strength, and dividing by the standard deviation of the strength of all 
that graph’s edges. As a result, all participants then have the same average graph 
connectivity strength, and so individuals with greater average connectivity values do 
not have undue topological influence. 
 
We then ran the Louvain community detection algorithm on the whole brain group 
level graph,13 in order to assign individual nodes to networks based on the 
connectivity patterns present in the current dataset. Due to the non-deterministic 
nature of the Louvain algorithm, a previously described consensus clustering 
approach was employed.14,15 Edges between nodes closer than 10mm were discarded 
(euclidean minimum distance between two closest points of the two nodes), and the 
strongest 5% of edges were retained and binarised. The gamma parameter was set 
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to 1.4. Networks defined by this approach were then labelled according to whichever 
of the apriori defined networks they showed the greatest overlap with, as quantified 
with the Sorensen-dice coefficient.12,16 This identified the default mode, sensorimotor, 
cinguloopercular, dorsal attention, auditory  and visual networks. The visual network 
was excluded in subsequent analysis given its relative lack of direct connections with 
the striatum.28 
 
Striatal Probabilistic Parcellation 
For each striatal voxel the z-transformed correlation coefficient between the voxel 
and the 333 Gordon nodes was calculated. Then for each of the networks defined in 
the Network Assignment step above the mean connectivity of that network’s nodes 
to the voxel was calculated, with negative values being set at 0. When this had been 
performed for each network these values were then scaled so that at each voxel the 












eFigure 1. Striatal probabilistic connectivity maps 
Each striatal voxel is assigned a value for each of the cortical networks, based on the mean connectivity 
of the voxel to each node in the network. The total connectivity score for each voxel sums to 1. In the 





At the individual participant level for each network, for each striatal voxel we 
multiplied the  Kicer value at that voxel by the weight assigned to that network at 







Cortical network assignment 
 
Numbers refer to the node labels provided by Gordon et al.12 
 
Default Mode = [7, 124, 162, 165, 167, 168, 170, 182, 186, 200, 219, 220, 225, 236, 
237, 240, 241, 242, 247, 250, 253, 259, 260, 261, 267, 272, 273, 275, 276, 277, 278, 
279, 283, 289, 290, 291, 301, 302, 315, 316, 319, 320, 321, 322, 323, 324, 325, 326, 
327, 328, 1, 4, 6, 9, 23, 24, 25, 44, 60, 61, 75, 78, 79, 85, 86, 94, 96, 107, 108, 109, 
113, 114, 115, 116, 126, 127, 128, 129, 133, 145, 146, 148, 150, 151, 156, 157, 158, 
159, 221, 292, 300, 333] 
 
Sensorimotor = [2, 30, 31, 32, 33, 35, 36, 37, 38, 45, 46, 47, 50, 51, 54, 55, 56, 57, 
58, 104, 163, 180, 190, 191, 193, 194, 195, 201, 202, 203, 204, 205, 206, 209, 210, 
211, 213, 214, 215, 216, 217, 251, 252, 262, 265, 270] 
 
Auditory = [3, 10, 22, 39, 53, 59, 62, 65, 66, 67, 68, 69, 70, 71, 72, 76, 77, 81, 101, 
102, 103, 105, 111, 160, 161, 164, 171, 196, 197, 212, 218, 222, 223, 224, 226, 227, 
228, 229, 230, 231, 232, 233, 234, 235, 238, 239, 244, 246, 268, 269, 271, 274, 329, 
330, 331, 332, 64] 
 
Cingulopercular = [12, 21, 26, 27, 28, 29, 80, 82, 83, 84, 117, 147, 149, 152, 153, 
181, 183, 184, 185, 187, 188, 192, 243, 245, 248, 249, 317, 318] 
 
Dorsal Attention = [34, 40, 41, 42, 43, 48, 49, 87, 91, 92, 93, 95, 154, 155, 189, 198, 



























eFigure 2. Comparison of connectivity derived and Martinez subdivisions 
 
A) Heatmap displaying correlation coefficients between Kicer values for different subdivisions. There is greater 
orthogonality between resting state defined subdivisions (rp = 0.23-0.65) compared to subdivisions defined 
using the method of Martinez et al divisions(rp0.71-0.92). 
 
B) Comparing the magnitude of these intra-method correlation coefficients, these are significantly lower (*= 
p<0.05) for the resting state method (i.e indicating greater orthogonality) for all but 4 of the 30 comparisons. 
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eFigure 3. Comparison of patients and controls resting state defined Kicer 
Average dopamine synthesis capacity within resting state defined striatal subdivisions for patients and 
controls. There were no significant differences between the groups for any of the subdivisions. Error bars = 
+/- 1SE. 
 
AUD- Auditory , CON – Cingulopercular, DAT – Dorsal attention, DMN – Default mode, SMN – Sensorimotor. 
 
 
eFigure 4. Striatal connectivity maps used to weight voxelwise Kicer maps and generate 
network specific Kicer. 
 







1  Leucht S, Winter-van Rossum I, Heres S, Arango C, Fleischhacker WW, 
Glenthøj B et al. The optimization of treatment and management of 
schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and 
a review of the effectiveness of switching antipsychotics. Schizophr Bull 2015; 
41: 549–558. 
2  Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale 
(PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261. 
3  Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in 
psychiatry. John Wiley & Sons, 2012. 
4  Howes OD, McCutcheon R, Agid O, De Bartolomeis A, Van Beveren NJM, 
Birnbaum ML et al. Treatment-ResistantSchizophrenia: TreatmentResponse 
and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines 
on Diagnosis and Terminology. Am J Psychiatry 2017; 174. 
doi:10.1176/appi.ajp.2016.16050503. 
5  Jauhar S, Veronese M, Rogdaki M, Bloomfield M, Natesan S, Turkheimer F 
et al. Regulation of dopaminergic function: an [18F]-DOPA PET 
apomorphine challenge study in humans. Transl Psychiatry 2017; 7: e1027. 
6  Turkheimer FE, Brett M, Visvikis D, Cunningham VJ. Multiresolution 
analysis of emission tomography images in the wavelet domain. J Cereb 




7  Studholme C, Hill DL, Hawkes DJ. Automated 3-D registration of MR and 
CT images of the head. Med Image Anal 1996; 1: 163–175. 
8  Patlak CS, Blasberg RG. Graphical Evaluation of Blood-to-Brain Transfer 
Constants from Multiple-Time Uptake Data. Generalizations. J Cereb Blood 
Flow Metab 1985; 5: 584–590. 
9  Howes O, Bose S, Turkheimer FE, Valli I, Egerton A, Valmaggia L et al. 
Dopamine synthesis capacity before onset of psychosis: a prospective -DOPA 
PET imaging study. Am J Psychiatry 2011; 168: 1311–1317. 
10  Turkheimer FE, Aston JAD, Asselin M-C, Hinz R. Multi-resolution Bayesian 
regression in PET dynamic studies using wavelets. Neuroimage 2006; 32: 
111–121. 
11  Whitfield-Gabrieli S, Nieto-Castanon A. Conn: A Functional Connectivity 
Toolbox for Correlated and Anticorrelated Brain Networks. Brain Connect 
2012; 2: 125–141. 
12  Gordon EM, Laumann TO, Adeyemo B, Huckins JF, Kelley WM, Petersen 
SE. Generation and Evaluation of a Cortical Area Parcellation from Resting-
State Correlations. Cereb Cortex 2016; 26: 288–303. 
13  Blondel VD, Guillaume JL, Lambiotte R, Lefebvre E. Fast unfolding of 
communities in large networks. J Stat Mech Theory Exp 2008; 2008: 1–12. 
14  Lancichinetti A, Fortunato S. Consensus clustering in complex networks. Sci 
Rep 2012; 2. doi:10.1038/srep00336. 
15  McCutcheon R, Nour MM, Dahoun T, Jauhar S, Pepper F, Expert P et al. 
 
162 
Mesolimbic Dopamine Function is Related to Salience Network Connectivity: 
An Integrative PET and MR Study. Biol Psychiatry 2018; : 1–11. 
16  Dice LR. Measures of the Amount of Ecologic Association Between Species. 









5. Chronic psychosocial stressors are associated with 
alterations in salience processing and corticostriatal 
connectivity 
 
Originally Published in Schizophrenia Research (2018) 
 
Robert A. McCutcheon1,2,3 MRCPsych 
Michael A.P. Bloomfield2,3,4,5,6,7 PhD 
Tarik Dahoun2,3,8 MD 
Mitul Mehta9 PhD 
Oliver D. Howes1,2,3,* PhD 
 
 
1. Department of Psychosis Studies, Institute of Psychiatry, Psychology & 
Neuroscience, Kings College London, De Crespigny Park, London SE5 8AF, UK 
 
2. Psychiatric Imaging Group, MRC London Institute of Medical Sciences, 
Hammersmith Hospital, London W12 0NN, UK 
 
3. Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, 
London, W12 0NN, UK 
 
4. Translational Psychiatry Research Group, Research Department of Mental 
Health Neuroscience, Division of Psychiatry, University College London, 6th Floor, 
Maple House, 149 Tottenham Court Road, London WC1T 7NF, UK 
 
5. Clinical Psychopharmacology Unit, Research Department of Clinical, 
Educational and Health Psychology, University College London, 1–19 Torrington 
Place, London WC1E 6BT, UK 
 
6. National Institute of Health Research University College London Hospitals 
Biomedical Research Centre, University College Hospital, Euston Road, London 
W1T 7DN 
 
7. The Traumatic Stress Clinic, St Pancras Hospital, 4 St Pancras Way, London 
NW1 0PE 
 
8. Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, 
OX37 JX, UK  
 
9. Department of Neuroimaging, Institute of Psychiatry, Psychology & 




*Corresponding author: oliver.howes@kcl.ac.uk  tel: ++44 (0)207 848 0355, Box 
67, Department of Psychosis Studies, Institute of Psychiatry, Psychology & 






Psychosocial stressors including childhood adversity, migration, and living in an 
urban environment, have been associated with several psychiatric disorders, 
including psychotic disorders. The neural and psychological mechanisms mediating 
this relationship remain unclear. In parallel, alterations in corticostriatal 
connectivity and abnormalities in the processing of salience, are seen in psychotic 
disorders. Aberrant functioning of these mechanisms secondary to chronic stress 
exposure, could help explain how common environmental exposures are associated 
with a diverse range of symptoms.  In the current study, we recruited two groups 
of adults, one with a high degree of exposure to chronic psychosocial stressors (the 
exposed group, n=20), and one with minimal exposure (the unexposed group, 
n=22). All participants underwent a resting state MRI scan, completed the 
Aberrant Salience Inventory, and performed a behavioural task – the Salience 
Attribution Test (SAT). The exposed group showed reduced explicit adaptive 
salience scores (cohen’s d= 0.69, p=0.03) and increased aberrant salience inventory 
scores (d=0.65, p=0.04). The exposed group also showed increased corticostriatal 
connectivity between the ventral striatum and brain regions previously implicated 
in salience processing. Corticostriatal connectivity in these regions negatively 
correlated with SAT explicit adaptive salience (r=-0.48, p=0.001), and positively 
correlated with aberrant salience inventory scores (r=0.42, p=0.006). Furthermore, 
in a mediation analysis there was tentative evidence that differences in striato-










Several environmental factors that can be considered chronic psychosocial stressors 
are associated with an increased risk of developing schizophrenia, but the 
psychological and neurobiological mechanisms mediating this increased risk remain 
incompletely understood (Tost et al., 2015). Disruption in salience processing has 
been proposed as a central deficit in schizophrenia, whereby the ‘salience’ of a 
stimulus refers to the significance that stimulus holds for an organism (Winton-
Brown et al., 2014). Corticostriatal circuits play an important role in salience 
processing, and disruption of these circuits is seen in schizophrenia (Dandash et al., 
2014; Fornito et al., 2013; Levitt et al., 2017). In the current study, we investigated 
whether exposure to chronic psychosocial stressors was associated with alterations 
in salience processing, and whether this was linked to changes in corticostriatal 
connectivity. 
 
1.1 Chronic Psychosocial Stressors and Schizophrenia 
Many of the environmental risk factors associated with schizophrenia can be 
broadly conceptualised as chronic psychosocial stressors (Selten and Cantor-Graae, 
2005; Walker and Diforio, 1997). These include childhood adversity, migration, and 
urbanicity (De Loore et al., 2007; Howes et al., 2017; Linscott and van Os, 2013; 
Morgan et al., 2009; Van Nierop et al., 2014).  
 
Studies investigating the influence of these psychosocial stressors upon brain 
function have typically investigated one factor at a time, despite the fact that the 
risk factors cluster together and potentially share common underlying mechanisms 
(Hjern et al., 2004; Morgan et al., 2007; Wicks et al., 2005). Moreover, 
epidemiological evidence suggests that there are at least additive, and potentially 
synergistic effects between risk factors (Guloksuz et al., 2015; Lataster et al., 2012; 




Several lines of evidence have suggested links between psychosocial stress exposure 
and alterations in salience processing. The finding that individuals exposed to early 
life trauma show evidence of both blunted responses to reward, and increased rates 
of psychotic experiences, suggests that alterations to both adaptive and aberrant 
salience processing mechanisms may be present (Croft et al., 2018; Hanson et al., 
2016). Given the central role of dopamine in salience processing, the finding that 
presynaptic dopamine function appears altered in immigrants and individuals that 
have suffered childhood adversity, suggests that this may be a mechanism via 
which these exposures lead to an increased risk of mental illness (Egerton et al., 
2017, 2016; Howes et al., 2017; Pruessner et al., 2004). There is also evidence that 
exposure to chronic psychosocial stressors is associated with functional alterations 
in brain regions involved in salience processing (Akdeniz et al., 2014; Lederbogen et 
al., 2011; McCutcheon et al., 2018; Teicher et al., 2016), and to corticostriatal 
functional connectivity (Hanson et al., 2018; Hart et al., 2018). (Hanson et al., 
2018; Hart et al., 2018). Taken together this suggests that psychosocial stress 
exposure could lead to cortico-striatal dysfunction and aberrant salience processing 
(figure 1). To our knowledge, however, none have directly investigated how these 






Figure 1. Proposed pathway in which exposure to chronic psychosocial stressors leads to alterations 
in corticostriatal connectivity and subsequent alterations in salience processing. 
 
 
1.2 Salience Processing 
The Salience Attribution Test (SAT) was developed to quantify four related 
aspects of salience processing. The test involves participants responding to a probe 
that is paired with stimuli that vary across two dimensions (e.g. colour and shape). 
One of these dimensions is associated with a greater probability of reward (the 
outcome relevant dimension), whereas the other bears no relationship to the 
likelihood of reward (the outcome irrelevant dimension). The test has both implicit 
(based on reaction times) and explicit (based on participant ratings) components, 
and measures both aberrant (the extent to which the irrelevant dimension is 
thought to signal outcome) and adaptive salience (the extent to which relevant 




Studies using the SAT in individuals with schizophrenia, have consistently 
demonstrated reduced adaptive salience compared to healthy controls (Abboud et 
al., 2016; Katthagen et al., 2016; Pankow et al., 2016; Roiser et al., 2009). 
Differences in aberrant salience have also been observed (Katthagen et al., 2016; 
Pankow et al., 2016), but this is not a consistent finding (Abboud et al., 2016; 
Roiser et al., 2009). Abnormal salience processing has also been demonstrated in 
those at high clinical risk of psychosis, and in dependent cannabis users 
(Bloomfield et al., 2016; Roiser et al., 2013); while in healthy controls greater 
dopamine synthesis capacity within the ventral striatum has been linked to higher 
aberrant salience scores (Boehme et al., 2015). The aberrant salience inventory 
(ASI) is a questionnaire that was developed in order to quantify the subclinical 
phenomenology of disrupted salience processing (Cicero et al., 2010). Inventory 
scores are related to measures of psychosis proneness (Cicero et al., 2010), and 
have been found to be increased in individuals treated with dopamine agonists 
(Poletti et al., 2014). 
 
Several neural systems are involved in salience processing. Schultz et al. 
demonstrated that mesostriatal dopamine neurons play a role in assigning value to 
stimuli, based on accompanying rewards (Schultz et al., 1997), while more recent 
research has shown that these neurons respond to surprising stimuli even in the 
absence of any change in value, suggesting that their role extends beyond value 
encoding to include signalling the salience of relevant stimuli in general (Takahashi 
et al., 2017; Winton-Brown et al., 2014). In concert with the role that striatal 
dopamine plays, cortical regions are also involved in the propagation of salience 
signals. Appropriate functioning of corticostriatal connections is necessary for the 
successful integration of these cortical networks and striatal dopamine signalling 
(Menon and Uddin, 2010; Peters et al., 2016; Roiser et al., 2010), and disruption of 
corticostriatal connectivity has been observed in disorders of salience processing 
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such as schizophrenia (Dandash et al., 2014; Fornito et al., 2013; Levitt et al., 
2017). 
 
In the current study, we recruited individuals with a history of either high or low 
exposure to chronic psychosocial stressors. Corticostriatal connectivity was 
measured using resting state functional magnetic resonance imaging (rfMRI), and 
participants also completed the Aberrant Salience Inventory and undertook the 
SAT. We hypothesised that exposed individuals would display increased aberrant, 
and reduced adaptive salience scores. We also hypothesised that exposed 
individuals would display alterations in corticostriatal functional connectivity, and 




Materials and Methods 
 
2.1 Participants 
Two groups of healthy volunteers were recruited, one that had been exposed to 
chronic psychosocial stressors (the ‘exposed’ group), and one with minimal 
exposure (the ‘unexposed’ group). Two groups of healthy volunteers were recruited, 
one that had been exposed to chronic psychosocial stressors (the ‘exposed’ group), 
and one with minimal exposure (the ‘unexposed’ group). Participants were 
recruited via online, leaflet and newspaper advertising. Online and newspaper 
advertising was performed in both and rural areas, while leaflet advertising was 
performed only in rural areas. Group assignment was made only following the 
screening interview. All subjects were aged 18-45, had no personal history of 
psychiatric illness, and no family history of psychotic illness. All participants 
provided written informed consent, and the study had research ethics committee 
permission.  
 
The exposed group had exposure to at least two of the following three risk factors: 
Childhood and current dwelling in urban environment (defined as local authority 
population density >50 persons/hectare); a history of 1st or 2nd generation 
migration; and a history of childhood adversity before age 16 years, which was 
defined as a Childhood Trauma Questionnaire subscale (physical, emotional, or 
sexual abuse) classification score of “moderate/severe” or “severe/ extreme” 
(Bernstein et al., 2003). The unexposed group currently lived in a non-urban area, 
had no history of urban living for longer than six months, had no history of 
migration, and no history of childhood adversity. 
 
Population density of current dwelling was obtained from the 2011 census (Office 
of National Statistics, 2011). Questionnaires conducted included the Aberrant 
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Salience Inventory (ASI) (Cicero et al., 2010), and the Childhood Trauma 
Questionnaire (Bernstein et al., 2003). 
 
 
2.2 Salience Attribution Test 
Aberrant and adaptive salience was measured using the SAT (Roiser et al., 2009). 
This is a task in which participants are presented with an image from 1 of 4 
possible categories (blue animal, red animal, blue household object, red household 
object), this image is immediately followed by a probe which the participant must 
respond to as rapidly as possible to maximise potential monetary reward (the 
magnitude of which is proportional to speed of response). One dimension of the 
pre-probe category is relevant to the probability of reward (e.g. if colour is the 
relevant dimension, 90% of probes following a red image would be accompanied by 
a reward, in contrast to 10% of probes following a blue image), while the other is 
irrelevant (e.g in the previous case, both animals and household objects would have 
a 50% chance of being followed by a reward).  
 
Two runs (64 trials each) were performed. Results are obtained for adaptive 
(relevant) and aberrant (irrelevant) salience, both based on participant reported 
estimated probabilities on visual analogue scales (SAT explicit salience) and 
reaction times (SAT implicit salience). SAT explicit adaptive salience represents 
the extent to which participants report a reward as more likely to follow following 
the relevant stimuli, compared to irrelevant stimuli. SAT implicit adaptive salience 
is a measure of how much more quickly a participant reacts to stimuli associated 
with reward in the relevant dimension. Measures of SAT aberrant salience relate to 
how much more likely participants rate or respond across the irrelevant dimension. 




SAT implicit aberrant, SAT explicit aberrant, and SAT implicit adaptive scores, 
and aberrant salience inventory scores were skewed and therefore square root 
transformed prior to analysis as previously recommended (Roiser et al., 2009). 
 
2.3 Demographic and Behavioural Data Analysis 
All statistical analysis was performed using R version 3.3.2. The normality of 
variables was checked using the Shapiro-Wilks test, and results were square root 
transformed if skewed (Roiser et al., 2009). The significance of differences between 
groups for continuous variables was determined using an independent samples t-




2.4 Resting State Functional Magnetic Resonance Imaging 
2.4.1 rfMRI: Data Acquisition 
Imaging data was acquired using a Philips 3T Intera magnetic resonance imaging 
system. A ten-minute resting state scan was performed using a T2* weighted 
transverse echo planar image sequence (TR = 3000 ms, TE = 30 ms, flip angle = 
90°, slice thickness = 3.25mm, 2.19mm x 2.19mm in plane resolution, 44 slices, 200 
volumes). A T1 structural image was then obtained with a gradient-echo scan 
(TR=9.7ms, TE=4.6ms, flip angle=90°, slice thickness=1.20 mm, 0.94 x 0.94 mm 
in plane resolution, 150 slices). 
 
2.4.2 rfMRI: Seed Definition 
Striatal seeds consisting of bilateral 3.5mm radius spheres were placed in the 
inferior ventral striatum, superior ventral striatum, dorsal caudate, dorsal rostral 
putamen, dorsal caudal putamen, and ventral rostral putamen. These predefined 
seeds were initially reported by Di Martino et al,(Di Martino et al., 2008) and have 
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been repeatedly used in investigations of striatal connectivity (DelDonno et al., 
2017; Fornito et al., 2013; Gabbay et al., 2013; Sarpal et al., 2016). 
 
2.4.3 rfMRI: Preprocessing 
fMRI data was analysed using the CONN toolbox (version 17) implemented in 
SPM12 (Whitfield-Gabrieli and Nieto-Castanon, 2012). A standard preprocessing 
pipeline was used consisting of slice timing correction, realignment, and 
normalisation to MNI space based on segmentation parameters derived from 
segmentation of the T1 structural image. Images were smoothed with a Gaussian 
kernel of 6 mm full-width-half-maximum. 
 
The Artifact Detection Tools (ART) toolbox (www.nitrc.org/projects/ 
artifact_detect) was used to account for motion and artefact detection using 
anatomical component based correction (aCompCor) of temporal confounds 
relating to head movement and physiological noise. This method models noise 
effects at a voxel level based on estimates derived from principal components of 
noise regions of interest (white matter and CSF, eroded by one voxel to minimise 
partial volume effects), and then removes these from the BOLD timeseries using 
linear regression, global signal regression is not performed.  Six residual head 
motion parameters and their first order temporal derivatives were also entered as 
regressors into the first level model, as was an effect accounting for magnetisation 
stabilisation and its first order derivative. Artifact/outlier scans (average intensity 
deviated more than 5 standard deviations from the mean intensity in the session, 
or composite head movement exceeding 0.9 mm from the previous image) were also 
regressed out. Preprocessed data were temporally bandpass filtered (0.008-0.09 Hz) 
 
2.4.4 rfMRI: Connectivity analysis 
Voxel wise connectivity maps for each participant were then derived by computing 
Pearson correlations between the signal average over each seed region, and the 
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signal at each voxel over the entire brain. These were then converted to normally 
distributed Fisher’s Z maps to allow second level general linear model analyses. At 
the second level, connectivity maps between exposed and unexposed groups were 
contrasted with each other for each seed (left and right hemisphere seeds were 
entered into the same model, so six group level comparisons were performed in 
total). Clusters were considered statistically significant if they passed height 
thresholds of P<0.001 and cluster-level thresholds of P<0.05 FWE-corrected.  
 
2.5 rfMRI Relationship with Salience Measures 
Fisher transformed correlation coefficients were extracted from significant clusters 
and averaged (weighted by cluster size) for each of the seeds showing statistically 
significant results. Pearson correlation coefficients were then calculated between 
these connectivity values and participant salience scores, with Spearman 
correlations also performed to ensure results were not outlier driven.  We next 
performed an exploratory analysis investigating whether the difference between 
exposed and unexposed groups’ salience scores might be mediated by altered 
corticostriatal connectivity. Where we had observed a significant bivariate 
relationship between corticostriatal connectivity and salience scores we tested a 
mediation model using the R package ‘mediation’ using quasi-Bayesian MonteCarlo 
simulation (10,000 simulations) to test for significance (Tingley, D., Yamamoto, T., 






3.1 Participant Demographics 
22 unexposed and 20 exposed participants were recruited; demographics are 
displayed in Table 1. No significant differences existed between groups for age or 
sex. As expected, measures of childhood trauma, population density and migration 
and were significantly different between the exposed and unexposed group. 
 
 
 Unexposed (n=22) Exposed(n=20) P-value 
Age (years), mean (SD) 26.3 (±6.5) 27.2 (±7.1) 0.67b 
Sex n (%female) 11 (50.0%) 11 (55.0%) 0.99c 
Aberrant Salience Inventorya 1.8 (±1.6) 2.7 (±1.3) 0.044b 
Childhood Trauma Questionnaire 29.2 (±5.4) 36.0 (±9.0) 0.005b 
Population Density (persons per 
hectare) 21.2 (±17.5) 81.2 (±32.5) < 0.001
b 
% 1st Gen. Migrant 0 (0.0%) 7 (35.0%) 0.009c 
% 2nd Gen. Migrant (both 
parents) 0 (0.0%) 9 (45.0%) 0.002
c 
% 2nd Gen. Migrant (one parent) 3 (13.6%) 3 (15.0%) 1.00c 
Mean Motion 0.2 (±0.1) 0.1 (±0.1) 0.76b 
Maximum Motion 1.4 (±2.3) 1.7 (±2.3) 0.69b 
Valid Volumes 193.1 (±14.2) 195.6 (±7.3) 0.49b 
 
a Square root transformed 
b Independent samples t-test 










3.2 Salience Measures 
The exposed group displayed significantly reduced SAT explicit adaptive salience 
(Cohen’s d=0.69, p=0.03, df=40), and increased aberrant salience inventory scores 
(d=0.65, p=0.04, df=40) compared to the unexposed group (see figure 2). There 
were no other significant differences between groups on SAT measures. Within the 
whole group, SAT explicit aberrant and SAT explicit adaptive salience were 
negatively correlated (rp=-0.44, p=0.004, df=40). There were no other statistically 






















Figure 2. Salience attribution test, and aberrant salience inventory 
scores in exposed and unexposed individuals.  




























*FWE corrected after initial p<0.001 cluster defining threshold 
3.3 rfMRI Data 
There were no differences between groups in terms of motion during the scan (see 
table 1). Compared to the unexposed group, the exposed group showed increased 
connectivity between the inferior ventral striatum and three clusters (see figure 3). 
These clusters were centred on the right supramarginal gyrus, insular operculum 
and middle temporal gyrus, and the largest would survive Bonferroni correction for 
the six seeds examined (0.05/6=p<0.0083). The dorsocaudal putamen also 
displayed increased connectivity in the exposed group, with significant clusters 
centred on the right supramarginal gyrus and left insular operculum. The largest of 
the dorsocaudal putamen clusters would also pass Bonferroni correction. No 
significant clusters were identified for the other seeds. No seeds displayed increased 
















Seed MNI coordinates Cluster size P* 
Inferior Ventral Striatum +58 +14 +22 219 0.00076 
Inferior Ventral Striatum +64 -42 +28 138 0.013 
Inferior Ventral Striatum +48 -56 +6 126 0.020 
Dorsocaudal Putamen +66 -26 +32 201 0.0017 
Dorsocaudal Putamen -44 -06 +30 124 0.016 
Figure 3. Areas of increased corticostriatal connectivity in the exposed compared to unexposed group.  




3.4 rfMRI Relationship with Salience Measures 
To investigate the potential behavioural relevance of the imaging findings, we 
averaged the connectivity z values within the significant clusters for each of the 
seeds (weighted by cluster size) to give a value for both average inferior ventral 
striatum connectivity, and dorsocaudal putamen connectivity. We then 
investigated correlations between these two summary connectivity measures and 
the behavioural measures. 
 
Within the whole group inferior ventral striatum connectivity negatively correlated 
with SAT explicit adaptive salience scores (rp=-0.48, p=0.001, df=40, see figure 
4A) and this was also present within the exposed group alone (rp=-.52, p=0.018, 
df=18). Inferior ventral striatum connectivity and SAT explicit aberrant salience 
scores were negatively correlated within the exposed group (rp=0.523, p=0.016, 
df=18, see Figure 4B), but not across the whole group. Inferior ventral striatum 
connectivity also positively correlated with Aberrant Salience Inventory scores 
across the whole group (rp=0.42, p=0.0056, df=40, see Figure 4C).  All these 
correlations remained significant when using Spearman’s coefficient, indicating 
statistical significance was not outlier driven. 
 
Dorsocaudal putamen connectivity also showed a negative correlation with SAT 
explicit adaptive salience scores (rp=-0.36, p=0.020, df=40) across the whole 
group, and a positive correlation with SAT explicit aberrant salience only in the 
exposed group (rp=0.50, p=0.025, df=18). When using Spearman’s coefficient the 
whole group correlation remained significant but the exposed group did not 
(rs=0.43, p=0.059). 
 
We next performed an exploratory mediation analysis to investigate whether the 
relationship between risk factor exposure (i.e. the binary variable of group) and 
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salience scores might be mediated by altered corticostriatal connectivity. In the 
case of the inferior ventral striatum this showed a significant mediation effect for 
explicit adaptive SAT scores (indirect path estimate ß=-17.8, 95% CI=-34.5, -3.2, 
p=0.02; direct path estimate ß 0.14, CI=-20.01, 20.87, p=0.99, see figure 4D), and 
aberrant salience inventory scores (indirect path estimate ß=4.5, 95% CI=0.35, 
9.26, p=0.03; direct path estimate ß -0.885, CI=-6.65, 5.02, p=0.77 ). The indirect 
path estimate between dorsocaudal putamen connectivity and explicit adaptive 




   
Figure 4. Relationship between salience scores and inferior ventral striatum connectivity 
(A) Inferior ventral striatum connectivity correlates with explicit adaptive SAT scores in both the whole sample (rp=-0.48, p=0.001) 
and exposed individuals (rp=-0.52, p=0.001) 
(B) Inferior ventral striatum connectivity correlates with explicit aberrant SAT scores in exposed individuals (rp=0.523, p=0.016) 
(C) Inferior ventral striatum connectivity correlates with Aberrant Salience Inventory Scores in the whole sample (rp =0.42, 
p=0.0056) 
(D) Mediation analysis – the relationship between risk factor exposure (i.e. whether participants in the exposed or unexposed 





In the current study, we demonstrated reduced adaptive salience in individuals 
that had been exposed to chronic psychosocial stressors, and found that this was 
related to increased connectivity between striatal seeds and cortical regions 
involved in salience processing. We also found increased scores on the aberrant 
salience inventory in the exposed group, but contrary to our initial hypotheses did 
not detect any between group differences on the aberrant or implicit measures of 
the SAT.  
 
The exposed group demonstrated reduced SAT explicit adaptive salience, which 
represents a relative impairment in the learning of stimulus-reward associations.  
Dopamine neurons projecting to the ventral striatum play a central role in this 
process (Schlagenhauf et al., 2013; Schultz et al., 1997), and impaired dopaminergic 
reward signalling secondary to chronic stress has been put forward as one of the 
neurochemical alterations contributing to affective (Cabib and Puglisi-Allegra, 
2012; Chen et al., 2015) and psychotic disorders (Howes et al., 2017). Reduced 
adaptive salience has been previously demonstrated in psychosis, and it was 
initially suggested that this primarily existed as a result of treatment with 
dopamine antagonists (Roiser et al., 2009). However, studies in un-medicated 
individuals at high risk of the disorder have displayed a similar pattern (Roiser et 
al., 2013; Schmidt et al., 2016), and some models suggest that although psychosis is 
associated with increased aberrant dopamine signalling (McCutcheon et al., 2018a), 
this may be accompanied by reductions in adaptive signalling (Maia and Frank, 
2017). The exposed group also demonstrated increased scores on the ASI but not 
on any of the SAT measures of aberrant salience. This is similar to several studies 
in clinical populations, where it appears that the measure of SAT explicit adaptive 
salience is the most sensitive to group differences (Abboud et al., 2016; Katthagen 
et al., 2016; Pankow et al., 2016; Roiser et al., 2009). In terms of the magnitude of 
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effect, the effect size observed in the current study for the measure of explicit 
adaptive salience (d=0.69), was smaller than what has been observed in 
schizophrenia (d=1.08 (Roiser et al., 2009)), but larger than what was reported in 
a recent study of individuals at clinical high risk of schizophrenia (d=0.25, (Roiser 
et al., 2013)). It may be that alterations in adaptive salience processing occur more 
readily in the face of chronic stress, while increases in aberrant salience scores are 
only observed in established illness. The lack of group differences in implicit 
measures is something that has also been observed in some patient cohorts, and the 
correct interpretation of these measures remains unclear(Abboud et al., 2016; 
Neumann and Linscott, 2018; Roiser et al., 2013). 
 
The exposed group also displayed increased functional connectivity between the 
ventral striatum and several cortical regions. A number of these clusters overlap 
with cortical areas that make up the cingulo-opercular or salience network (Gordon 
et al., 2016). This network is involved in the detection of relevant stimuli and the 
coordination of switching to appropriate brain states (Uddin, 2015), and shows an 
association with striatal dopamine function (McCutcheon et al., 2018c). Increased 
connectivity of the ventral striatum has also been observed in individuals with 
schizophrenia (Fornito et al., 2013), those at increased risk of the disorder 
(Dandash et al., 2014; Fornito et al., 2013), and those specifically affected by 
hallucinations (Rolland et al., 2015). In contrast to the current results, two of these 
studies simultaneously observed a pattern of reduced connectivity with the dorsal 
striatum (Dandash et al., 2014; Fornito et al., 2013). The pattern of connectivity 
alterations observed in the exposed group, therefore overlapped to an extent with 
what has been previously observed in schizophrenia, but also showed significant 
differences. 
 
The environmental exposures, neural circuits, and cognitive mechanisms we studied 
have all been implicated in schizophrenia, but have transdiagnostic relevance, and 
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as such may be best interpreted as mechanisms of general relevance to 
psychopathology rather than being disorder specific (Insel et al., 2010). Increased 
functional connectivity of the ventral striatum in has also been linked to an 
increased risk of subsequently developing depression (Pan et al., 2017), although 
findings in those with the established disorder have been inconsistent (Furman et 
al., 2011; Gabbay et al., 2013). This may be secondary to pathophysiological 
heterogeneity, illustrated by the fact that increased ventral striatum connectivity 
has been specifically observed in a high anxiety subgroup (Drysdale et al., 2016), 
while reduced connectivity has been observed in a high inflammation subgroup 
(Felger et al., 2016). 
 
Recent work has also found that both early life adversity (Hanson et al., 2018), 
and economic disadvantage (Marshall et al., 2018) are associated with increased 
functional connectivity of the ventral striatum; although earlier work demonstrated 
a reduction in ventral striatum connectivity in those raised in households of lower 
parental education (Gianaros et al., 2011). Another study reported reduced 
functional connectivity of the caudate and putamen during an error monitoring 
task but did not use a ventral seed (Hart et al., 2018). Studies of urbanicity and 
migration have not directly examined corticostriatal connectivity, although 
mesolimbic signalling has been shown to relate to urban living (Kramer et al., 
2017), and altered activation of the ventral striatum has been demonstrated in 
migrant individuals (Akdeniz et al., 2014). 
 
We found that differences in ventral striatum connectivity mediated the association 
between chronic social stress and both reduced adaptive salience scores, and 
increased aberrant salience inventory scores. While the whole striatum appears to 
play a role in salience processing (Ilango et al., 2014; Oyama et al., 2015), it is the 
ventral striatum that has been principally implicated in studies using the SAT 
(Boehme et al., 2015; Roiser et al., 2010), and it is the ventral striatum that shows 
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alterations in dopamine function in studies of early life stress(Oswald et al., 2014; 
Pruessner et al., 2004). It is, however, the associative striatum that displays the 
most marked dopaminergic dysfunction in schizophrenia (McCutcheon et al., 
2018a), and the precise mechanism through which corticostriatal connectivity 
contributes to salience attribution is yet to be fully elucidated, although it is likely 
that dopaminergic mechanisms contribute (Bell et al., 2015; Boehme et al., 2015; 
Nagy et al., 2012; Roiser et al., 2010). 
 
The study of risk factor exposure in individuals free of psychiatric illness means 
that the effect of exposure is not obscured by the presence of disease; however, a 
limitation is that it also raises the possibility that observed differences are markers 
of resilience as opposed to sequelae of exposure.  
 
Psychosocial stress is a multidimensional construct and as a result we studied 
multiple stressors. The threshold used for defining groups in the case of migration 
was based on the finding that both first and second generation immigrants have an 
increased risk of psychosis,(Bourque et al., 2011), childhood adversity thresholds 
were based on previous studies (Kraan et al., 2017; Philip et al., 2014), while our 
cutoff for urbanicity was based was on census data for population densities in 
London suburbs. It may have been beneficial to specify even lower cutoffs 
regarding population density for the unexposed group, although this may have 
impeded recruitment. Our approach aimed to maximise the distance between 
groups in terms of exposure, however the resulting collinearity of risk factor 
exposures means that we were unable to determine the extent to which each 
individual exposure drives the observed group differences. While a limitation, this 
is typically an issue in single exposure studies as well (albeit a less explicit one), 
given that these do not tend to measure other potential risk factors, and the fact 
that these stressors show a tendency to cluster (Hjern et al., 2004; Morgan et al., 




A further potential limitation is the fact that apart from the inverse correlation 
between the two explicit SAT measures no significant association was observed 
between the other salience measures. This has been previously studied, and while 
this may be a result of the various measures capturing different aspects of salience 
processing it also suggests caution may be required when interpreting the meaning 
of these measures (Neumann and Linscott, 2018). In addition, the results of the 
mediation analysis only just reached statistical significance, and should be viewed 
with caution given the relatively low sample size for this form of analysis. 
 
Future research has the potential to address several of the study’s limitations. 
Longitudinal follow up can clarify whether observed behavioural and 
neurobiological differences relate primarily to resilience or risk. Studies in patient 
populations, also have the potential to determine the pathophysiological relevance 
of our findings. Future studies might consider a factorial design, which would 
enable testing as to specific effects of individual exposures, and whether additive 
and synergistic effects exist. Even when considering only three risk factors, 
however,  eight possible combinations exists and a large sample would therefore be 
required. Alternatively using a continuous exposure score would be a powerful 
approach, although while recent scores have been proposed these remain to be 
validated (Padmanabhan et al., 2017; Vassos et al., 2018). Studies using positron 
emission tomography may allow for the investigation of whether the connectivity 
and behavioural differences observed involve dopaminergic alterations. 
 
In conclusion, we found evidence that exposure to chronic psychosocial stressors 
was associated with alterations in salience processing and corticostriatal 
connectivity. Longitudinal studies may help probe the implications that this holds 
for the development of psychiatric disorders. In addition, future studies using 
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multimodal methodologies are necessary to further understand the relationship 
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A wide range of neuropsychiatric disorders from schizophrenia to drug addiction 
involve abnormalities in both the mesolimbic dopamine system and the cortical 
salience network. Both systems play a key role in the detection of behaviourally 
relevant environmental stimuli. Although anatomical overlap exists, the functional 
relationship between these systems remains unknown. Preclinical research has 
suggested the firing of mesolimbic dopamine neurons may activate nodes of the 
salience network, but in vivo human research is required given the species-specific 
nature of this network. 
 
Methods 
We employed positron emission tomography to measure both dopamine release 
capacity (using [11C]-(+)-PHNO, n =23), and dopamine synthesis capacity (using 
3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine, n =21) within the ventral striatum. 
Resting-state functional magnetic resonance imaging was also undertaken in the 
same individuals to investigate salience network functional connectivity. A graph 
theoretical approach was used to characterise the relationship between dopamine 
measures and network connectivity. 
 
Results 
Dopamine synthesis capacity was associated with greater salience network 
connectivity, and this relationship was particularly apparent for brain regions that 
act as information processing hubs. In contrast, dopamine release capacity was 
associated with weaker salience network connectivity. There was no relationship 
between dopamine measures and visual and sensorimotor networks, indicating 
specificity of the findings. 
 
Conclusions 
Our findings demonstrate a close relationship between the salience network and 
mesolimbic dopamine system, and are relevant to neuropsychiatric illnesses in 





Resting state functional magnetic resonance imaging (rfMRI) has demonstrated 
that activity within networks of brain regions is temporally correlated even in the 
absence of explicit external demands(1), and furthermore that these networks 
underlie human cognition and behaviour(2,3). The salience network, also referred 
to as the cingulo-opercular network, is centred around the anterior insula and 
dorsal anterior cingulate, and in some instances has also been proposed to contain 
subcortical structures including the limbic (ventral) striatum and substantia 
nigra(4,5). Recent meta-analyses synthesising structural and functional imaging 
data have identified this network as uniquely affected across psychiatric 
disorders(4,5). 
 
The salience network plays a key role in identifying the most relevant internal and 
external stimuli in order to guide behaviour appropriately(6–11).  Connectivity 
within the salience network is increased by externally-directed demands, which 
contrasts with the default mode network (centred around the ventromedial prefrontal 
cortex and the posterior cingulate cortex)(12,13), where connectivity is enhanced 
during self-generated thought(14,15). The salience network dynamically coordinates 
the activity of other networks, in particular switching away from the default mode 
to task positive networks when appropriate, and impaired communication between 
the default mode and salience network is seen in a range of disorders, including 
schizophrenia, drug addiction, and cognitive impairment(16–21). 
 
Dopamine neurons also play a role in the identification of behaviourally relevant 
environmental stimuli. Mesolimbic dopamine neurons (projecting from the ventral 
tegmental area to the limbic striatum) have been proposed to signal reward 
prediction errors, which signal the discrepancy in the observed and predicted value 
of a stimulus(22). More recent research, however, has shown that these neurons 
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respond to surprising stimuli even in the absence of any change in value, suggesting 
that their role extends to assigning salience to relevant environmental stimuli in 
general, not solely on the basis of value(23,24). Dysfunction of this system is also 
observed in many neuropsychiatric illnesses(25,26). 
 
The need to develop an integrative understanding regarding the roles of the salience 
network and the mesolimbic dopamine system has been previously stressed(9). Given 
their overlap in function, it may be hypothesised that mesolimbic dopamine 
signalling plays a role in the modulation of the salience network. Recently, 
chemogenetic, optogenetic, and electrical stimulation of mesolimbic dopamine 
neurons in rodent models has been shown to activate salience network nodes, 
including regions not directly innervated by the ventral tegmental area(27–30). 
While cross species similarities exist in the organisation of cortical networks, there 
are also marked differences. Longer distance connections in particular are 
proportionally much weaker in primates, potentially contributing to an increased 
vulnerability to ‘disconnection syndromes’ such as schizophrenia(31). As a result, in 
vivo human research is required for a comprehensive understanding of the 
relationship between network connectivity and neurochemical signalling. Human 
studies have demonstrated effects of pharmacological dopaminergic challenges on 
salience network connectivity, suggesting dopamine might regulate the salience 
network in humans, but, crucially, these studies are limited in their explanatory 
potential because of the non-physiological and anatomically non-specific effects of 
the intervention(32–34). Thus, it remains unclear if mesolimbic dopaminergic 
signalling is linked to the salience network in humans. 
 
To address this, we employed positron emission tomography (PET) to measure both 
dopamine synthesis capacity and dopamine release capacity, and rfMRI to evaluate 
salience and default mode networks at rest in the same subjects. Based on recent 
preclinical findings that stimulation of dopamine neurons projecting to the limbic 
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striatum activates regions of the salience network(27–29), our primary hypothesis 
was that individuals with greater striatal dopamine synthesis and release capacity 
would show greater connectivity within the salience network, and, due to the 
reciprocal relationship between salience and default mode networks, weaker 
connectivity within the default mode network(27). 
 
In addition, we identified within these networks, regions that played the most 
important role in information processing (‘hub nodes’). Hubs support the rapid 
integration of information across a complex system, and as such can be considered 
an optimal target via which a network input may efficiently maximise its influence 
in a coordinated fashion(35,36). We therefore hypothesised that there would not be 
a uniform association between dopamine function and connectivity, but rather that 
hub nodes would show the strongest association with dopamine function. 
 
Given the preclinical emphasis on the mesolimbic dopamine projection, we focused 
on dopamine measures within the limbic striatum. However, we also explored the 
relationship between network connectivity and dopamine function in the associative 
and sensorimotor (dorsal) striatum. In addition, to provide a control condition, we 
investigated the relationship between striatal dopamine function and the visual and 
sensorimotor networks (networks not directly involved in salience processing), where 






The experimental approach is summarised in Figures 1 and 2. PET was used to 
investigate two different aspects of dopaminergic functioning. In experiment 1 we 
measured dopamine synthesis capacity, while in experiment 2 we measured dopamine 
release capacity. rfMRI was used to investigate salience and default mode network 
connectivity. The relationship between salience/default mode connectivity, and 
dopamine function was then investigated using a graph theoretical approach in which 
brain regions are represented as nodes, and functional connections between these 
regions are represented as edges linking these nodes.  
 
We first investigated whether network connectivity was associated with measures of 
dopamine function, and identified specific nodes that were associated with dopamine 
function. We then separately classified nodes as information processing hubs solely 
based upon their pattern of rfMRI connectivity, and determined whether dopamine-
associated nodes overlapped significantly with these hub nodes. 
 
In addition, the visual and sensorimotor networks were examined as control networks 
as they are not directly involved in salience processing, and show a lack of activation 
in preclinical studies of mesolimbic dopamine effects(27–29). Further details are 




Figure 1. Summary of methods 
A) Kicer or ∆BPND obtained for each 
participant from PET data 
B) rfMRI time courses extracted 
from salience network nodes, and 
individual functional connectivity 
graphs constructed for each 
participant 
C) Relationship between salience 
network average strength and 
dopamine measure investigated 
D) Dopamine associated 
subnetworks identified using 
network-based statistics 
E) Hub nodes identified from rfMRI 
data 
F) Overlap between hub nodes and 




Figure 2. The network based statistic and identifying hub overlap 
A) Identifying dopamine associated nodes using the network-based statistic  
B) Identifying overlap between dopamine associated nodes and hub nodes 
FC – Functional Connectivity, DSC – Dice Similarity Coefficient, NBS – Network Based statistic 
 
(A) Individual FC graphs constructed for 
the salience network from rfMRI data 
for each participant  
(B) Limbic Kicer obtained for each 
participant from PET data  
(C) Kicers randomly permuted 10,000 
times  
(D) Group PET-MRI graph constructed, 
each edge represents the correlation 
between that edge’s FC and the limbic 
Kicer values  
(E) PET-MRI graphs thresholded and 
binarised 
(F) Number of edges of the largest 
connected component in both the 
actual PET-MRI graph (five edges in the 
illustrated example), and the permuted 
graphs (three edges in the example) 
compared. P values calculated based on 
the proportion of permuted examples 
the true example is larger than 
A) Each node is ranked according to degree, betweenness 
centrality, and participation coefficient, at each MRI threshold. 
The average rank across thresholds for each metric is then 
calculated. 
(B) Nodes thresholded at a given rank, here the top ranked 30% 
are chosen 
(C) Determine which nodes pass the threshold for all 3 metrics, 
here 20%  of nodes classified as 'combination hubs' 
(D) Calculate the DSC between the 'combination hubs' and the 
nodes that form part of the dopamine subnetwork previously 
identified (Fig 1A). Do this for each NBS threshold and calculate 
the average DSC across thresholds. 
(E) Randomly pick a selection of nodes equal in number to the 
number of nodes in the subnetwork at the most lenient NBS 
threshold 
(F) Match the number of nodes in this random selection to that 
in the subnetwork at more stringent thresholds by randomly 
deleting a node (red arrow) when necessary to match 
(G) Calculate the mean DSC across thresholds for this randomly 
permuted node selection. 
  (H) Repeat E-G 10,000 times to generate a null distribution of mean DSCs 
( I) Test significance by determining where the 'true' mean DSC stands in relation to the null distribution 
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Experiment 1: Dopamine synthesis Capacity (18F-DOPA PET) 
Participants received a PET scan with the ligand 3,4-dihydroxy-6-[18F]fluoro-L-
phenylalanine (18F-DOPA). 18F-DOPA PET measures the rate constant (Kicer) for 
18F-DOPA uptake, transport into synaptic vesicles, and its conversion into 18F-
dopamine, thus providing a measure of dopamine synthesis capacity(37). 
 
A region-of-interest analysis was performed to determine the limbic striatum influx 
constant (Kicer [1/min])(38). We also determined influx constants for associative and 
sensorimotor striatum, with these regions defined using the approach outlined by 
Martinez and colleagues(38).  
 
Participants also received a rfMRI scan on a 3T GE Signa MR scanner. 
 
 
Experiment 2: Dopamine release capacity (11C-(+)-PHNO PET) 
Participants received two PET scans with the D2/3 receptor ligand [11C]-(+)-4-
propyl-9-hydroxy-naphthoxazine (11C-(+)-PHNO). A placebo scan gives a measure 
of baseline D2/3R availability (non-displaceable binding potential, BPND), while a 
scan following dexamphetamine administration allows quantification of the change 
in BPND due to competition from increased synaptic dopamine concentrations. The 
percentage reduction in D2/3R availability between placebo and dexamphetamine 
scans thus provides an index of dopamine release capacity. We calculate the percent 
change in BPND as follows: 
 
Either placebo or 0.5mg/kg dexamphetamine was administered orally 3hrs before 
11C-(+)-PHNO administration, so that scan acquisition coincided with the expected 
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time of peak action(39). ∆BPND was measured in the same regions as experiment 
one. 
 
Participants also received a rfMRI scan using a Siemens MAGNETOM Verio 3T 
scanner.   
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eFigure1: Salience and default mode networks of the Gordon atlas 




Participants had no previous or current history of psychiatric illness (assessed by the 
Structured Clinical Interview for DSM-IV Axis I Disorders).  
 
MRI Analysis 
Time-series were extracted from N=333 predefined nodes of interests of the Gordon 
cortical atlas. The salience and default mode network nodes of the Gordon atlas are 
displayed in eFigure 1.  For each participant, a graph representing a functional 
connectivity network was constructed, each edge representing the level of functional 
connectivity between a pair of nodes. In order to demonstrate robustness of our 
findings, we also replicated all analyses using two alternative atlases - the Power(40), 
and CONN network atlases(41). Furthermore, in addition to using the a priori 
defined network labels  for each node (i.e. salience, default mode etc.), we also ran a 
whole brain community detection algorithm for each atlas(42), to generate definitions 
of the salience and default mode networks based on the connectivity patterns present 





Network Strength and Dopamine Function  
For each participant and each network, average network strength was defined as the 
mean z-transformed Pearson’s correlation coefficient between all network nodes (i.e. 
mean edge strength)(43). We first calculated Pearson correlation coefficients between 
network average strength, and the PET measures of dopamine function.  We then 
tested whether the correlation between network strength and dopamine function was 
significantly different between default mode and salience networks using the method 
described by Meng et al. as implemented in the cocor (1.1-3) package for R 
3.3.2(44,45). We also investigated the correlation between dopamine measures and 
salience-default mode ‘balance’ (salience network average strength minus default 
mode network average strength). 
 
Identifying Dopamine-Associated Nodes 
In order to identify whether specific nodes show a significant relationship with limbic 
dopamine synthesis capacity we used the network-based statistic to investigate 
salience, default mode, sensorimotor, and visual networks separately (see Figure 2A 
and supplementary methods)(46). Within each network, we identified sub-networks 
showing a significant relationship with dopamine function and term these ‘dopamine-
associated subnetworks’, and the nodes within these networks ‘dopamine-associated 
nodes’. In addition to examining intra-network connectivity we used the same 
approach to examine salience and default mode inter-network connectivity. To 
ensure robustness of the results, this approach was undertaken across a range of 
network-based statistic thresholds (100 thresholds, t=1.3-3.1, equivalent to p=0.2-
0.005 for n=23), where weaker thresholds will capture subnetworks showing a 
widespread diffuse relationship with dopamine function, and more stringent 
thresholds identify smaller clusters showing the strongest relationship. 
 
Identifying Network Hubs 
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Based on the patterns of resting state connectivity within the salience and default 
mode network we then calculated several graph metrics to identify network hubs. 
We calculated node degree(47), betweenness centrality(47), and participation 
coefficient(48). We termed a node that ranked highly on all three metrics a 
combination hub (Figure 2B steps A-C), highlighting its importance as an all-round 
information processing node. By varying the stringency of criteria used to defined 
nodes as hubs we defined sets of combination hubs comprising between 10 and 40% 
of the total number of nodes. 
 
Identifying Overlap Between Dopamine-Associated Nodes and Network Hubs  
We next asked whether dopamine-associated nodes were statistically more likely to 
be combination hubs. We quantified the overlap of dopamine-associated nodes and 
combination hubs using the Dice Similarity Coefficient (where e.g. A is the set of 
dopamine-associated nodes and B is the set of combination hub nodes)(49,50): 
 
 
The Dice Coefficient was calculated for each of the 100 NBS thresholds (t=1.3-3.1) 
and then averaged to give a single score (Figure 2B part D). Permutation testing 
was used to test whether this overlap score was statistically significant. This 
procedure was then repeated for each of the combination hub thresholds (10-40%), 
thereby giving a p-value for each hub threshold.  
 
We also investigated whether there was a significant overlap between 18F-DOPA and 








Twenty-one participants took part in experiment 1, the 18F-DOPA study 
(mean(SD) age=23.5 years (3.36); 67 % male). Twenty-three participants took part 
in experiment 2, the 11C-(+)-PHNO study (age =24.4 years (4.5); 57 % male). 
 
 
Network Strength and Dopamine Function 
 
Experiment 1: Dopamine synthesis capacity (18F-DOPA)  
The correlations between edge strength and limbic dopamine synthesis capacity are 
displayed in the lower triangle of figure 3A.  Average network strength of the salience 
network positively correlated with limbic dopamine synthesis capacity (rp=0.51, 
p=0.017, figure 3B), and this was also significant for all other parcellations (rp=0.44-
0.62, efigure 3). In contrast, average network strength of the default mode network 
did not show a significant relationship with limbic dopamine synthesis capacity (rp=-
0.32, p=0.16, figure 3B).  
 
The correlation between dopamine synthesis capacity and salience network average 
strength was significantly different from that between dopamine synthesis capacity 
and default mode average network strength (z=-2.7, p=0.008). Furthermore, 
salience-default mode ‘balance’ (salience network average strength minus default 
mode network average strength) correlated with dopamine synthesis capacity (rp = 
0.60, p=0.004, Figure 3B). 
 
When the relationship between salience network average strength and dopamine 
synthesis capacity in other striatal regions was investigated, the findings were 
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significant for the associative striatum (rp=0.46, p=0.034) but not the sensorimotor 
striatum (rp=0.43, p=0.053) (eFigure 2). As hypothesised, there was no association 
between limbic dopamine synthesis capacity and average network strength of either 
the visual (rp=0.05, p=0.85) or sensorimotor networks(rp=0.09, p=0.68). 
 
Experiment 2: Dopamine release capacity (11C-(+)-PHNO) 
The correlations between edge strength and limbic dopamine release capacity are 
displayed in the upper triangle of figure 3A. Contrary to our hypothesis, average 
network strength of the salience network was negatively correlated with limbic 
dopamine release capacity (xrp=-0.42, p=0.049, figure 3B), a finding that was also 
significant for some (Gordon data driven, Power data driven) but not all (Power 
apriori, CONN) of the alternative parcellations (rp=-0.24 - -0.52, efigure 3). There 
was no significant correlation between dopamine release capacity and default mode 
average network strength (rp=0.03, p=0.9). The difference between these two 
correlations was not significant (z=1.43, p=0.15), and salience-default mode 
‘balance’ did not correlate significantly with dopamine release capacity (rp=-0.29, 
p=0.18).  
 
As in experiment 1, salience network strength was significantly associated with 
dopamine release capacity in the associative striatum (rp=-0.5, p=0.015), but showed 
no relationship with the sensorimotor striatum (rp=-0.17, p=0.44) (eFigure 2). 
Furthermore, as in experiment 1, there were no associations between limbic 
dopamine release capacity and average network strength in either the visual (r=-
0.27, p=0.22) or sensorimotor (r=-0.28, p=0.20) networks. Interestingly, however, in 
an exploratory analysis dopamine release capacity within the sensorimotor striatum 





There was no relationship between rfMRI motion and either network strength or 
dopamine measures (results in supplementary information). 





Figure 3: Resting state networks and their relationship with limbic dopamine function 
(A) Dopamine associated graphs – each edge represents the correlation between that edge’s rfMRI functional connectivity values and limbic dopamine 
synthesis/release capacity (B) Dopamine synthesis capacity is correlated with salience network strength (N=21, rp=0.51, p=0.017), did not correlate with 
DMN strength (rp=-0.32, p=0.16), and positively correlated with the difference between SAL and DMN strength (rp = 0.60, p=0.004)  (C) Dopamine release 
capacity negatively correlated with salience network strength (rp = -0.42, p=0.049) (D)Network-based statistic identifies subnetworks significantly 




eFigure 2: Correlation between average network strength (Gordon parcellation) and dopamine 
measures in striatal subdivisions 
11C-PHNO Salience Network 
18F-DOPA Salience Network 
18F-DOPA Default Mode Network 






eFigure 3: Correlation between limbic dopamine measures and salience network strength for a range of parcellation schemes 
18F-DOPA Salience Network 




Identifying Dopamine-Associated Nodes 
 
Experiment 1: Dopamine synthesis capacity( 18F-DOPA) 
Using the network-based statistic we identified salience network subnetworks 
showing a significant positive relationship with limbic dopamine synthesis capacity 
across a range of thresholds (Figure 3D). In contrast, subnetworks within the default 
mode network showed a significant negative relationship with dopamine synthesis 
capacity.  
 
We also used the network-based statistic to examine internetwork connections 
between default mode and salience networks. At specific thresholds, greater 
dopamine synthesis capacity was associated with weaker internetwork connectivity 
(i.e. greater decoupling), although this was not significant across a wide range of 
thresholds (eFigure 4). 
 
When dopamine synthesis capacity in other striatal subdivisions was examined, the 
findings were again significant for the associative but not sensorimotor striatum 
(eFigure 5). The specificity of the findings was again demonstrated by the fact that 
no dopamine associated subnetworks were identified in either visual (p>0.29 for all 
thresholds) or sensorimotor (p>0.38) networks.  
 
Experiment 2: Dopamine release capacity (11C-(+)-PHNO) 
We identified subnetworks within the salience network showing a significant negative 
relationship with limbic dopamine release capacity (Figure 3D). No default mode 
subnetworks showed a significant association with dopamine release capacity. As in 
experiment 1 examination of internetwork connections suggested that release 
capacity was associated with internetwork coupling only at specific thresholds, and 





Dopamine release in other regions was examined and similarly to experiment 1, 
significant results were observed for the salience network with the dopamine measure 
in the associative striatum but not sensorimotor striatum (eFigure 5). As before we 
demonstrated specificity of findings in that no visual (p>0.12 all thresholds) or 
sensorimotor subnetworks (p>0.11 all thresholds) were associated with limbic 
dopamine release capacity. 
 
In both experiments these findings were seen in various parcellations and methods 





eFigure 4. Relationship between salience-default internetwork connectivity and limbic 
dopamine function 
For 11C-PHNO the p-value represents the significance of the relationship between greater BPND and greater internetwork 
connectivity as calculated using NBS, while for 18F-DOPA this refers to an association with weaker internetwork connectivity. 
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eFigure 5: Network-based statistic results for and dopamine measures in various regions (Gordon 
parcellation). 
11C-PHNO Salience Network 
18F-DOPA Salience Network 18F-DOPA Default Mode Network 





eFigure 6: Network based statistic identifies subnetworks significantly associated with limbic 
dopamine measures for a range of parcellations 




Identifying Overlap Between Dopamine-Associated Nodes and Network Hubs  
 
Experiment 1: Dopamine synthesis capacity (18F-DOPA) 
We next investigated whether the dopamine-associated nodes identified in the 
previous step, overlapped significantly with nodes that were classified as information-
processing hubs. Within the salience network we found that regardless of how many 
nodes were defined as hubs within our range of investigation (i.e. the top ranked 10-
40%), these nodes were likely to be dopamine-associated nodes, and this overlap was 
significantly more likely than expected by chance for all hub thresholds (see Figure 
4B), and this was the case for all parcellations and methods of node 
assignment(eFigure 7). The Dice Coefficient between nodes in salience-FDOPA 
subnetworks and combination hubs across a range of thresholds is shown in Figure 
4C, illustrating that the nodes that are most strongly associated with dopamine 
synthesis capacity (i.e. those surviving the more stringent network-based statistic 
thresholds) are also the most likely to be key information processing hubs (as defined 
by resting state functional connectivity).  
 
The Dice Coefficient between combination hubs and the dopamine-associated nodes 
within the default mode network was numerically greater than the random network 
at all thresholds but this difference was only statistically significant for certain hub 
thresholds and parcellation (see figure 4B and eFigure 7). 
 
Experiment 2: Dopamine release capacity (11C-(+)-PHNO)  
The Dice Coefficient between combination hubs and the salience-PHNO subnetworks 
were numerically greater than the mean overlap expected of the random network, 
but this difference was only statistically significant for certain thresholds and 
parcellations (figure 4B and eFigure 7). 
 
Overlap between Experiments 
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Dice overlap scores between the 11C-PHNO and 18F-DOPA associated nodes 
ranged from 0.36 at the most stringent NBS threshold where equal node networks 
existed (number of nodes=11),  to 0.92 at the least stringent threshold(number of 
nodes=36). None of these overlaps were greater than would be expected by chance 
(p>0.20 for all thresholds). We then investigated which nodes were in dopamine 
associated networks at the most stringent threshold, and were also combination 
hubs (ranked in the top 11/40 nodes in both experiments). Only two nodes fulfilled 




Figure 4: Characterisation of dopamine associated subnetworks 
 
 (A) Salience network hubs and dopamine associated subnetworks: Red nodes represent network combination hubs. Green nodes and edges 
represent dopamine-associated network, in which edge strength correlates with limbic dopamine synthesis capacity. (i) Hub nodes in experiment 
1 (ii) dopamine associated network in Experiment 1 at a specific network based statistic threshold (iii) dopamine associated network in Experiment 
2 (iv) 2 nodes classified as both dopamine associated nodes and hub nodes in both experiments at the most stringent threshold. 
 
(B) Graph displaying whether overlap between dopamine-associated nodes and combination hubs is significant. 
 
(C) Illustrating the overlap between salience network hub nodes, and nodes involved in 18F-DOPA associated subnetworks. The top (green-yellow) 
layer represents the Dice Similarity Coefficients for the observed dopamine-associated nodes and the combination hub nodes, while the bottom 
(blue-red) layer represents the mean overlap coefficients of 10,000 randomised networks. In this figure, the dice coefficient is plotted individually 




eFigure 7: Significance of overlap between nodes showing strongest association with limbic dopamine measures and 
network combination hubs, for a range of parcellations 
18F-DOPA Salience Network 18F-DOPA Default Mode Network 






Using rfMRI and a dual-tracer PET paradigm we demonstrate a strong relationship 
between limbic dopamine function and salience network functional connectivity in 
humans. Both the salience network and mesolimbic dopamine system are central to 
the pathophysiology of various neuropsychiatric disorders (4,5,25,26). To our 
knowledge, however, this is the first human study to both measure limbic dopamine 
function, and investigate its relationship with the salience network.  
 
Specifically, we demonstrated that stronger connectivity within the salience network 
was directly associated with limbic dopamine synthesis capacity, and contrary to our 
initial hypothesis was inversely associated with limbic dopamine release capacity. 
Furthermore, the biological relevance of this result is supported by the finding that 
there was significant overlap between nodes in salience subnetworks associated with 
dopamine synthesis capacity, and nodes separately identified as information 
processing hubs. We also identified default-mode subnetworks in which edge strength 
was inversely correlated with synthesis capacity.  
 
The relationship between mesolimbic dopamine function and the salience network 
The current study advances our understanding regarding the relationship between 
mesolimbic dopamine activity and salience network function. Preclinical studies have 
suggested a link between mesolimbic dopamine function and nodes of the salience 
network(27–29). However, a precise homologue of the salience network is not present 
in rodent models, both due to the species-specific nature of cortical networks, and 
the fact that in humans the network is characterised by the presence of Von Economo 
neurons, a distinct set of pyramidal neurons, which are not observed in 
rodents(31,51,52). Previous studies in humans have used rfMRI in combination with 
pharmacological manipulations of the dopamine system(32,53–55). Without the use 
of PET, however, it is not possible to obtain a measure of the dopaminergic effect of 
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the pharmacological intervention, which can vary significantly between individuals 
for the same dose. Furthermore, drug challenges perturb the system widely, causing 
various neurochemical changes across the brain and affecting neurovascular 
coupling(56). In contrast, our resting state data was obtained in a drug free state, 
and 18F-DOPA PET indexes physiological dopamine function. 
 
Although previous studies have integrated PET and the examination of resting state 
networks, these have predominantly obtained only measures of baseline dopamine 
receptor availability(57–60). Two studies have measured dopamine function, but did 
not examine the relationship with the salience network(34,61).  
 
Dopamine synthesis and release capacity 
We hypothesised that release and synthesis capacity would capture similar facets of 
a single construct – the activity of an individual’s mesolimbic dopamine system. Our 
finding of divergent relationships between these two measures and salience network 
connectivity does not support this interpretation. Both release and synthesis capacity 
are complex signals, and the relationship between the two is not clear(62,63). 
Synthesis capacity represents the rate of L-DOPA decarboxylation, and depends on 
the number of dopaminergic neurons, and their mean firing rate. Measures of release 
capacity will be determined by the reactivity of mesolimbic dopamine neurons to the 
effects of amphetamine. Agonist tracers such as 11C-PHNO preferentially bind to 
the high affinity state of the D2 receptor(64,65). This means that our measure of 
percentage release could be affected by the proportion of D2 receptors in a high 
affinity state as well as the level of dopamine release. Future studies combining 
antagonist and agonist radiotracers would help determine the potential influence of 
inter-individual differences in the proportion of D2 receptors in the high affinity 
state.  A tentative hypothesis that unites our findings assumes that, in a healthy 
individual, dopamine synthesis capacity reflects a summary measure of tonic 
dopamine neuron firing and appropriate adaptive phasic firing; while release capacity 
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reflects that individual’s propensity for spontaneous phasic firing in the absence of 
behaviourally relevant stimuli(66). Taken with the finding that reduced salience 
network connectivity is observed in disorders of aberrant salience processing, this 
suggests a model in which greater salience network connectivity is associated with 
the appropriate attribution of salience, mediated by robust adaptive dopaminergic 
signalling; while a propensity for stimulus independent dopamine neuron firing is 
associated with weakening of the network, and misattribution of salience(67–71). 
This is a speculative interpretation, however, and assumes that the consequences of 
higher dopamine synthesis capacity in healthy participants differ from those in 
patient populations where it has been linked to disorders of salience(72). 
 
Dopamine Pathways 
Preclinical research has often focused upon the dopamine neurons of the ventral 
tegmental area. The limbic striatum is a major projection target for these neurons, 
and as such an appropriate region of focus. In rodents, however, the mesolimbic 
pathway is proportionally larger than in humans, and therefore although the 
associative striatum receives dopaminergic innervation from the nigra, parts of the 
human midbrain-associative striatum pathway are homologous to the rodent 
mesolimbic pathway(73,74). As a result, it is not surprising that the relationship 
observed between the salience network and limbic dopamine function was also seen 
when using measures of associative striatum dopamine function. No relationship, 
however, was seen with dopamine measures obtained from the sensorimotor striatum 
and salience network connectivity, although an association was seen with release 
capacity in this region and sensorimotor network connectivity suggesting a degree of 






Structural and functional abnormalities within the salience network are a common 
biological substrate of mental illness, and exist trans-diagnostically across a broad 
range of disorders including depression, schizophrenia, and Parkinson’s 
disease(4,5,75–77). The mesolimbic dopamine system is also affected in these 
disorders(25,26,78,79). Our finding that the two systems show coupling in humans 
could explain why they are disordered in several illnesses, as dysfunction in any one 
of the network’s nodes could conceivably lead to impairment across both systems. 
Our findings also highlight opportunities for the development of pharmacological 
interventions. The ability to link the effects of quantifiable neurochemical 
modulation to change in network function, raises the possibility of mapping receptor 
actions to desired network alterations.  
 
Limitations and Further Questions 
Given that the firing of mesolimbic neurons has been shown to provoke widespread 
neural activity in regions receiving no direct dopaminergic innervation(29), our 
findings could be interpreted as indicating that mesolimbic dopaminergic signalling 
is able to regulate  salience network function. However, while differences in 
dopaminergic tone could feasibly shift the balance between the two networks, it is 
not possible for us to infer the direction of causality.  
 
Likewise, the precise site of relevant dopaminergic activity is not clear. 11C-(+)-
PHNO and 18F-DOPA are unable reliably characterise dopamine function outside of 
the striatum, and it was therefore not possible to test whether a relationship between 
direct dopaminergic innervation of network nodes and network connectivity also 
existed. 
 
We used an eyes closed resting state scan, and some networks have shown greater 
reliability when participants have kept eyes open. The differences are relatively 
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small, however, and therefore unlikely to have significantly influenced our 
findings(80). 
 
The use of acute dopaminergic challenges during simultaneous PET-MRI would 
allow for the study of intra-individual effects of dopaminergic release upon network 
average strength and organisation, and may help to disentangle some of these issues. 
Studies in clinical populations, such as individuals with schizophrenia, where 
measures of both dopaminergic and network function may show wider ranges(81), 
and the inclusion of behavioural tests would help further determine the relevance of 
these findings to pathophysiology and psychopathology. 
 
Measures of dopamine function showed strong associations with salience network 
connectivity, and in the case of dopamine synthesis capacity this was particularly 
the case for nodes that were identified as information processing hubs within the 
salience network. These findings are relevant to developing integrated models of 
brain function in health and disease, and for the development of treatments that 
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Ethical permission was obtained from the local ethics committee, and all participants 
provided informed written consent. Healthy controls were recruited via 
advertisements online and in local media. Subjects had no history of psychiatric or 
neurological disorders, and had a urine drug screen and pregnancy test (where 
appropriate) prior to scanning. 
 
PET Data Acquisition and Analysis 
Participants were not permitted to smoke or consume caffeine for four hours 
preceding the scan. After acquiring a CT scan for attenuation correction, PET 
images were acquired using a Siemens Biograph HiRez XVI PET scanner (Siemens 
Healthcare, Erlangen, Germany) at Imanova Centre for Imaging Sciences.   
 
Experiment 1: FDOPA study 
One hour prior to scanning, participants received 400mg entacapone and 150mg 
carbidopa, to prevent formation of radiolabelled metabolites and reduce peripheral 
metabolism. Approximately 160 MBq of 18F-DOPA was administered by bolus 
intravenous injection. The quantification pipeline was consistent with previous 
works.1 Correction for head movement during the scan was performed by denoising 
the non- attenuation-corrected dynamic images using a level 2, order 64 Battle-
Lemarie wavelet filter. Frames were realigned to a single reference frame, acquired 
20 minutes post-injection, employing a mutual information algorithm.2,3 The 
transformation parameters were then applied to the corresponding attenuated-
corrected dynamic images, creating a movement-corrected dynamic image, which 
was used in the analysis. Realigned frames were then summated to create an 
individual motion-corrected reference map for the brain tissue segmentation. The 
cerebellum was used as a reference region, and Kicer was calculated with the Patlak-
 
239 
Gjedde graphical approach adapted for reference tissue input function4. Image 
processing and quantification was done using in-house code with Matlab 2012b. 
 
Experiment 2: PHNO study 
Approximately 170 MBq of 11C-(+)-PHNO was administered by bolus injection. 
After the administration of the radiotracer, dynamic emission data were acquired 
continuously for 90 minutes. The dynamic images were reconstructed using a filtered 
back-projection algorithm into 31 frames (8 x 15 seconds, 3 x 60 seconds, 5 x 120 
seconds, 15 x 300 seconds) with a 128 matrix, a zoom of 2.6 and a transaxial Gaussian 
filter of 5mm. 
 
An individual parcellation of the brain was implemented in MIAKAT release 4.2.6 
(http://www.miakat.org),5 SPM12 and FSL (version 5.0.9). Cerebellar grey matter 
was used as the reference region, and the simplified reference tissue model (SRTM) 
was used to derive BPND from the regional time activity curves.6,7 The magnitude of 
dexamphetamine-induced dopamine release within the limbic striatum was 
quantified as the percentage change in BPND in the dexamphetamine condition vs. 




MRI data acquisition 
Participants were instructed to remain still, keep awake, and keep their eyes 
closed.  
 
Experiment 1: FDOPA study  
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MRI data was obtained using a General Electric (Milwaukee, Wisconsin, USA) Signa 
HDxt 3T magnetic resonance imaging system. Functional imaging consisted of T2* 
weighted echo planar image slices. 256 volumes were acquired, consisting of 39 
interleaved slices (3.5 mm slice thickness, 3.75 mm x 3.75 mm voxel dimensions in 
plane) with a repetition time (TR) of 2000 ms, echo time(TE) of 30 ms, and a scan 
time of 8 minutes 32 seconds.  
 
A structural image was obtained using a gradient-echo scan (TR=7.0s, TE=2.8s, flip 
angle=11°, in plane resolution=1mm x 1mm, slice thickness=1.2mm, 196 slices).  
 
Experiment 2: PHNO study 
MRI data was obtained using a Siemens MAGNETOM Verio 3-T magnetic 
resonance imaging scanner. Functional imaging involved a multiband sequence based 
on the multiband EPI WIP v012b provided by the University of Minnesota,8–11 using 
a multiband acceleration factor of 2. 238 volumes were acquired, consisting of 72 
interleaved slices (2mm thickness, and in-plane resolution of 3 x 3 mm), with a TR 
of 2000 ms, TE of 30 ms and a scan time of 7 minutes 56 seconds. 
 
A structural image was also obtained using a gradient echo scan (TR = 2300 ms, 
TE = 2.98 ms, flip angle = 9°, 1 mm isotropic voxels, parallel imaging (PI) factor 




Image pre-processing was performed via the CONN toolbox (version 17.b)13 for 
Statistical Parametric Mapping software (SPM 12 (6906)). A standard preprocessing 
pipeline was used consisting of slice timing correction, realignment, and 
normalisation to MNI space. Images were smoothed with a Gaussian kernel of 8mm 
full-width-half-maximum. The ART toolbox was used to account for motion and 
artefact detection using anatomical component based correction (aCompCor) of 
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temporal confounds relating to head movement and physiological noise. This method 
models noise effects at a voxel level based on estimates derived from principal 
components of noise regions of interest (white matter and CSF, eroded by one voxel 
to minimise partial volume effects), and then removes these from the BOLD 
timeseries using linear regression.  Six residual head motion parameters and their 
first order temporal derivatives were also entered as regressors into the first level 
model. A confounding effect accounting for magnetisation stabilisation, and its first 
order derivative was entered. Artifact/outlier scans (average intensity deviated more 
than 5 standard deviations from the mean intensity in the session, or composite head 
movement exceeded 0.9 mm from the previous image) were also regressed out. 
Preprocessed data were temporally bandpass filtered (0.008-0.09 Hz) 
 
Time-series were extracted from N=333 predefined nodes of interests of the Gordon 
cortical atlas. The salience and default mode network nodes of the Gordon atlas 
are displayed in eFigure 1.  For each participant, a graph representing a functional 
connectivity network was constructed, each edge representing the level of 
functional connectivity between a pair of nodes, which was computed as the z-






MRI-analysis: Atlas selection 
The Gordon parcellation is based upon resting state boundary maps observed in a 
sample of 120 healthy young adults, and shows superior within parcel homogeneity 
when compared to other parcellations, making it an ideal choice for the analysis 
of  resting state data.14 In order to demonstrate robustness of our findings, we also 
undertook all analyses using two alternative atlases - the Power atlas (a collection 
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of 264  10 mm diameter spheres derived from connectivity data in over 300 healthy 
volunteers performing various tasks),15 and the CONN network atlas (a 32 node 
atlas in which nodes are defined on the basis of an independent components 
analysis of 497 subjects from the Human Connectome Project).13 
 
MRI-analysis: Network Strength 
For a network formed of N nodes, the average network strength !¯can be computed 
similarly to the link density ρ of unweighted networks16:  
 
 
MRI-analysis: Community Detection 
On the basis of the original Gordon atlas labels 41 nodes were a priori defined as 
belonging to the default mode network, and 44 to the cinguloopercular/salience 
network (referred to in the current paper as the salience network).14 The Power atlas 
assigns 32 and 58, while the CONN atlas assigns 7 and 4 nodes to the salience and 
default mode networks respectively. As a result, the networks of interest were defined 
across a wide range of scales both in terms of node volume, and maximal network 
size.  
 
In addition to the apriori network labels, however, we also ran a whole brain 
community detection algorithm for each atlas,17 to generate definitions of the salience 
and default mode networks based on the connectivity patterns present in the current 
datasets. To accomplish this each subject’s fully weighted functional connectome was 
subjected to the Louvain community detection algorithm, and the results of this were 
used to generate community assignments at the group level (individual level 
community assignments are not appropriate for subsequent analyses).17  Due to the 
non-deterministic nature of the Louvain algorithm, a previously described consensus 
clustering approach was employed,18 negative weights were treated symmetrically, 
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and the gamma parameter was set to 1.7 as this produced community sizes in relative 
agreement with existing parcellation schemes. 
 
Identifying Dopamine Associated Nodes– Network Based Statistic 
In order to identify whether specific subnetworks show a significant relationship with 
limbic dopamine synthesis capacity we used the Network-Based Statistic (NBS) to 
investigate salience, default mode, sensorimotor, and visual networks separately (the 
method is summarised in Figure 2A in the main text).19 A t-statistic was generated 
for each edge based on the Pearson correlation coefficient computed over each 
population between the functional connectivity z values of that edge, and the limbic 
striatum Kicer or ∆BPND values (i.e. a positive value indicates that greater limbic 
dopamine synthesis/release capacity is associated with stronger connectivity at that 
edge). This generated a group level PET-MRI graph for each cohort, which was 
thresholded at 100 separate thresholds (t=1.3-3.1, equivalent to p=0.2-0.005 for 
n=23). The connected component with the greatest density (i.e. greatest number of 
edges) within this t-statistic graph was then determined at each of these t-thresholds. 
If there were multiple networks of equal density the one with greatest average 
strength in the weighted version of the graph was selected. Permutation testing was 
performed to calculate a p-value for each threshold, by determining whether the 
density of the densest component was significantly greater than expected by chance. 
This was calculated by comparing the density of the observed component with 
densest components in 10,000 PET-MRI graphs generated for each threshold (t=1.3-
3.1) via random assignment of the Kicer or ∆BPND values. We subsequently term the 
components identified as showing a relationship with limbic dopamine function as 
‘dopamine-associated subnetworks’. We repeated the analysis using measures for 
dopamine function in the associative and sensorimotor striatum in place of the limbic 
measure. We used the same approach to examine inter-network connectivity between 




Hub Node Identification 
Group level binary graphs were constructed for the salience and default mode 
networks separately. First individual level graphs were rescaled by subtracting from 
each individual participant’s graph that participant’s average network strength, and 
dividing by the standard deviation of all that network’s edges’ strength. In this way 
all participants then had an average network strength of zero and so individuals with 
greater network mean strength would not have undue topological influence.  
 
We next averaged across individuals to create a group level graph. Proportional 
thresholding was performed on this group averaged matrix by assigning a value of 1 
to all edges with connection strength above a set threshold, and setting all remaining 
edges to 0. We used 100 thresholds, retaining 20% of edges at the most lenient 
threshold, and 7% at the most stringent. There is no ‘correct’ set of thresholds but 
at more lenient thresholds one risks including a high degree of spurious connections, 
while at more stringent thresholds the graph became overly fragmented. The fact 
that this is a more lenient range than reported elsewhere is appropriate given we are 
investigating intranetwork connectivity, where there will be a lower proportion of 
spurious edges.20 
 
Graph metrics were computed using the Brain Connectivity Toolbox.21 Node 
degree  refers to the number of neighbours a node has, and is thus a measure of the 
local, direct importance of a node: #$ = ∑ '$,)*)+, .22 While this intuitively captures 
the relative importance of a node within a network, in correlation based graphs, it 
may also reflect membership of a larger community, as opposed to the importance 
of the node in information processing.23 We therefore also calculated for each node 
betweenness centrality -$,,22 and the node participation coefficient ./$.24 The node 
betweenness centrality measures the proportion of shortest paths between all pairs 
of nodes that pass through it, and reflects its position as a potential information 
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broker in the network. It is formally defined as: -$ = ∑ 012,3($)0012,30
*
6,7+,|$9697  , 
with 0:6,70 the number of shortest paths between nodes m and n.22 The node 
participation coefficient was calculated after first assigning each node to a 
community using the Louvain community detection algorithm.17 A participation 
coefficient of zero means that all the edges of a node are restricted to its own 
community, indicating a rather local role, whereas a value approaching 1 means that 
its edges are evenly distributed among all the communities of the graph – indicating 
that the node plays a role in integrating different clusters of the graph. The 











with E the degree of a node restricted to community C.  
 
At each MRI threshold, every node was ranked on each of these metrics, and the 
mean rank of each node across MRI thresholds was then calculated. We then set a 
rank threshold, and for each metric selected only the nodes ranking above it. If any 
node ranked above this threshold for all three metrics it was termed a combination 
hub (main text Figure 2B steps A-C), highlighting its importance as an all-round 
information processing node. By next lowering the rank threshold we gradually 
increased the number of nodes meeting combination hub criteria, and so defined sets 
of combination hubs comprising between 10 and 40% of the total number of nodes. 
In some cases it is possible a specific hub threshold might have no eligible nodes (e.g. 
in the main paper figure 4B – the 18F-DOPA salience network does not have 
combination until the threshold reaches 15%). 
 
Identifying Overlap Between Dopamine Associated Nodes and Network Hubs  
After identifying nodes within the default mode and salience networks that showed 
an association with measures of limbic dopamine function, we sought to identify 
whether these dopamine associated nodes tended to overlap with nodes classified as 




The overlap of dopamine associated nodes and combination hubs was quantified 
using the Dice Similarity Coefficient:25,26 
 
 
A is the set of nodes in the dopamine associated subnetwork and B is the set of 
combination hub nodes. The Dice Coefficient was calculated for each of the 100 NBS 
thresholds (t=1.3-3.1) and then averaged to give a single ‘true’ score ( main 
textFigure 2B part D). We then randomly selected an assortment of nodes, equal in 
number to the number of nodes present in the most leniently thresholded original 
network-based statistic subnetwork (main text Figure 2B part E). Next, we randomly 
deleted a node from this original assortment whenever the number of nodes in the 
‘true’ subnetwork dropped as NBS threshold stringency increased (main text Figure 
2B part F). This gave us 100 thresholds for this randomly generated subnetwork, 
and for each we calculated the Dice Coefficient with the same combination hubs, 
and then calculated a single mean ‘random’ Dice Coefficient as before. We repeated 
this procedure 10,000 times yielding 10,000 random Dice Coefficients ( main text 
Figure 2B parts G-H), which allowed us to test the significance of the true Dice 
Coefficient ( main text Figure 2B part I). This procedure was then repeated for each 
of the combination hub thresholds (10-40%), thereby giving a p-value for each hub 
threshold. 
 
At some more lenient network-based statistic thresholds the network-based statistic 
defined dopamine associated networks contained all nodes of the SAL/DMN 
networks. In these cases, all nodes will overlap with the hub nodes, and so it is not 
valid to test if overlap is statistically significant. In these cases, we increased NBS 




We finally examined overlap between the dopamine associated nodes identified in 
Experiment 1 and those identified in Experiment 2. In this case we only compared 
overlap at NBS thresholds where both experiments showed the same number of 
dopamine associated nodes. We calculated the dice coefficient between the two 
networks, and compare it to a null distribution generated as before. 
 
Software 
Statistical analysis was undertaken in Matlab 2016b and R 3.3.2 
Diagrams were constructed in R using ggplot2 (2.2.1) and plotly (4.7.1). 
Ball and stick networks diagrams (figure 4A) were constructed using BrainNet 
viewer.27  
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7. Conclusions and future work  
 
 
Summary of findings 
 
The work presented in this thesis examined striatal function in individuals with 
psychotic disorders, individuals exposed to risk factors for psychotic disorders, and 
healthy controls. 
 
The main findings are firstly that dopamine dysfunction in psychosis does not 
occur uniformly across the striatum but shows significant spatial variability. 
Furthermore, this variability shows a relationship with the severity of certain 
psychotic symptoms, dependent on corticostriatal connectivity patterns. I also 
showed that exposure to environmental risk factors for psychosis led to changes in 
corticostriatal connectivity, and that these changes were linked to changes in 
salience processing. Finally, I showed that in healthy controls, striatal dopamine 
function and salience network connectivity are linked. 
 
Specific findings are as follows: 
 
• Chapter 3: I aimed to synthesise the results of all PET studies that have 
measured striatal presynaptic dopamine function in schizophrenia, and thereby 
determine where within the striatum dopaminergic dysfunction is greatest. 
i. Hypothesis: Presynaptic dopamine function will be greater in individuals with 
schizophrenia compared to healthy controls. 
 
Results: Presynaptic dopamine function was significantly elevated in 





ii. Hypothesis: This presynaptic hyperdopaminergia will not occur uniformly 
across the striatum but will be greater in certain subdivisions compared to 
others. 
 
Results: Significant differences were found between patients and controls for 
associative (schizophrenia – g=0.73, p = 0.002) and sensorimotor 
(schizophrenia – g = 0.54, p=0.009) subdivisions, but not for the limbic 
subdivision (schizophrenia – g=0.29, p=0.09). In individuals with 
schizophrenia, the difference between associative and limbic subdivisions was 
significantly greater in patients compared to controls (g=0.38, P=0.004). 
 
• Chapter 4: I used PET to measure dopamine synthesis capacity in individuals 
with schizophrenia, and resting state fMRI to parcellate the striatum of these 
individuals on the basis of corticostriatal connectivity patterns. On the basis of 
this, to then investigate whether dopamine dysfunction within specific striatal 
regions is linked to the specific symptoms one would predict on the basis of the 
connected cortical area. 
i. Hypothesis: Specific symptoms will be associated with dopamine dysfunction 
in specific striatal subregions that show preferential connectivity with 
functionally-relevant cortical regions. I focused on auditory hallucinations and 
motor symptoms because these are symptoms that have a priori links to well 
circumscribed (auditory and motor) cortical areas. Specifically, I predicted 
that both baseline severity and change (following antipsychotic treatment) in 
severity of hallucinations and of motor symptoms, would correlate with 
dopamine synthesis capacity in striatal regions preferentially connected to 
auditory and motor cortex, respectively.  
Results: I found that the relationship between dopamine function and 
symptoms varied according to the striatal region examined. Specifically, 
dopamine function in striatal regions linked to sensorimotor cortex was 
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associated with both the severity of motor retardation pre-treatment, and the 
change in motor retardation following treatment with a dopamine antagonist. 
There was no clear association, however, between hallucination severity and 
dopamine function within striatal regions linked to the auditory cortex. 
 
ii. I also undertook an exploratory analysis investigating whether appeared 
notable relationships between dopamine dysfunction appeared in other cortical 
connectivity defined striatal subregions and other symptom clusters. 
Results: Dopamine function within the striatal regions linked to the default 
mode network, and cingulopercular network were associated with 
negative/cognitive and affective symptoms respectively. 
 
iii. Finally, I compared our connectivity defined striatal parcellation with 
published atlas-defined subdivisions, in order to examine whether a 
individualised data-driven connectivity-based method is able to provide 
additional information over an atlas-based approach. 
Results: I demonstrated significantly greater orthogonality in our 
individualised connectivity-based approach, which allowed, for the first time 
to my knowledge, specific subregion-symptom relationship to be investigated. 
 
• Chapter 5: To investigate the cognitive and neurobiological correlates of exposure 
to chronic psychosocial stressors that are established environmental risk factors 
for psychosis. To do this I employed resting state MRI and a behavioural task 
(the salience attribution task) to test the following hypotheses. 
i. Hypothesis: Individuals with a history of high exposure to chronic 
psychosocial stressors will display increased aberrant, and reduced adaptive, 
salience scores compared to individuals with a history of low exposure. 
Results: In the current study, I demonstrated reduced adaptive salience in 
individuals that had been exposed to chronic psychosocial stressors. I also 
found increased scores on the aberrant salience inventory in the exposed 
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group, but contrary to our initial hypotheses did not detect any between 
group differences on the aberrant or implicit measures of the SAT. 
 
ii. Hypothesis: Individuals with a history of high exposure to chronic 
psychosocial stressors will display altered corticostriatal functional 
connectivity compared to individuals with a history of low exposure. 
Results: The exposed group displayed increased functional connectivity 
between the ventral striatum and several cortical regions. A number of these 
clusters overlapped with cortical areas that make up the cingulo-opercular  
or salience network. 
 
iii. Hypothesis: Alteration in corticostriatal connectivity will be related to 
alterations in salience processing. 
Results: Reduced adaptive salience score were related to increased 
connectivity between striatal seeds and cortical regions involved in salience 
processing. 
 
• Chapter 6: To examine the relationship between two key salience processing 
systems: the cortical salience network and the mesolimbic dopamine system. We 
used resting state fMRI to characterise the salience network in two separate 
cohorts – one that had received an 18F-DOPA PET scan (to measure dopamine 
synthesis capacity), and the other that had received an 11C-PHNO scan before 
and after amphetamine administration (to measure dopamine release capacity).  
i.   Hypothesis: My primary hypothesis was that individuals with greater striatal 
dopamine synthesis and release capacity would show greater connectivity 
within the salience network, and, because of the reciprocal relationship 
between salience and default mode networks, weaker connectivity within the 
default mode network. 
Results: I demonstrated that stronger connectivity within the salience 
network was directly associated with limbic dopamine synthesis capacity, 
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and contrary to our initial hypothesis was inversely associated with limbic 
dopamine release capacity. I also identified default-mode subnetworks in 
which edge strength was inversely correlated with synthesis capacity. 
 
ii.  Hypothesis: I hypothesized that there would not be a uniform association 
between dopamine function and connectivity but that hub nodes would show 
the strongest association with dopamine. 
Results: Significant overlap existed between nodes in salience subnetworks 
associated with dopamine synthesis capacity, and nodes separately identified 
as information processing hubs. 
 
In summary, I demonstrated in Chapter 3 how dopamine dysfunction is most 
pronounced in the dorsal as opposed to limbic striatum, suggesting that the 
mesolimbic hypothesis of schizophrenia is unlikely to be accurate. This was built 
upon in chapter 4 to show that different symptoms vary in their association with 
dopamine function across the striatum, depending on the functional connections 
between striatal and cortical regions. While, I have at times highlighted the role of 
the dorsal striatum, it is however likely that the limbic striatum still plays an 
important role in the pathophysiology of schizophrenia. It was the limbic striatum 
that showed changes in connectivity related to environmental exposures and 
salience processing measures in chapter 5. It was also dopamine function within the 
limbic striatum that showed a strong relationship with salience network 





Specific limitations have been covered in each chapter. Below I discuss a more 





A frequent aim of science is to reveal causal structures, and neuroscience is no 
exception. Although correlational data has value in and of itself, for example in 
classification tasks, in neuroimaging experiments we frequently wish to understand 
information processing pathways within the brain, and the influence that various 
brain regions have upon one another.   
 
The inferences we are able to draw in standard functional connectivity 
experiments, however, are limited, due to the potential confounding inherent in the 
vast number of unobserved variables potentially underlying the observed data. The 
recorded signals are a tiny fraction of the true causal variables. It is because of this 
high ratio of the unobserved:observed that methods aimed at imputing effective 
connectivity cannot return causal information1,2. There is a potential solution, 
however, to this quagmire of unlimited confounding. Paradigms involving a 
perturbation of the system, allow one to step beyond solely correlational 
experiments. Pharmacological challenges, and noninvasive brain stimulation 
techniques are examples that may be employed in humans, while preclinical 





The results of the current work present a number of potential avenues for further 
investigation. 
 
Spatially specific modulation of striatal dopamine function 
In Chapter 3 I found that striatal hyperdopaminergia in schizophrenia appears to 
primarily be located within the dorsal striatum. This raises the possibility that 
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targeting dorsal striatal dopaminergic neurotransmission specifically, may have 
benefits in terms of efficacy and side effect burden.  
 
An initial step is to determine whether this is possible. Preclinical studies have 
demonstrated that M4 positive allosteric modulators act on striatal medium spiny 
neurons to specifically inhibit dorsal striatum dopamine3,4. A PET study using a 
D2/3 receptor ligand such as 11C-PHNO in combination with an amphetamine 
challenge could test whether these compounds are able to specifically inhibit dorsal 
striatal dopamine release in humans. 
 
Dopamine and symptoms in psychosis 
In Chapter 4 I used an fMRI informed parcellation of the striatum to investigate 
the relationship between striatal dopamine function and symptoms in individuals 
with a first episode psychosis. It would be interesting to compare this approach 
with a striatal parcellation based on white matter pathways as quantified using 
diffusion weighted imaging. 
 
It would also be of interest to have a more in-depth phenotypic assessment of 
patients, for example including tasks and behavioural modelling in order to allow 
for a more precise quantification of symptom-dopamine function relationships. 
 
Studies of environmental risk factors 
In Chapter 5 I examined the effect of multiple environmental factors upon resting 
state functional connectivity. As discussed, this approach is in contrast to the 
majority of studies which have tended to focus upon single risk factors. The sample 
size and distribution of risk factors did not allow for the detection of interaction 
effects. Determining whether risk factors interact in an additive or synergistic 
manner is of considerable interest but can be properly investigated only with 
samples sizes that are orders of magnitude greater than those reported in most 
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neuroimaging studies. In recent years, the availability of publicly available large-
scale datasets such as the UK biobank which in includes neuroimaging measures in 
addition to genetic, and environmental information allows for testing of these 
hypothesis with adequate power 5. 
 
 
Neurochemically informed models of brain networks 
In chapter 6 I investigated associations between PET measures of dopamine 
function and the architecture of resting state brain networks. My findings, 
however, solely related to between individual correlations and do not allow 
comment on within individual relationships between dopamine and functional brain 
networks. The use of acute dopaminergic challenges during simultaneous PET-MRI 
would allow for the study of intra-individual effects of dopaminergic release upon 
network strength and organisation. Furthermore, although generative models of 
resting state functional connectivity allow one to impute underlying neuronal 
parameters that could potentially give rise to observed functional connectivity 
patterns,6,7 as discussed above, true causal inferences are not possible given the 
potential for unobserved confounding. The integration of resting state data with 
simultaneously obtained measures of neurochemical perturbation has, however, the 
potential to provide information that addresses these issues. 
 
Other areas for further work include studies in clinical populations, such as 
individuals with schizophrenia, where measures of both dopaminergic and network 
function may show wider ranges, and the inclusion of behavioural tasks would help 
further determine the relevance of these findings to pathophysiology and 
psychopathology. Investigating the relationship between brain networks and other 
measures of neurochemical function (e.g. 1H-MRS to measure glutamate 




I investigated static connectivity where for each individual the entire run is 
condensed into a single functional connectivity matrix. There have been recent 
advances studying time varying functional connectivity in order to take account of 
the fact that brain states within individuals are not static but show frequent 
transitions8. It would be of significant interest to see the relationship between 




In the current thesis I have shown that dopamine dysfunction in schizophrenia is 
greatest in the associative striatum, refuting the mesolimbic hypothesis. I have 
then highlighted the clinical relevance of this by demonstrating how spatial 
variability in dopamine function may shape psychotic symptoms. I next 
investigated the potential role of the striatum in the pathogenesis of psychosis by 
examining how environmental risk factors are associated with altered striatal 
connectivity and changes in salience processing. Finally, I have shown how striatal 
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Appendix B: Additional Analyses 
 
Following the suggestion of the PhD examiners the following analysis was 
performed on the data presented in chapter 3. 
 
To determine whether patient-control effect sizes differ between subdivisions a 
multivariate meta analytic approach is required given the lack of independence 
between subdivision effect sizes. We used an unstructured variance-covariance 
matrix, and employed the R packages metafor and clubSandwich.  
 
As in earlier analyses, because within-study correlations between outcomes are not 
reported in all studies, we employed a correlation coefficient of 0.72 based on the 
lower limit of between-subdivision correlations observed in a set of individual 
participant data. Another suggested approach is to estimate this coefficient based 
on the correlation between the available effect estimates in the studies that provide 
data on both outcomes, and we also used this approach [4]. 
 
We found that both the associative (z=2.4, p=0.016) and sensorimotor (z=2.1, 
p=0.034) striatum showed greater patient-control differences in measures of 
dopamine function compared to the limbic striatum. The comparison between 
associative and sensorimotor striatum was not significant (z=1.7, p=0.10) using the 
original correlation coefficient. However, when using either the coefficient for 
associative-sensorimotor correlations in individual patient data (r=0.87), or that 
derived from across study correlation (r=0.97), the difference was statistically 
significant (z = 2.2, p=0.03; z=2.6, p=0.01 respectively). 
 
This complements our published analysis by showing that the magnitude of 
patient-control differences differs between subdivisions. 
 
 
